P703 | found in taxon | Homo sapiens | Q15978631 |
Q84097994 | "Ether-à-go-go" proliferation of iPSC-derived mesenchymal stem cells. Focus on "Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-à-go-go 1 (hEAG1) potassium channel" |
Q34360907 | "Footprint-free" human induced pluripotent stem cell-derived astrocytes for in vivo cell-based therapy. |
Q92190113 | "Thorough QT/QTc in a Dish": Can Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Predict Thorough QT Outcomes? |
Q91796595 | 2-Cl-C.OXT-A stimulates contraction through the suppression of phosphodiesterase activity in human induced pluripotent stem cell-derived cardiac organoids |
Q55190076 | 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling. |
Q38709608 | 2‑Deoxy‑D‑glucose initiates hepatocyte differentiation in human induced pluripotent stem cells |
Q48092864 | 3D Bioprinting Human Induced Pluripotent Stem Cell Constructs for In Situ Cell Proliferation and Successive Multilineage Differentiation. |
Q33730154 | 3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells |
Q58036527 | 3D Micropillars Guide the Mechanobiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q104753721 | 3D Printing of Neural Tissues Derived from Human Induced Pluripotent Stem Cells Using a Fibrin-Based Bioink |
Q90438842 | 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro |
Q89307104 | 3D printing human induced pluripotent stem cells with novel hydroxypropyl chitin bioink: scalable expansion and uniform aggregation |
Q60618583 | 437. Modeling Schizophrenia in Human Induced Pluripotent Stem Cells (hiPSCs): Phenotypic Differences in Patients with Mutations in NDE1 |
Q90287470 | 5-Fluorouracil inhibits neural differentiation via Mfn1/2 reduction in human induced pluripotent stem cells |
Q91714275 | A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes |
Q55325868 | A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection. |
Q36293290 | A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell-Based Models for Cardiovascular Diseases |
Q57074707 | A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes |
Q58566500 | A Human Gonadal Cell Model From Induced Pluripotent Stem Cells |
Q40233317 | A Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte (hiPSC-CM) Multielectrode Array Assay for Preclinical Cardiac Electrophysiology Safety Screening |
Q102051030 | A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities |
Q64102960 | A Human Induced Pluripotent Stem Cell-Derived Tissue Model of a Cerebral Tract Connecting Two Cortical Regions |
Q90394655 | A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15 |
Q41934843 | A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G>A mutation, ISMMSi002-B, for disease modeling |
Q45162471 | A Micropatterned Human Pluripotent Stem Cell-Based Ventricular Cardiac Anisotropic Sheet for Visualizing Drug-Induced Arrhythmogenicity |
Q29619964 | A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells |
Q60721874 | A New Feeder-Free Technique to Expand Human Embryonic Stem Cells and Induced Pluripotent Stem Cells |
Q30824665 | A Novel Protocol for Directed Differentiation of C9orf72-Associated Human Induced Pluripotent Stem Cells Into Contractile Skeletal Myotubes |
Q50767299 | A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming. |
Q38895292 | A Paracrine Mechanism Accelerating Expansion of Human Induced Pluripotent Stem Cell-Derived Hepatic Progenitor-Like Cells |
Q92261443 | A Protocol for One-Step Differentiation of Human Induced Pluripotent Stem Cells into Mature Podocytes |
Q57135453 | A Rapid and Highly Efficient Method for the Isolation, Purification, and Passaging of Human-Induced Pluripotent Stem Cells |
Q49168576 | A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids. |
Q39226698 | A Review of Research-Grade Human Induced Pluripotent Stem Cells Qualification and Biobanking Processes |
Q104286454 | A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells |
Q88673721 | A Simple Multistep Protocol for Differentiating Human Induced Pluripotent Stem Cells into Functional Macrophages |
Q41600655 | A Simple and Efficient Method of Slow Freezing for Human Embryonic Stem Cells and Induced Pluripotent Stem Cells |
Q47448557 | A Simple and Robust Method for Culturing Human-Induced Pluripotent Stem Cells in an Undifferentiated State Using Botulinum Hemagglutinin |
Q48261139 | A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells. |
Q89627766 | A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential |
Q95829047 | A Temperature-Controlled Patch Clamp Platform Demonstrated on Jurkat T Lymphocytes and Human Induced Pluripotent Stem Cell-Derived Neurons |
Q93161618 | A Toolbox to Characterize Human Induced Pluripotent Stem Cell-Derived Kidney Cell Types and Organoids |
Q96648876 | A circular RNA map for human induced pluripotent stem cells of foetal origin |
Q42953242 | A comparative study of osteogenic differentiation human induced pluripotent stem cells and adipose tissue derived mesenchymal stem cells |
Q36283545 | A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease. |
Q28543975 | A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells |
Q35726346 | A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture |
Q36329502 | A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells |
Q33564271 | A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells |
Q35200170 | A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach |
Q89104784 | A feasibility study of the toxic responses of human induced pluripotent stem cell-derived hepatocytes to phytochemicals |
Q38708222 | A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A. |
Q35588556 | A functionally characterized test set of human induced pluripotent stem cells |
Q102059951 | A heterozygous SCN1A (c.A5768G/+) mutant human induced pluripotent stem cell line (USTCi002-A) generated using TALEN-mediated precise gene editing |
Q36637076 | A high-content platform to characterise human induced pluripotent stem cell lines |
Q34825742 | A high-efficiency system for the generation and study of human induced pluripotent stem cells |
Q36165855 | A highly efficient method for generation of therapeutic quality human pluripotent stem cells by using naive induced pluripotent stem cells nucleus for nuclear transfer |
Q36849503 | A human Dravet syndrome model from patient induced pluripotent stem cells |
Q38791196 | A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity |
Q34347694 | A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. |
Q91545653 | A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene |
Q38659899 | A human induced pluripotent stem cell-based in vitro assay predicts developmental toxicity through a retinoic acid receptor-mediated pathway for a series of related retinoid analogues |
Q96110139 | A human induced pluripotent stem cell-derived cortical neuron human-on-a chip system to study Aβ42 and tau-induced pathophysiological effects on long-term potentiation |
Q101051186 | A method for differentiating human induced pluripotent stem cells toward functional cardiomyocytes in 96-well microplates |
Q39226635 | A method for efficiently generating neurospheres from human-induced pluripotent stem cells using microsphere arrays |
Q39478225 | A microRNA-based system for selecting and maintaining the pluripotent state in human induced pluripotent stem cells |
Q38722673 | A molecular roadmap of definitive erythropoiesis from human induced pluripotent stem cells |
Q37139621 | A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation |
Q34439974 | A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes |
Q58697388 | A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis |
Q100388880 | A novel GNAS-mutated human induced pluripotent stem cell model for understanding GNAS-mutated tumors |
Q39244112 | A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures. |
Q41857309 | A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells |
Q37211218 | A novel feeder-free culture system for human pluripotent stem cell culture and induced pluripotent stem cell derivation |
Q47830673 | A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis. |
Q38880823 | A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation |
Q37286523 | A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells |
Q39406831 | A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation |
Q90834944 | A novel screening test to predict the developmental toxicity of drugs using human induced pluripotent stem cells |
Q92345266 | A novel tool for suspension culture of human induced pluripotent stem cells: Lysophospholipids as a cell aggregation regulator |
Q41926934 | A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells |
Q42267058 | A preliminary analysis of volatile metabolites of human induced pluripotent stem cells along the in vitro differentiation |
Q64084510 | A proteomic time course through the differentiation of human induced pluripotent stem cells into hepatocyte-like cells |
Q90094588 | A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) |
Q35105698 | A rare human syndrome provides genetic evidence that WNT signaling is required for reprogramming of fibroblasts to induced pluripotent stem cells |
Q30884171 | A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells |
Q36765305 | A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host |
Q60637050 | A scale out approach towards neural induction of human induced pluripotent stem cells for neurodevelopmental toxicity studies |
Q39963155 | A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells. |
Q96577393 | A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells |
Q50443487 | A simplified protocol for differentiation of electrophysiologically mature neuronal networks from human induced pluripotent stem cells. |
Q47766729 | A synthetic DNA-binding inhibitor of SOX2 guides human induced pluripotent stem cells to differentiate into mesoderm. |
Q37299126 | A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells. |
Q34506099 | A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells |
Q33961690 | A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. |
Q35214817 | A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs). |
Q27349038 | A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability |
Q50091811 | A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells |
Q89578114 | AAV-Mediated Gene Delivery to 3D Retinal Organoids Derived from Human Induced Pluripotent Stem Cells |
Q54659770 | ADAR1 is involved in the regulation of reprogramming human fibroblasts to induced pluripotent stem cells. |
Q50518321 | ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy. |
Q100382073 | AMPA RECEPTOR CONTRIBUTION TO METHYLMERCURY-MEDIATED ALTERATION OF INTRACELLULAR Ca2+ CONCENTRATION IN HUMAN INDUCED PLURIPOTENT STEM CELL MOTOR NEURONS |
Q42290507 | ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion |
Q33560284 | Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. |
Q39427747 | Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia |
Q48456378 | Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2. |
Q92235480 | Acid-Sensitive Ion Channels Are Expressed in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q58718042 | Aconitine-induced cardiac arrhythmia in human induced pluripotent stem cell-derived cardiomyocytes |
Q47795240 | Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology |
Q34862866 | Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density |
Q46115062 | Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells |
Q104068538 | Activation of Wnt/β-catenin signaling and HIF1α Stabilization Alters Pluripotency and Differentiation/Proliferation Properties of Human Induced Pluripotent Stem Cells |
Q51748407 | Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes. |
Q45796627 | Activin A is essential for Feeder-free culture of human induced pluripotent stem cells |
Q34414522 | Activin A maintains pluripotency markers and proliferative potential of human induced pluripotent stem cells |
Q43062745 | Activity-Dependent Changes in Gene Expression in Schizophrenia Human-Induced Pluripotent Stem Cell Neurons |
Q34019032 | Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells |
Q39665198 | Adenovirus vector-mediated efficient transduction into human embryonic and induced pluripotent stem cells |
Q54964081 | Adherent vs. Free-Floating Neural Induction by Dual SMAD Inhibition for Neurosphere Cultures Derived from Human Induced Pluripotent Stem Cells. |
Q51793352 | Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. |
Q89259986 | Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology |
Q57288032 | Advances and Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cells in Modeling Neurodegenerative Disease |
Q92360006 | Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing |
Q101123859 | Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions |
Q52722649 | Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues. |
Q44081221 | Albumin gene targeting in human embryonic stem cells and induced pluripotent stem cells with helper-dependent adenoviral vector to monitor hepatic differentiation |
Q98386079 | Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells |
Q91211288 | Alpha7 nicotinic acetylcholine receptors and neural network synaptic transmission in human induced pluripotent stem cell-derived neurons |
Q64088724 | Alteration of Genomic Imprinting Status of Human Parthenogenetic Induced Pluripotent Stem Cells during Neural Lineage Differentiation |
Q104061582 | Alterations of Glycosphingolipid Glycans and Chondrogenic Markers during Differentiation of Human Induced Pluripotent Stem Cells into Chondrocytes |
Q35904650 | Altered WNT Signaling in Human Induced Pluripotent Stem Cell Neural Progenitor Cells Derived from Four Schizophrenia Patients |
Q34038613 | Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor |
Q38073545 | Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells |
Q36200473 | Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes |
Q41327539 | An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells |
Q34044130 | An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells |
Q37563507 | An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells |
Q38909474 | An Optimal Medium Supplementation Regimen for Initiation of Hepatocyte Differentiation in Human Induced Pluripotent Stem Cells |
Q38913129 | An atypical human induced pluripotent stem cell line with a complex, stable, and balanced genomic rearrangement including a large de novo 1q uniparental disomy. |
Q91012095 | An effective detachment system for human induced pluripotent stem cells cultured on multilayered cultivation substrates using resonance vibrations |
Q33787107 | An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells |
Q39043857 | An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity |
Q34314350 | An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells |
Q101212726 | An epilepsy-associated ACTL6B variant captures neuronal hyperexcitability in a human induced pluripotent stem cell model |
Q38940259 | An extracellular matrix culture system for induced pluripotent stem cells derived from human dental pulp cells |
Q82364629 | An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cells |
Q43208271 | An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells |
Q83903746 | An improved method for generating and identifying human induced pluripotent stem cells |
Q34637386 | An in vitro model of human neocortical development using pluripotent stem cells: cocaine-induced cytoarchitectural alterations |
Q94948559 | An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cells |
Q50912648 | An inner nuclear membrane protein induces rapid differentiation of human induced pluripotent stem cells. |
Q38390349 | An integrated platform for simultaneous multi-well field potential recording and Fura-2-based calcium transient ratiometry in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes |
Q42804873 | An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells. |
Q92457828 | An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons |
Q39356795 | An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background |
Q37521095 | An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca²⁺ rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria. |
Q38841460 | Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. |
Q89791195 | Analysis of Circulating Waves in Tissue Rings derived from Human Induced Pluripotent Stem Cells |
Q94449826 | Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays |
Q104130419 | Analysis of Tembusu virus infection of human cell lines and human induced pluripotent stem cell derived hepatocytes |
Q35893663 | Analysis of embryoid bodies derived from human induced pluripotent stem cells as a means to assess pluripotency |
Q35357741 | Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative |
Q33700366 | Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate? |
Q47654465 | Analysis of mitochondrial function in human induced pluripotent stem cells from patients with mitochondrial diabetes due to the A3243G mutation |
Q90003790 | Analysis of multi-lineage gene expression dynamics during primordial germ cell induction from human induced pluripotent stem cells |
Q93195805 | Analysis of the mechanism underlying liver diseases using human induced pluripotent stem cells |
Q89853363 | Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia |
Q35202814 | Aneuploidy is permissive for hepatocyte-like cell differentiation from human induced pluripotent stem cells |
Q50947816 | Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human |
Q37678032 | Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q37564286 | Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells. |
Q33975595 | Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model |
Q97593194 | Apolipoprotein E expression pattern in human induced pluripotent stem cells during in vitro neural induction |
Q91963530 | Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells |
Q40062343 | Apoptosis and failure of checkpoint kinase 1 activation in human induced pluripotent stem cells under replication stress. |
Q96952061 | Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease |
Q57283462 | Application of Human Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders |
Q90996070 | Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts |
Q91088457 | Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine |
Q89859199 | Application of a human mesoderm tissue elongation system in vitro derived from human induced pluripotent stem cells to risk assessment for teratogenic chemicals |
Q91045729 | Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers |
Q38210765 | Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases |
Q39439904 | Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva |
Q48567516 | Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias |
Q85690361 | Applications of human-induced pluripotent stem cells in the investigation of inherited cardiomyopathy |
Q38241312 | Applications of induced pluripotent stem cells in the modeling of human inflammatory bowel diseases |
Q67529447 | Approach for Profiling of Glycosphingolipid Glycosylation by Multiplexed Capillary Gel Electrophoresis Coupled to Laser-Induced Fluorescence Detection To Identify Cell-Surface Markers of Human Pluripotent Stem Cells and Derived Cardiomyocytes |
Q92981513 | Approach for differentiating trophoblast cell lineage from human induced pluripotent stem cells with retinoic acid in the absence of bone morphogenetic protein 4 |
Q104479482 | Arrhythmia mechanisms in human induced pluripotent stem cell-derived cardiomyocytes |
Q58618376 | Arrhythmogenicity Test Based on a Human Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocyte Layer |
Q64387349 | Arsenic trioxide blocked proliferation and cardiomyocyte differentiation of human induced pluripotent stem cells: Implication in cardiac developmental toxicity |
Q39855073 | Arterial specification of endothelial cells derived from human induced pluripotent stem cells in a biomimetic flow bioreactor |
Q58555461 | Assessing the ability of human endothelial cells derived from induced pluripotent stem cells to form functional microvasculature in vivo |
Q99353013 | Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array |
Q38812804 | Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes. |
Q35008383 | Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity |
Q41652755 | Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes |
Q39396502 | Assessment of extracellular field potential and Ca2+ transient signals for early QT/pro-arrhythmia detection using human induced pluripotent stem cell-derived cardiomyocytes |
Q92807451 | Assessment of hypertrophic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes reveals abnormal excitation contraction coupling |
Q90258426 | Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms |
Q37692680 | Astroglial cells regulate the developmental timeline of human neurons differentiated from induced pluripotent stem cells |
Q89180457 | Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells |
Q60300806 | Author Correction: Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells |
Q46670919 | Autologous human cardiac stem cells transplantation for the treatment of ischaemic cardiomyopathy: first study of human-induced pluripotent stem (iPS) cell-derived cardiomyocytes transplantation. |
Q92203227 | Automated Dynamic Clamp for Simulation of IK1 in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Real Time Using Patchliner Dynamite8 |
Q98649127 | Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring |
Q39109857 | Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales |
Q36356060 | Automated and manual patch clamp data of human induced pluripotent stem cell-derived dopaminergic neurons |
Q39264623 | Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell-derived neuroepithelial-like stem cells. |
Q104132274 | Automating Human Induced Pluripotent Stem Cell Culture and Differentiation of iPSC-Derived Retinal Pigment Epithelium for Personalized Drug Testing |
Q37399492 | Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells |
Q42705957 | Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation |
Q51851772 | Avian-induced pluripotent stem cells derived using human reprogramming factors. |
Q97537766 | BEaTS-α an open access 3D printed device for in vitro electromechanical stimulation of human induced pluripotent stem cells |
Q47872003 | BMP/SMAD pathway promotes neurogenesis of midbrain dopaminergic neurons in vivo and in human induced pluripotent and neural stem cells |
Q46906155 | BMP10 as a potent inducer of trophoblast differentiation in human embryonic and induced pluripotent stem cells |
Q36595637 | BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages |
Q34037858 | Back to the future: how human induced pluripotent stem cells will transform regenerative medicine |
Q37236805 | Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells. |
Q39086542 | Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells? |
Q88641951 | Basal glucocorticoid receptor activation induces proliferation and inhibits neuronal differentiation of human induced pluripotent stem cell-derived neuronal precursor cells |
Q90352360 | Base-Resolution Methylome of Retinal Pigment Epithelial Cells Used in the First Trial of Human Induced Pluripotent Stem Cell-Based Autologous Transplantation |
Q38685965 | Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors. |
Q39251971 | Behaviour of human induced pluripotent stem cell-derived neural progenitors on collagen scaffolds varied in freezing temperature and laminin concentration |
Q39122632 | Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair |
Q57469275 | Bezafibrate Upregulates Mitochondrial Biogenesis and Influence Neural Differentiation of Human-Induced Pluripotent Stem Cells |
Q36597551 | Bilayered vascular graft derived from human induced pluripotent stem cells with biomimetic structure and function |
Q57792732 | Biliary Atresia Relevant Human Induced Pluripotent Stem Cells Recapitulate Key Disease Features in a Dish. |
Q50152556 | Billion-scale production of hepatocyte-like cells from human induced pluripotent stem cells |
Q37408336 | Binary colloidal crystals (BCCs) as a feeder-free system to generate human induced pluripotent stem cells (hiPSCs). |
Q92457761 | Bio-engineering a tissue flap utilizing a porous scaffold incorporating a human induced pluripotent stem cell-derived endothelial cell capillary network connected to a vascular pedicle |
Q42265138 | Bioengineering of functional human induced pluripotent stem cell-derived intestinal grafts. |
Q41623522 | Bioinformatics method identifies potential biomarkers of dilated cardiomyopathy in a human induced pluripotent stem cell-derived cardiomyocyte model |
Q51402656 | Biomarker Discovery by Modeling Behçet's Disease with Patient-Specific Human Induced Pluripotent Stem Cells. |
Q33870611 | Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes |
Q37846211 | Biomaterials for the feeder-free culture of human embryonic stem cells and induced pluripotent stem cells |
Q51165887 | Biomimetic Cardiac Tissue Model Enables the Adaption of Human Induced Pluripotent Stem Cell Cardiomyocytes to Physiological Hemodynamic Loads. |
Q50058052 | Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes |
Q52618857 | Biophysical study of human induced Pluripotent Stem Cell-Derived cardiomyocyte structural maturation during long-term culture. |
Q90615728 | Bioprinting 3D Human Induced Pluripotent Stem Cell Constructs for Multilineage Tissue Engineering and Modeling |
Q91421706 | Bladder smooth muscle cell differentiation of the human induced pluripotent stem cells on electrospun Poly(lactide-co-glycolide) nanofibrous structure |
Q95287397 | Blinded, multi-centre evaluation of drug-induced changes in contractility using human induced pluripotent stem cell-derived cardiomyocytes |
Q36336661 | Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium. |
Q47218845 | Botulinum hemagglutinin-mediated in situ break-up of human induced pluripotent stem cell aggregates for high-density suspension culture. |
Q40486827 | Brief Report: Inhibition of miR-145 Enhances Reprogramming of Human Dermal Fibroblasts to Induced Pluripotent Stem Cells. |
Q34354862 | Brief report: a human induced pluripotent stem cell model of cernunnos deficiency reveals an important role for XLF in the survival of the primitive hematopoietic progenitors |
Q38994975 | Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells |
Q37220380 | Brown-like adipose progenitors derived from human induced pluripotent stem cells: Identification of critical pathways governing their adipogenic capacity |
Q107617312 | Brüstle v. Greenpeace |
Q34463138 | Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. |
Q35777502 | Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke |
Q98469617 | CAGE-seq analysis of osteoblast derived from cleidocranial dysplasia human induced pluripotent stem cells |
Q33794759 | CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes |
Q41919795 | CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle |
Q92908866 | CD140b and CD73 are markers for human induced pluripotent stem cell-derived erythropoietin-producing cells |
Q38787812 | CD30 Receptor-Targeted Lentiviral Vectors for Human Induced Pluripotent Stem Cell-Specific Gene Modification. |
Q46611428 | CORRIGENDUM: CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes. |
Q52430638 | CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells. |
Q38978116 | CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes |
Q64091028 | CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells |
Q39347915 | Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions. |
Q39150543 | Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. |
Q33869568 | Calcium handling in human induced pluripotent stem cell derived cardiomyocytes |
Q35580463 | Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes |
Q99547311 | Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs): Comparison of RyR2-R420Q, F2483I and Q4201R |
Q40581656 | Cancer Immunotherapy Using Human Induced Pluripotent Stem Cell-Derived Dendritic Cells(iPSDCs)Expressing Carcinoembryonic Antigen |
Q49604712 | Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it? |
Q59837377 | Canine Fibroblasts Expressing Human Transcription Factors: What is in the Route for the Production of Canine Induced Pluripotent Stem Cells |
Q101234895 | Capacity of Retinal Ganglion Cells Derived from Human Induced Pluripotent Stem Cells to Suppress T-Cells |
Q52683407 | Cardiac Progenitors Induced from Human Induced Pluripotent Stem Cells with Cardiogenic Small Molecule Effectively Regenerate Infarcted Hearts and Attenuate Fibrosis. |
Q38927700 | Cardiac differentiation potential of human induced pluripotent stem cells in a 3D self-assembling peptide scaffold |
Q38393181 | Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes |
Q97586700 | Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes |
Q27303668 | Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells |
Q51110763 | Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. |
Q37959029 | Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models |
Q39794134 | Cardiomyocyte differentiation of human induced pluripotent stem cells |
Q38791791 | Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates |
Q37294886 | Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure |
Q38042792 | Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility |
Q57465354 | Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review |
Q37692479 | Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes |
Q39140489 | Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells |
Q34044521 | Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice |
Q42778138 | Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells |
Q64109751 | Cell culture conditions affect the ability of high content imaging assay to detect drug-induced changes in cellular parameters in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) |
Q41869556 | Cell fiber-based three-dimensional culture system for highly efficient expansion of human induced pluripotent stem cells |
Q36870902 | Cell freezing protocol suitable for ATAC-Seq on motor neurons derived from human induced pluripotent stem cells. |
Q34534994 | Cell fusion enhances mesendodermal differentiation of human induced pluripotent stem cells |
Q61800671 | Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells |
Q33648633 | Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells |
Q90162955 | Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes |
Q51143196 | Cell-cycle-dependent Ca2+ transients in human induced pluripotent stem cells revealed by a simultaneous imaging of cell nuclei and intracellular Ca2+ level. |
Q36570136 | Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells. |
Q40018834 | Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells. |
Q41841616 | Cellular Zinc Homeostasis Contributes to Neuronal Differentiation in Human Induced Pluripotent Stem Cells |
Q92358867 | Cellular and molecular characterization of multiplex autism in human induced pluripotent stem cell-derived neurons |
Q37631001 | Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? |
Q48218690 | Characterisation of human induced pluripotent stem cell-derived endothelial cells under shear stress using an easy-to-use microfluidic cell culture system. |
Q45971585 | Characterisation of human induced pluripotent stem cell-derived hepatocyte-like cells and endodermal progenitors. |
Q36078060 | Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. |
Q45780611 | Characteristics of induced human pluripotent stem cells using DNA microarray technology. |
Q91539291 | Characterization and application of electrically active neuronal networks established from human induced pluripotent stem cell-derived neural progenitor cells for neurotoxicity evaluation |
Q48460538 | Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells |
Q91628873 | Characterization of Functional Primary Cilia in Human Induced Pluripotent Stem Cell-Derived Neurons |
Q28475963 | Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells |
Q92661328 | Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases |
Q33645683 | Characterization of Induced Pluripotent Stem Cell-derived Human Serotonergic Neurons |
Q50095816 | Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation |
Q91233080 | Characterization of a small molecule that promotes cell cycle activation of human induced pluripotent stem cell-derived cardiomyocytes |
Q50095857 | Characterization of calcium signals in human induced pluripotent stem cell-derived dentate gyrus neuronal progenitors and mature neurons, stably expressing an advanced calcium indicator protein |
Q90045722 | Characterization of dystroglycan binding in adhesion of human induced pluripotent stem cells to laminin-511 E8 fragment |
Q48292118 | Characterization of energy and neurotransmitter metabolism in cortical glutamatergic neurons derived from human induced pluripotent stem cells: A novel approach to study metabolism in human neurons. |
Q38707519 | Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease |
Q37581657 | Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. |
Q91821470 | Characterization of human induced pluripotent stem cells carrying homozygous RB1 gene deletion |
Q84658446 | Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening |
Q98720013 | Characterization of intracellular buffering power in human induced pluripotent stem cells and the loss of pluripotency is delayed by acidic stimulation and increase of NHE1 activity |
Q38610057 | Characterization of lincRNA expression in the human retinal pigment epithelium and differentiated induced pluripotent stem cells. |
Q40135854 | Characterization of microRNAs profiles of induced pluripotent stem cells reprogrammed from human dental pulp stem cells and stem cells from apical papilla |
Q92807956 | Characterization of neural networks of human induced pluripotent stem cell-derived neurons-Report from iPS non-clinical experiments for nervous system (iNCENS) project in collaboration with CSAHi and HESI NeuTox |
Q92726371 | Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation |
Q30596680 | Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system |
Q36413620 | Characterizing PCDH19 in human induced pluripotent stem cells (iPSCs) and iPSC-derived developing neurons: emerging role of a protein involved in controlling polarity during neurogenesis. |
Q48136083 | Characterizing human ion channels in induced pluripotent stem cell-derived neurons |
Q39650972 | Chemical inhibition of sulfation accelerates neural differentiation of mouse embryonic stem cells and human induced pluripotent stem cells |
Q61444287 | Chemically defined conditions for long-term maintenance of pancreatic progenitors derived from human induced pluripotent stem cells |
Q91682685 | Chemically fixed autologous feeder cell-derived niche for human induced pluripotent stem cell culture |
Q37680996 | Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells. |
Q37099898 | Chemotaxis of human induced pluripotent stem cell-derived endothelial cells |
Q104505573 | Chitosan 3D cell culture system promotes naïve-like features of human induced pluripotent stem cells: A novel tool to sustain pluripotency and facilitate differentiation |
Q37599871 | Chlorpyrifos inhibits neural induction via Mfn1-mediated mitochondrial dysfunction in human induced pluripotent stem cells |
Q28085565 | Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies |
Q36621970 | Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation |
Q57799405 | Chondrocytes differentiated from human induced pluripotent stem cells: Response to ionizing radiation |
Q95576404 | Chondrogenic differentiation of murine and human induced pluripotent stem cells in vitro: challenges and differences in comparison to ES cells |
Q24620932 | Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells |
Q48353831 | Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes. |
Q39024182 | Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells |
Q47978293 | Clinically Amendable, Defined, and Rapid Induction of Human Brain Organoids from Induced Pluripotent Stem Cells |
Q37186456 | Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. |
Q50651044 | Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate. |
Q39807456 | Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells |
Q54473585 | Clump Passaging and Expansion of Human Embryonic and Induced Pluripotent Stem Cells on Mouse Embryonic Fibroblast Feeder Cells |
Q50675460 | Co-Seeding Human Endothelial Cells with Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on Calcium Phosphate Scaffold Enhances Osteogenesis and Vascularization in Rats. |
Q91231149 | Co-culture of human induced pluripotent stem cell-derived retinal pigment epithelial cells and endothelial cells on double collagen-coated honeycomb films |
Q101566217 | Coadministration of endothelial and smooth muscle cells derived from human induced pluripotent stem cells as a therapy for critical limb ischemia |
Q57024344 | Collagen coated electrospun polyethersulfon nanofibers improved insulin producing cells differentiation potential of human induced pluripotent stem cells |
Q48258260 | Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. |
Q96767421 | Combination of IKVAV, LRE, and GPQGIWGQ Bioactive Signaling Peptides Increases Human Induced Pluripotent Stem Cell Derived Neural Stem Cells Extracellular Matrix Remodeling and Neurite Extension |
Q39516163 | Combinatorial extracellular matrix microenvironments promote survival and phenotype of human induced pluripotent stem cell-derived endothelial cells in hypoxia. |
Q27329596 | Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes |
Q47399280 | Combined delivery of chondroitinase ABC and human induced pluripotent stem cell-derived neuroepithelial cells promote tissue repair in an animal model of spinal cord injury. |
Q50095819 | Commercially Available Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Another Piece in Our Tool Box, but Not a Swiss Army Knife Yet. |
Q58094146 | Commitment of human pluripotent stem cells to a neural lineage is induced by the pro-estrogenic flavonoid apigenin |
Q38752980 | Comparability of automated human induced pluripotent stem cell culture: a pilot study |
Q93049378 | Comparative Evaluation of Hormones and Hormone-Like Molecule in Lineage Specification of Human Induced Pluripotent Stem Cells |
Q99628431 | Comparative Transcriptomic Analysis of Cerebral Organoids and Cortical Neuron Cultures Derived from Human Induced Pluripotent Stem Cells |
Q39619452 | Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation |
Q47332440 | Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment. |
Q36861735 | Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines |
Q92265548 | Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism |
Q84977319 | Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue |
Q39043203 | Comparative gene expression signature of pig, human and mouse induced pluripotent stem cell lines reveals insight into pig pluripotency gene networks |
Q37217420 | Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells |
Q84591616 | Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells |
Q90124556 | Comparative study between lactose-silk fibroin conjugates and extracellular matrices as a substrate for the culture of human induced pluripotent stem cell-derived hepatocytes |
Q39037025 | Comparative study of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) as a treatment for retinal dystrophies |
Q44608716 | Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts |
Q39298527 | Comparative study using Raman microspectroscopy reveals spectral signatures of human induced pluripotent cells more closely resemble those from human embryonic stem cells than those from differentiated cells |
Q36087426 | Comparison between the cultures of human induced pluripotent stem cells (hiPSCs) on feeder-and serum-free system (Matrigel matrix), MEF and HDF feeder cell lines. |
Q47412734 | Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells. |
Q91061065 | Comparison of Decellularized Cow and Human Bone for Engineering Bone Grafts with Human Induced Pluripotent Stem Cells |
Q37737588 | Comparison of Four Protocols to Generate Chondrocyte-Like Cells from Human Induced Pluripotent Stem Cells (hiPSCs). |
Q38657244 | Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q49341169 | Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction. |
Q87175977 | Comparison of different protocols for neural differentiation of human induced pluripotent stem cells |
Q30629611 | Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays |
Q49340579 | Comparison of growth kinetics between static and dynamic cultures of human induced pluripotent stem cells. |
Q34757318 | Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? |
Q27318070 | Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction |
Q93196349 | Comparison of in vitro and computational experiments on the relation of inter-beat interval and duration of repolarization in a specific type of human induced pluripotent stem cell-derived cardiomyocytes |
Q37720218 | Comparison of the early response of human embryonic stem cells and human induced pluripotent stem cells to ionizing radiation. |
Q53641553 | Comparison of the glycosphingolipids of human-induced pluripotent stem cells and human embryonic stem cells. |
Q34147670 | Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin |
Q50905350 | Compartmentalized microfluidic perfusion system to culture human induced pluripotent stem cell aggregates. |
Q39522868 | Complete meiosis from human induced pluripotent stem cells |
Q26745947 | Complexities of X chromosome inactivation status in female human induced pluripotent stem cells-a brief review and scientific update for autism research |
Q90484133 | Composite Nanoscaffolds Modified with Bio-ceramic Nanoparticles (Zn2SiO4) Prompted Osteogenic Differentiation of Human Induced Pluripotent Stem Cells |
Q34480596 | Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis |
Q51146786 | Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias. |
Q34485661 | Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells |
Q44400946 | Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes. |
Q95648954 | Concentration-dependent toxicogenomic changes of silver nanoparticles in hepatocyte-like cells derived from human induced pluripotent stem cells |
Q50020156 | Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics? |
Q48221282 | Concise Review: Human Induced Pluripotent Stem Cell Models of Retinitis Pigmentosa. |
Q37913263 | Concise review: Genomic stability of human induced pluripotent stem cells |
Q22241147 | Concise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease |
Q34051160 | Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia |
Q90394555 | Conducting Polymer Mediated Electrical Stimulation Induces Multilineage Differentiation with Robust Neuronal Fate Determination of Human Induced Pluripotent Stem Cells |
Q104077302 | Conducting composite films based on chitosan or sodium hyaluronate. Properties and cytocompatibility with human induced pluripotent stem cells |
Q57818774 | Confirmation of Causal rs9349379- PHACTR1 Expression Quantitative Trait Locus in Human-Induced Pluripotent Stem Cell Endothelial Cells |
Q42776466 | Connective Tissue Growth Factor Promotes Efficient Generation of Human Induced Pluripotent Stem Cell-Derived Choroidal Endothelium |
Q39192308 | Connexin 43 is involved in the generation of human-induced pluripotent stem cells |
Q47663858 | Construction of human induced pluripotent stem cell-derived oriented bone matrix microstructure by using in vitro engineered anisotropic culture model. |
Q91762640 | Construction of nano-scale cellular environments by coating a multilayer nanofilm on the surface of human induced pluripotent stem cells |
Q59767031 | Contractile behaviors of human-induced pluripotent stem cell-derived cardiomyocyte monolayers evaluated with an image-based analysis using motion vector prediction technique: A comparison with extracellular electrophysiology |
Q55399061 | Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue. |
Q53592882 | Control of adhesion of human induced pluripotent stem cells to plasma-patterned polydimethylsiloxane coated with vitronectin and γ-globulin. |
Q92247119 | Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells |
Q92154050 | Conversion of Human Induced Pluripotent Stem Cells (iPSCs) into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors |
Q37254098 | Cooperation of endothelial and smooth muscle cells derived from human induced pluripotent stem cells enhances neovascularization in dermal wounds |
Q38997127 | Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2. |
Q36842162 | Coordinated development of voltage-gated Na+ and K+ currents regulates functional maturation of forebrain neurons derived from human induced pluripotent stem cells |
Q42327814 | Cornea organoids from human induced pluripotent stem cells. |
Q93598578 | Correction for Samuel et al., Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells |
Q38710558 | Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function. |
Q90042650 | Correction to: An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons |
Q90904046 | Correction to: Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells |
Q64098458 | Correction to: Differential Expression of Cholinergic System Components in Human Induced Pluripotent Stem Cells, Bone Marrow-Derived Multipotent Stromal Cells, and Induced Pluripotent Stem Cell-Derived Multipotent Stromal Cells by Weist R, Flörkemei |
Q93138039 | Correction to: Particulate matter 2.5 induced arrhythmogenesis mediated by TRPC3 in human induced pluripotent stem cell-derived cardiomyocytes |
Q99552462 | Correction to: Retinoic acid receptor γ activation promotes differentiation of human induced pluripotent stem cells into esophageal epithelium |
Q95835251 | Correction to: Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts |
Q45965747 | Correction: A Synthetic, Xeno-Free Peptide Surface for Expansion and Directed Differentiation of Human Induced Pluripotent Stem Cells. |
Q60614107 | Correction: A Systemic Evaluation of Cardiac Differentiation from mRNA Reprogrammed Human Induced Pluripotent Stem Cells |
Q42825439 | Correction: Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems |
Q46257936 | Correction: Efficient Commitment to Functional CD34+ Progenitor Cells from Human Bone Marrow Mesenchymal Stem-Cell-Derived Induced Pluripotent Stem Cells. |
Q42362404 | Correction: Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP. |
Q43216350 | Correction: Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch. |
Q54970079 | Correction: Human Induced Pluripotent Stem Cell-Derived Models to Investigate Human Cytomegalovirus Infection in Neural Cells. |
Q55493369 | Correction: Identification and Characterization of Calcium Sparks in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. |
Q55543975 | Correction: Survival of Primary Human Hepatocytes and Death of Induced Pluripotent Stem Cells in Media Lacking Glucose and Arginine. |
Q43178077 | Correction: negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts |
Q52846171 | Corrigendum to "Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using an integration free vector" [Stem Cell Res. 16/2 (2016) 314-317]. |
Q92534869 | Corrigendum to "Generation of human induced pluripotent stem cell lines (hiPSC) from one bipolar disorder patient carrier of a DGKH risk haplotype and one non-risk-variant-carrier bipolar disorder patient" [Stem Cell Res. 2018 Oct;32:104-109. doi: 1 |
Q88317587 | Corrigendum: Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing |
Q91836749 | Cost-effective culture of human induced pluripotent stem cells using UV/ozone-modified culture plastics with reduction of cell-adhesive matrix coating |
Q47620045 | Craniometaphyseal Dysplasia Mutations in ANKH Negatively Affect Human Induced Pluripotent Stem Cell Differentiation into Osteoclasts |
Q36636124 | Crispr-mediated Gene Targeting of Human Induced Pluripotent Stem Cells |
Q64098288 | Critical Functionality Effects from Storage Temperature on Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Suspensions |
Q45874878 | Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells |
Q46870120 | Cryopreservation of Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells Is Enhanced by Rho-Associated Coiled Coil-Containing Kinase Inhibition |
Q101222579 | Cryopreservation of human induced pluripotent stem cells by using a new CryoLogic vitrification method |
Q51161394 | Culture medium refinement by dialysis for the expansion of human induced pluripotent stem cells in suspension culture. |
Q98614194 | Culture substrate-associated YAP inactivation underlies chondrogenic differentiation of human induced pluripotent stem cells |
Q41635361 | Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells |
Q38774569 | Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications |
Q90696095 | Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells |
Q103828225 | Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells |
Q88268653 | Cytochrome P450-dependent drug oxidation activities in commercially available hepatocytes derived from human induced pluripotent stem cells cultured for 3 weeks |
Q99574229 | Cytotoxicity comparison of 35 developmental neurotoxicants in human induced pluripotent stem cells (iPSC), iPSC-derived neural progenitor cells, and transformed cell lines |
Q47216413 | Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes. |
Q42073566 | DMSO-Free Programmed Cryopreservation of Fully Dissociated and Adherent Human Induced Pluripotent Stem Cells |
Q64386965 | DNA damage response after ionizing radiation exposure in skin keratinocytes derived from human induced pluripotent stem cells |
Q33728554 | DNA damage responses in human induced pluripotent stem cells and embryonic stem cells |
Q37715647 | DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing |
Q50156957 | DNA hypermethylation enhanced telomerase reverse transcriptase expression in human-induced pluripotent stem cells |
Q38809458 | DNA methylation dynamics in human induced pluripotent stem cells |
Q33921145 | DNA methylation dynamics in human induced pluripotent stem cells over time |
Q39636477 | DNp73 improves generation efficiency of human induced pluripotent stem cells |
Q38786228 | Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model. |
Q47266500 | Decellularized Human Liver Extracellular Matrix (hDLM) Mediated Hepatic Differentiation of Human Induced Pluripotent Stem Cells (hIPSc). |
Q92995006 | Decellularized Wharton's jelly extracellular matrix as a promising scaffold for promoting hepatic differentiation of human induced pluripotent stem cells |
Q38001652 | Deciphering the complexities of human diseases and disorders by coupling induced-pluripotent stem cells and systems genetics |
Q89170102 | Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes |
Q35308217 | Deep sequencing reveals low incidence of endogenous LINE-1 retrotransposition in human induced pluripotent stem cells |
Q47698746 | Defined Culture Conditions Accelerate Small-molecule-assisted Neural Induction for the Production of Neural Progenitors from Human-induced Pluripotent Stem Cells |
Q27318107 | Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems |
Q30610991 | Defining the optimal window for cranial transplantation of human induced pluripotent stem cell-derived cells to ameliorate radiation-induced cognitive impairment |
Q36845124 | Definitive Endoderm Formation from Plucked Human Hair-Derived Induced Pluripotent Stem Cells and SK Channel Regulation |
Q54667239 | Definitive endoderm differentiation of human-induced pluripotent stem cells using signaling molecules and IDE1 in three-dimensional polymer scaffold. |
Q48429641 | Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. |
Q33694696 | Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke |
Q52659350 | Derivation and Identification of Motor Neurons from Human Urine-Derived Induced Pluripotent Stem Cells. |
Q38930645 | Derivation and characterization of a transgene-free human induced pluripotent stem cell line and conversion into defined clinical-grade conditions |
Q57833355 | Derivation and characterization of putative craniofacial mesenchymal progenitor cells from human induced pluripotent stem cells |
Q43047116 | Derivation and long-term culture of transgene-free human induced pluripotent stem cells on synthetic substrates |
Q36093981 | Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells |
Q92705008 | Derivation of Cell-Engineered Nanovesicles from Human Induced Pluripotent Stem Cells and Their Protective Effect on the Senescence of Dermal Fibroblasts |
Q36177320 | Derivation of Corneal Keratocyte-Like Cells from Human Induced Pluripotent Stem Cells |
Q47773987 | Derivation of Cortical Spheroids from Human Induced Pluripotent Stem Cells in a Suspension Bioreactor |
Q38826669 | Derivation of Ethnically Diverse Human Induced Pluripotent Stem Cell Lines |
Q47296243 | Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances |
Q40269105 | Derivation of Human-Induced Pluripotent Stem Cells in Chemically Defined Medium |
Q40557846 | Derivation of Intestinal Organoids from Human Induced Pluripotent Stem Cells for Use as an Infection System. |
Q47442251 | Derivation of a disease-specific human induced pluripotent stem cell line from a biliary atresia patient |
Q90132757 | Derivation of a human induced pluripotent stem cell line (QBRIi007-A) from a patient carrying a homozygous intronic mutation (c.613-7T>G) in the SLC2A2 gene |
Q35460935 | Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation. |
Q38707509 | Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient |
Q40249637 | Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease |
Q50134785 | Derivation of human induced pluripotent stem cell line (HUSTi001-A) from a 40-year-old patient with idiopathic infertility |
Q58791677 | Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50 |
Q37870042 | Derivation of human induced pluripotent stem cells for cardiovascular disease modeling |
Q36635948 | Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young |
Q53440897 | Derivation of human induced pluripotent stem cells through continued exposure of OCT4-induced plastic human fibroblasts to reprogramming media. |
Q42153094 | Derivation of induced pluripotent stem cells from fetal human skin fibroblasts. |
Q28750802 | Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes |
Q36547230 | Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. |
Q35170589 | Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells |
Q35671320 | Derivation of smooth muscle cells with neural crest origin from human induced pluripotent stem cells |
Q38708206 | Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring |
Q100430443 | Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton's jelly samples |
Q31161161 | Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions |
Q104103615 | Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells |
Q51010111 | Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System. |
Q37034262 | Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications. |
Q40272131 | Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells |
Q92807416 | Detecting drug-induced long QT and arrhythmic risks with 28 CIPA compounds using a Ca2+ transient assay in human induced pluripotent stem cell-derived cardiomyocytes: A consortium from 3 sites |
Q49895049 | Detection of synchronized burst firing in cultured human induced pluripotent stem cell-derived neurons using a 4-step method |
Q84394016 | Determination of appropriate stage of human-induced pluripotent stem cell-derived cardiomyocytes for drug screening and pharmacological evaluation in vitro |
Q48685161 | Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes. |
Q35661071 | Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes |
Q86291312 | Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes |
Q40083714 | Development of Hepatocyte-like Cell Derived from Human Induced Pluripotent Stem cell as a Host for Clinically Isolated Hepatitis C Virus |
Q47611653 | Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells |
Q96644062 | Development of a 3-D Organoid System Using Human Induced Pluripotent Stem Cells to Model Idiopathic Autism |
Q35925098 | Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture |
Q40249629 | Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene |
Q103825528 | Development of a kinetic model expressing anomalous phenomena in human induced pluripotent stem cell culture |
Q90778825 | Development of a model of ischemic heart disease using cardiomyocytes differentiated from human induced pluripotent stem cells |
Q35594915 | Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis |
Q91256223 | Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes |
Q47681144 | Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets. |
Q38707523 | Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma |
Q64040074 | Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells |
Q92982076 | Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update |
Q57188200 | Development of trophoblast cystic structures from human induced pluripotent stem cells in limited-area cell culture |
Q41198652 | Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs) |
Q46854596 | Developmental changes in electrophysiological characteristics of human-induced pluripotent stem cell-derived cardiomyocytes |
Q34388687 | Differences in the microrheology of human embryonic stem cells and human induced pluripotent stem cells |
Q52726734 | Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells. |
Q64060131 | Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells |
Q90499475 | Different murine-derived feeder cells alter the definitive endoderm differentiation of human induced pluripotent stem cells |
Q90403833 | Differential Effects of Heparin and Hyaluronic Acid on Neural Patterning of Human Induced Pluripotent Stem Cells |
Q47284258 | Differential Expression of Cholinergic System Components in Human Induced Pluripotent Stem Cells, Bone Marrow-Derived Multipotent Stromal Cells, and Induced Pluripotent Stem Cell-Derived Multipotent Stromal Cells |
Q64926916 | Differential Metabolism of Medium-Chain Fatty Acids in Differentiated Human-Induced Pluripotent Stem Cell-Derived Astrocytes. |
Q40369134 | Differential X Chromosome Inactivation Patterns during the Propagation of Human Induced Pluripotent Stem Cells |
Q24629646 | Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts |
Q35966957 | Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells |
Q33789907 | Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells |
Q33894805 | Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells |
Q50163149 | Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells |
Q93173198 | Differentiating Human Induced Pluripotent Stem Cells (iPSCs) Into Lung Epithelial Cells |
Q50067732 | Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture. |
Q39444466 | Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells |
Q58695043 | Differentiation and transplantation of human induced pluripotent stem cell-derived otic epithelial progenitors in mouse cochlea |
Q52567921 | Differentiation of Brown Adipocyte Progenitors Derived from Human Induced Pluripotent Stem Cells. |
Q36475810 | Differentiation of Definitive Endoderm from Human Induced Pluripotent Stem Cells on hMSCs Feeder in a Defined Medium |
Q33694976 | Differentiation of Human Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons in Mouse Hippocampal Slice Cultures |
Q97092809 | Differentiation of Human Induced Pluripotent Stem Cells Into Male Germ Cells |
Q98781218 | Differentiation of Human Induced Pluripotent Stem Cells into Epicardial-Like Cells |
Q50556720 | Differentiation of Human Induced Pluripotent Stem Cells to Chondrocytes. |
Q37644723 | Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids |
Q50149415 | Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous Recombination |
Q35895038 | Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols |
Q35852699 | Differentiation of Human Protein-Induced Pluripotent Stem Cells toward a Retinal Pigment Epithelial Cell Fate |
Q38860800 | Differentiation of Human-Induced Pluripotent Stem Cells Into Insulin-Producing Clusters by MicroRNA-7. |
Q41762987 | Differentiation of Inflammation-Responsive Astrocytes from Glial Progenitors Generated from Human Induced Pluripotent Stem Cells |
Q90233723 | Differentiation of Intrafusal Fibers from Human Induced Pluripotent Stem Cells |
Q86931878 | Differentiation of Urine-Derived Human Induced Pluripotent Stem Cells to Alveolar Type II Epithelial Cells |
Q39001525 | Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells |
Q48746183 | Differentiation of functional endothelial cells from human induced pluripotent stem cells: A novel, highly efficient and cost effective method |
Q50230276 | Differentiation of hepatocytes from induced pluripotent stem cells derived from human hair follicle mesenchymal stem cells |
Q40311122 | Differentiation of human and murine induced pluripotent stem cells to microglia-like cells |
Q39317208 | Differentiation of human embryonic stem cells and human induced pluripotent stem cells into steroid-producing cells |
Q24618089 | Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview |
Q36115457 | Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells |
Q87910219 | Differentiation of human induced pluripotent stem cells in William's E initiation medium supplemented with 3‑bromopyruvate and 2‑deoxy‑d‑glucose |
Q64066939 | Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds |
Q33896006 | Differentiation of human induced pluripotent stem cells into a keratinocyte lineage |
Q46988067 | Differentiation of human induced pluripotent stem cells into brown and white adipocytes: role of Pax3. |
Q102073845 | Differentiation of human induced pluripotent stem cells into erythroid cells |
Q39131049 | Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method |
Q38971980 | Differentiation of human induced pluripotent stem cells into insulin-like cell clusters with miR-186 and miR-375 by using chemical transfection. |
Q51734977 | Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells. |
Q35188827 | Differentiation of human induced pluripotent stem cells to mature functional Purkinje neurons |
Q41925642 | Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. |
Q59405892 | Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2 |
Q33884915 | Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2. |
Q55037316 | Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering. |
Q39035011 | Differentiation of human-induced pluripotent stem cells into insulin-producing clusters. |
Q44643755 | Differentiation of serum-free embryoid bodies from human induced pluripotent stem cells into networks |
Q43109367 | Differentiation potential of o bombay human-induced pluripotent stem cells and human embryonic stem cells into fetal erythroid-like cells. |
Q50061414 | Differentiation, Evaluation, and Application of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells |
Q39002054 | Differentiation, polarization, and migration of human induced pluripotent stem cell-derived neural progenitor cells co-cultured with a human glial cell line with radial glial-like characteristics |
Q33659124 | Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays |
Q98195596 | Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey |
Q98231808 | Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem Cells |
Q36297893 | Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells |
Q64128448 | Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines |
Q84289022 | Direct generation of induced pluripotent stem cells from human nonmobilized blood |
Q47550123 | Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset |
Q41631736 | Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium |
Q48708784 | Directed Differentiation of Human-Induced Pluripotent Stem Cells to Mesenchymal Stem Cells. |
Q53506908 | Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells. |
Q34039059 | Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies |
Q33787914 | Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells |
Q89567134 | Directed differentiation of human induced pluripotent stem cells into mature kidney podocytes and establishment of a Glomerulus Chip |
Q92035077 | Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium |
Q33816228 | Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays |
Q54449904 | Directed differentiation of human induced pluripotent stem cells: a retina perspective. |
Q39863440 | Directed differentiation of human-induced pluripotent stem cells generates active motor neurons |
Q39433128 | Directed neural differentiation of induced pluripotent stem cells from non-human primates |
Q90573469 | Directing differentiation of human induced pluripotent stem cells toward androgen-producing Leydig cells rather than adrenal cells |
Q30585778 | Directing human induced pluripotent stem cells into a neurosensory lineage for auditory neuron replacement |
Q64101027 | Discovery and characterization of variance QTLs in human induced pluripotent stem cells |
Q52430924 | Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells. |
Q38107799 | Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells |
Q35463524 | Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. |
Q91225608 | Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells |
Q28650516 | Disease modeling using human induced pluripotent stem cells: lessons from the liver |
Q42024000 | Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery |
Q90003847 | Disruption of histamine/H1R signaling pathway represses cardiac differentiation and maturation of human induced pluripotent stem cells |
Q35112764 | Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells |
Q57461449 | Dissolvable Microcarriers Allow Scalable Expansion And Harvesting Of Human Induced Pluripotent Stem Cells Under Xeno-Free Conditions |
Q36069168 | Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions |
Q36171095 | Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors |
Q48183741 | Divergent effect of adrenaline in human induced pluripotent stem cell derived cardiomyocytes obtained from hypertrophic cardiomyopathy |
Q38253146 | Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense? |
Q34236195 | Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells |
Q36140488 | Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells |
Q39788084 | Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats |
Q99617590 | Downregulation of long noncoding RNA SNHG6 rescued propofol-induced cytotoxicity in human induced pluripotent stem cell-derived cardiomyocytes |
Q34793218 | Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation |
Q39125638 | Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells |
Q99413745 | Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping |
Q34631498 | Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity |
Q47141643 | Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q34652434 | Dual gene expression in embryoid bodies derived from human induced pluripotent stem cells using episomal vectors |
Q27349008 | Dual small-molecule targeting of SMAD signaling stimulates human induced pluripotent stem cells toward neural lineages |
Q61816639 | Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress |
Q50574415 | EOS lentiviral vector selection system for human induced pluripotent stem cells. |
Q38881012 | Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q35879018 | Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells |
Q35031911 | Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors |
Q27308743 | Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells. |
Q41311531 | Early-stage development of human induced pluripotent stem cell-derived neurons. |
Q46318400 | Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model |
Q92620150 | Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes |
Q91208968 | Effect of Celecoxib on Differentiation of Human Induced Pluripotent Stem Cells into Hepatocytes Involves STAT5 Activation |
Q48332216 | Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells |
Q91764836 | Effect of cell culture biomaterials for completely xeno-free generation of human induced pluripotent stem cells |
Q41385806 | Effect of densely ionizing radiation on cardiomyocyte differentiation from human-induced pluripotent stem cells |
Q41885727 | Effect of different feeding schedules on the survival and neural differentiation of human embryonic and induced pluripotent stem cells. |
Q34053605 | Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells |
Q49379683 | Effect of leukocyte inhibitory factor on neuron differentiation from human induced pluripotent stem cell-derived neural precursor cells |
Q92345232 | Effect of mechanical vibration stress in cell culture on human induced pluripotent stem cells |
Q59793896 | Effect of migratory behaviors on human induced pluripotent stem cell colony formation on different extracellular matrix proteins |
Q35219340 | Effect of potent γ-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers |
Q92958795 | Effective Differentiation and Biological Characterization of Retinal Pigment Epithelium Derived from Human Induced Pluripotent Stem Cells |
Q27320840 | Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF |
Q39534506 | Effective vitrification of human induced pluripotent stem cells using carboxylated ε-poly-l-lysine |
Q104500098 | Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles |
Q35679665 | Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells |
Q47095035 | Effects of Propofol Treatment in Neural Progenitors Derived from Human-Induced Pluripotent Stem Cells. |
Q91216166 | Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function |
Q36632323 | Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes |
Q37078215 | Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells |
Q47726647 | Effects of glucose, lactate and basic FGF as limiting factors on the expansion of human induced pluripotent stem cells. |
Q50043343 | Effects of hawthorn ( Crataegus pentagyna) leaf extract on electrophysiologic properties of cardiomyocytes derived from human cardiac arrhythmia-specific induced pluripotent stem cells |
Q46615811 | Effects of induced pluripotent stem cells-derived conditioned medium on the proliferation and anti-apoptosis of human adipose-derived stem cells |
Q33781250 | Effects of mechanical stimulation on the reprogramming of somatic cells into human-induced pluripotent stem cells |
Q37676765 | Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells |
Q45825322 | Effects of neural differentiation maturity status of human induced pluripotent stem cells prior to grafting in a subcortical ischemic stroke model |
Q40107518 | Effects of oxidative and thermal stresses on stress granule formation in human induced pluripotent stem cells. |
Q50244515 | Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells |
Q33722606 | Efficacy and Safety of Immuno-Magnetically Sorted Smooth Muscle Progenitor Cells Derived from Human-Induced Pluripotent Stem Cells for Restoring Urethral Sphincter Function |
Q89072426 | Efficient Derivation of Human Induced Pluripotent Stem Cells with a c-Myc-Free Non-Integrating Episomal Vector |
Q43168906 | Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder |
Q101470190 | Efficient Differentiation of Human Induced Pluripotent Stem Cells into Endothelial Cells under Xenogeneic-free Conditions for Vascular Tissue Engineering |
Q47949925 | Efficient Encapsulation and Sustained Release of Basic Fibroblast Growth Factor in Nanofilm: Extension of the Feeding Cycle of Human Induced Pluripotent Stem Cell Culture. |
Q38997397 | Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene. |
Q64387466 | Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 |
Q94566217 | Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors |
Q57790513 | Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus |
Q40618763 | Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes |
Q91802473 | Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes |
Q47909800 | Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes |
Q92293773 | Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells |
Q64942430 | Efficient Production of Hepatocyte-like Cells from Human-induced Pluripotent Stem Cells by Optimizing Growth Factors. |
Q98781222 | Efficient Protocols for Fabricating a Large Human Cardiac Muscle Patch from Human Induced Pluripotent Stem Cells |
Q43047094 | Efficient and cost-effective generation of mature neurons from human induced pluripotent stem cells |
Q29614341 | Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes |
Q36306140 | Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP. |
Q21135255 | Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression |
Q42521874 | Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells |
Q42485760 | Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. |
Q28482184 | Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells |
Q90182699 | Efficient differentiation and purification of human induced pluripotent stem cell-derived endothelial progenitor cells and expansion with the use of inhibitors of ROCK, TGF-β, and GSK3β |
Q34188870 | Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. |
Q34241616 | Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
Q34040833 | Efficient generation human induced pluripotent stem cells from human somatic cells with Sendai-virus. |
Q39712582 | Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells |
Q59357838 | Efficient generation of functional cardiomyocytes from human umbilical cord-derived virus-free induced pluripotent stem cells |
Q34373911 | Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions |
Q35665145 | Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. |
Q50523887 | Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells. |
Q39802426 | Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. |
Q50757676 | Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells. |
Q33816218 | Efficient generation of integration-free human induced pluripotent stem cells from keratinocytes by simple transfection of episomal vectors. |
Q33420698 | Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents |
Q47568205 | Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes |
Q35180600 | Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors |
Q39137401 | Efficient hepatic differentiation of human induced pluripotent stem cells in a three-dimensional microscale culture |
Q51303005 | Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells. |
Q40051880 | Efficient method to create integration-free, virus-free, Myc and Lin28-free human induced pluripotent stem cells from adherent cells |
Q34788268 | Efficient preparation and labeling of human induced pluripotent stem cells by nanotechnology |
Q38712453 | Efficient production of trophoblast lineage cells from human induced pluripotent stem cells |
Q41021257 | Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone. |
Q51035614 | Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy. |
Q36405737 | Electrical Stimulation Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells. |
Q52642664 | Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy. |
Q35580471 | Electrically guiding migration of human induced pluripotent stem cells. |
Q42060920 | Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells |
Q55316326 | Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes. |
Q47254766 | Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers |
Q39452942 | Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells |
Q33727734 | Electrophysiological properties of human induced pluripotent stem cells. |
Q46213908 | Electrospun Scaffolds: Enhanced Lineage-Specific Differentiation Efficiency of Human Induced Pluripotent Stem Cells by Engineering Colony Dimensionality Using Electrospun Scaffolds (Adv. Healthcare Mater. 12/2016). |
Q52981339 | Electrospun biomaterial scaffolds with varied topographies for neuronal differentiation of human-induced pluripotent stem cells. |
Q51153995 | Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells. |
Q92558408 | Electrospun silk nanofibers improve differentiation potential of human induced pluripotent stem cells to insulin producing cells |
Q45104521 | Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells |
Q94542997 | Elimination of Teratogenic Human Induced Pluripotent Stem Cells by Bee Venom via Calcium-Calpain Pathway |
Q85358460 | Elimination of remaining undifferentiated induced pluripotent stem cells in the process of human cardiac cell sheet fabrication using a methionine-free culture condition |
Q35306023 | Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells |
Q90013877 | Elucidation of human induced pluripotent stem cell behaviors in colonies based on a kinetic model |
Q41813455 | Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells |
Q98734671 | Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin |
Q92669325 | Encapsulation boosts islet-cell signature in differentiating human induced pluripotent stem cells via integrin signalling |
Q92345220 | Endodermal differentiation of human induced pluripotent stem cells using simple dialysis culture system in suspension culture |
Q91355637 | Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 |
Q30575995 | Engineered Human Muscle Tissue from Skeletal Muscle Derived Stem Cells and Induced Pluripotent Stem Cell Derived Cardiac Cells |
Q46515077 | Engineered Microvasculature in PDMS Networks Using Endothelial Cells Derived from Human Induced Pluripotent Stem Cells |
Q36884199 | Engineering bone tissue substitutes from human induced pluripotent stem cells |
Q64985956 | Engineering the vasculature of decellularized rat kidney scaffolds using human induced pluripotent stem cell-derived endothelial cells. |
Q27309127 | Engrafted human induced pluripotent stem cell-derived anterior specified neural progenitors protect the rat crushed optic nerve |
Q36305534 | Engraftment of human induced pluripotent stem cell-derived hepatocytes in immunocompetent mice via 3D co-aggregation and encapsulation |
Q95260186 | Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy |
Q48318402 | Enhanced Cardiac Differentiation of Human Cardiovascular Disease Patient-Specific Induced Pluripotent Stem Cells by Applying Unidirectional Electrical Pulses Using Aligned Electroactive Nanofibrous Scaffolds. |
Q90603771 | Enhanced Ex Vivo Generation of Erythroid Cells from Human Induced Pluripotent Stem Cells in a Simplified Cell Culture System with Low Cytokine Support |
Q91122053 | Enhanced Hepatic Differentiation of Human Induced Pluripotent Stem Cells Using Gas-Permeable Membrane |
Q41928588 | Enhanced Human-Induced Pluripotent Stem Cell Derived Cardiomyocyte Maturation Using a Dual Microgradient Substrate |
Q46516210 | Enhanced Lineage-Specific Differentiation Efficiency of Human Induced Pluripotent Stem Cells by Engineering Colony Dimensionality Using Electrospun Scaffolds |
Q28550776 | Enhanced Reprogramming Efficiency and Kinetics of Induced Pluripotent Stem Cells Derived from Human Duchenne Muscular Dystrophy |
Q55254664 | Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered Chips. |
Q49886907 | Enhanced chondrogenesis differentiation of human induced pluripotent stem cells by MicroRNA-140 and transforming growth factor beta 3 (TGFβ3). |
Q46521119 | Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells |
Q39845257 | Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells |
Q33672340 | Enhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45. |
Q27341904 | Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts |
Q34615265 | Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix |
Q91511250 | Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system |
Q43723618 | Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart |
Q33964014 | Enhancement of arsenic trioxide-mediated changes in human induced pluripotent stem cells (IPS) |
Q57813213 | Enhancement of human induced pluripotent stem cells adhesion through multilayer laminin coating |
Q60721765 | Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A |
Q92247106 | Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity |
Q39094576 | Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro |
Q60943366 | Enriched Differentiation of Human Otic Sensory Progenitor Cells Derived From Induced Pluripotent Stem Cells |
Q97546599 | Enrichment differentiation of human induced pluripotent stem cells into sinoatrial node-like cells by combined modulation of BMP, FGF, and RA signaling pathways |
Q101575980 | Enrichment of retinal ganglion and Müller glia progenitors from retinal organoids derived from human induced pluripotent stem cells - possibilities and current limitations |
Q39825327 | Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes |
Q45302039 | Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model |
Q34056154 | Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome |
Q34469474 | Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation |
Q33564357 | Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells |
Q34197304 | Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells |
Q38754538 | Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity |
Q35557622 | Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease. |
Q38762078 | Episomal plasmid-based generation of induced pluripotent stem cells from fetal femur-derived human mesenchymal stromal cells |
Q94601797 | Erratum to "Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients" |
Q56910936 | Erratum: Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells |
Q92351484 | Erratum: Investigating the Therapeutic Mechanism of Cannabidiol in a Human Induced Pluripotent Stem Cell (iPSC)-Based Model of Dravet Syndrome |
Q56768447 | Erratum: Modelling schizophrenia using human induced pluripotent stem cells |
Q41980282 | Error-Correcting Output Codes in Classification of Human Induced Pluripotent Stem Cell Colony Images. |
Q34797997 | Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin. |
Q112699006 | Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with PKD1 Mutation |
Q104800263 | Establishment human induced pluripotent stem cell line from idiopathic non-familial Parkinson's disease patient using self-replicating RNA vector |
Q36885838 | Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins |
Q36805034 | Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells. |
Q92023663 | Establishment of MDR1-knockout human induced pluripotent stem cell line |
Q38708210 | Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2. |
Q92700339 | Establishment of a Beals syndrome patient-derived human induced pluripotent stem cell line HELPi001-A |
Q49923296 | Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells |
Q91922303 | Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation |
Q97075060 | Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi010-A) from a healthy Jordanian female skin dermal fibroblasts |
Q89680336 | Establishment of a human induced pluripotent stem cell line (CSUASOi005-A), from peripheral blood mononuclear cells of a patient with X-linked juvenile retinoschisis carrying a novel mutation in RS1 gene |
Q90130661 | Establishment of a human induced pluripotent stem cell line (SDQLCHi004-A) from a patient with nemaline myopathy-4 disease carrying heterozygous mutation in TPM2 gene |
Q90110366 | Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene |
Q99358364 | Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene |
Q55003782 | Establishment of a human trisomy 18 induced pluripotent stem cell line from amniotic fluid cells. |
Q92525224 | Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells |
Q51833401 | Establishment of a rabbit induced pluripotent stem cell (RbiPSC) line using lentiviral delivery of human pluripotency factors. |
Q100509012 | Establishment of co-culture of human induced pluripotent stem cell-derived melanocytes and keratinocytes in vitro |
Q36549011 | Establishment of feeder-free culture system for human induced pluripotent stem cell on DAS nanocrystalline graphene |
Q99604392 | Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2 |
Q90866069 | Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q13 |
Q90733047 | Establishment of human induced pluripotent stem cell line from dermal fibroblasts of a healthy individual |
Q39544488 | Establishment of human induced pluripotent stem cell lines from normal fibroblast TIG-1. |
Q96773626 | Establishment of human induced pluripotent stem cells derived from skin cells of a patient with Dravet syndrome |
Q92480938 | Establishment of human trophoblast stem cells from human induced pluripotent stem cell-derived cystic cells under micromesh culture |
Q39640235 | Establishment of induced pluripotent stem cells from human neonatal tissues |
Q47566946 | Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes |
Q100955083 | Establishment of three human induced pluripotent stem cell lines from a type 1 diabetic family harboring sequence variants associated with autoimmunity |
Q36632919 | Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation. |
Q42731927 | Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes |
Q48741700 | Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes. |
Q49283054 | Evaluating the potential of endothelial cells derived from human induced pluripotent stem cells to form microvascular networks in 3D cultures |
Q35069104 | Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells |
Q39056543 | Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers |
Q27307789 | Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch |
Q64076581 | Evaluation of Retinal Pigment Epithelial Cell Cytotoxicity of Recombinant Tissue Plasminogen Activator Using Human-Induced Pluripotent Stem Cells |
Q53192226 | Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes. |
Q28542837 | Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes |
Q38711442 | Evaluation of the effects of power-frequency magnetic fields on the electrical activity of cardiomyocytes differentiated from human induced pluripotent stem cells. |
Q50859912 | Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells. |
Q90000351 | Evaluation of the susceptibility of neurons and neural stem/progenitor cells derived from human induced pluripotent stem cells to anticancer drugs |
Q49987365 | Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis |
Q47581837 | Evidence brings hope for high-yield dopaminergic human-induced pluripotent stem cell transplant |
Q40155273 | Ex vivo Generation of Genetically Modified Macrophages from Human Induced Pluripotent Stem Cells. |
Q30593372 | Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes |
Q33746497 | Excision of viral reprogramming cassettes by Cre protein transduction enables rapid, robust and efficient derivation of transgene-free human induced pluripotent stem cells |
Q26781319 | Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes |
Q42962196 | Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations |
Q89066055 | Exosomes Derived from Human Induced Pluripotent Stem Cells Ameliorate the Aging of Skin Fibroblasts |
Q60922766 | Exosomes Derived from Human Induced Pluripotent Stem Cells-Endothelia Cells Promotes Postnatal Angiogenesis in Mice Bearing Ischemic Limbs |
Q95627587 | Exosomes Facilitate Transmission of SARS-CoV-2 Genome into Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q37012144 | Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats |
Q37675908 | Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis |
Q49960448 | Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway |
Q35212390 | Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. |
Q35944791 | Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice |
Q33413336 | Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells |
Q48853858 | Expansion of 3D human induced pluripotent stem cell aggregates in bioreactors: Bioprocess intensification and scaling-up approaches. |
Q87115758 | Expansion of Human Induced Pluripotent Stem Cells in Stirred Suspension Bioreactors |
Q33921142 | Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential |
Q34514844 | Experimental study on the differentiation of human induced pluripotent stem cells into epidermal-like stem cells |
Q41429796 | Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons. |
Q92911205 | Expression and Functional Properties of NMDA and GABAA Receptors during Differentiation of Human Induced Pluripotent Stem Cells into Ventral Mesencephalic Neurons |
Q58097412 | Expression and functional characterization of drug transporters in brain microvascular endothelial cells derived from human induced pluripotent stem cells |
Q50033859 | Expression of Pluripotency Genes in Chondrocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. |
Q51820702 | Extending human induced pluripotent stem cell technology to infectious diseases: new model for viral myocarditis. |
Q94497076 | Extracellular Vesicles Isolated from Human Induced Pluripotent Stem Cell-Derived Neurons Contain a Transcriptional Network |
Q60954969 | Extracellular Vesicles Released by Human Induced-Pluripotent Stem Cell-Derived Cardiomyocytes Promote Angiogenesis |
Q47300876 | Extracellular vesicles from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect against renal ischemia/reperfusion injury via delivering specificity protein (SP1) and transcriptional activating of sphingosine k |
Q47706870 | FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells |
Q64099669 | Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine |
Q88495945 | Fabrication of a co-culture micro-bioreactor device for efficient hepatic differentiation of human induced pluripotent stem cells (hiPSCs) |
Q38891583 | Fabrication of a myocardial patch with cells differentiated from human-induced pluripotent stem cells |
Q36605380 | Factor-Reduced Human Induced Pluripotent Stem Cells Efficiently Differentiate into Neurons Independent of the Number of Reprogramming Factors |
Q34236560 | Factors from human embryonic stem cell-derived fibroblast-like cells promote topology-dependent hepatic differentiation in primate embryonic and induced pluripotent stem cells |
Q62564965 | Faculty of 1000 evaluation for Engineering bone tissue substitutes from human induced pluripotent stem cells |
Q38883920 | Fail-Safe Therapy by Gamma-Ray Irradiation Against Tumor Formation by Human-Induced Pluripotent Stem Cell-Derived Neural Progenitors |
Q91274866 | Fatty acid metabolism driven mitochondrial bioenergetics promotes advanced developmental phenotypes in human induced pluripotent stem cell derived cardiomyocytes |
Q43659756 | Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model |
Q42812467 | Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells. |
Q30524908 | Feeder-free derivation of human induced pluripotent stem cells with messenger RNA |
Q37337807 | Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells |
Q39764925 | Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells |
Q52568713 | Feeder-free differentiation of cells exhibiting characteristics of corneal endothelium from human induced pluripotent stem cells. |
Q34576243 | Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells |
Q34661781 | Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells |
Q42775362 | Fibrin hydrogels induce mixed dorsal/ventral spinal neuron identities during differentiation of human induced pluripotent stem cells |
Q38732711 | Fibroblast-like cells as an effective feeder for the cultivation and derivation of new lines of human induced pluripotent stem cells |
Q47396219 | Fibrogenic and angiogenic commitments of human induced pluripotent stem cells derived mesenchymal stem cells in connective tissue growth factor-delivering scaffold in an immune-deficient mice model |
Q96017498 | Fibronectin Patches as Anchoring Points for Force Sensing and Transmission in Human Induced Pluripotent Stem Cell-Derived Pericytes |
Q90650776 | Fingolimod Enhances Oligodendrocyte Differentiation of Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitors |
Q42725966 | Flicking the switch: adult hemoglobin expression in erythroid cells derived from cord blood and human induced pluripotent stem cells |
Q101575163 | Flow-Induced Transcriptomic Remodeling of Endothelial Cells Derived From Human Induced Pluripotent Stem Cells |
Q35166240 | Fluorescent labeling and visualization of human induced pluripotent stem cells with the use of transcription activator-like effector nucleases |
Q49260119 | Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model. |
Q34408810 | Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source |
Q39060361 | Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells. |
Q34664934 | Formation of well-defined embryoid bodies from dissociated human induced pluripotent stem cells using microfabricated cell-repellent microwell arrays |
Q39160886 | Fourier transform infrared microspectroscopy reveals unique phenotypes for human embryonic and induced pluripotent stem cell lines and their progeny. |
Q63707115 | From Human-Induced Pluripotent Stem Cells to Liver Disease Modeling: A Focus on Dyslipidemia |
Q34820435 | From beat rate variability in induced pluripotent stem cell-derived pacemaker cells to heart rate variability in human subjects |
Q98614761 | Functional Coculture of Sympathetic Neurons and Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells |
Q52916380 | Functional Comparison of Neuronal Cells Differentiated from Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Different Oxygen and Medium Conditions. |
Q36212655 | Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model |
Q48153253 | Functional Human Beige Adipocytes From Induced Pluripotent Stem Cells. |
Q64072324 | Functional Properties of Engineered Heart Slices Incorporating Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q41978287 | Functional Thyroid Follicular Cells Differentiation from Human-Induced Pluripotent Stem Cells in Suspension Culture |
Q30397539 | Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells |
Q38712589 | Functional analysis of carboxylesterase in human induced pluripotent stem cell-derived enterocytes |
Q36808601 | Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q88647574 | Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes |
Q45907362 | Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell lines. |
Q37341034 | Functional cardiomyocytes derived from human induced pluripotent stem cells |
Q49907223 | Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes |
Q48232062 | Functional changes of AMPA responses in human induced pluripotent stem cell-derived neural progenitors in fragile X syndrome. |
Q35237418 | Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells. |
Q33862395 | Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. |
Q30575719 | Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. |
Q40627523 | Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells |
Q39878390 | Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells. |
Q47435516 | Functional innervation of human induced pluripotent stem cell-derived cardiomyocytes by co-culture with sympathetic neurons developed using a microtunnel technique |
Q39736437 | Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice |
Q38844039 | Functional modules distinguish human induced pluripotent stem cells from embryonic stem cells |
Q50545992 | Functional properties of different collagen scaffolds to create a biomimetic niche for neurally committed human induced pluripotent stem cells (iPSC). |
Q84977292 | Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells |
Q34263805 | Functional recovery of the murine brain ischemia model using human induced pluripotent stem cell-derived telencephalic progenitors |
Q37133657 | Functional vascular endothelium derived from human induced pluripotent stem cells. |
Q36647033 | Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates |
Q40772027 | Functionalizing Ascl1 with Novel Intracellular Protein Delivery Technology for Promoting Neuronal Differentiation of Human Induced Pluripotent Stem Cells |
Q104741791 | Functionally Integrated Top-Down Proteomics for Standardized Assessment of Human Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissues |
Q35235968 | Future of liver transplantation: non-human primates for patient-specific organs from induced pluripotent stem cells |
Q51818682 | Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases. |
Q36760607 | Fyn Kinase regulates GluN2B subunit-dominant NMDA receptors in human induced pluripotent stem cell-derived neurons |
Q59789119 | GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells |
Q92172438 | GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes |
Q60912271 | GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells |
Q99556947 | GS-967 and Eleclazine Block Sodium Channels in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes |
Q36569943 | GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells. |
Q41914268 | Gelatin scaffold combined with bone morphogenetic protein-4 induces odontoblast-like cell differentiation involving integrin profile changes, autophagy-related gene 10, and Wnt5 sequentially in human induced pluripotent stem cells |
Q100531958 | Gellan Gum Promotes the Differentiation of Enterocytes from Human Induced Pluripotent Stem Cells |
Q40574364 | Gene Signature of Human Oral Mucosa Fibroblasts: Comparison with Dermal Fibroblasts and Induced Pluripotent Stem Cells |
Q89783884 | Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect |
Q41531525 | Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells. |
Q33930103 | Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead |
Q45858446 | Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. |
Q48603432 | Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9. |
Q35093771 | Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1. |
Q33670843 | Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A |
Q33674433 | Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part B. |
Q33552001 | Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment |
Q42235958 | Gene targeting in human-induced pluripotent stem cells with adenoviral vectors |
Q37287210 | Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells |
Q38659708 | Generating CNS organoids from human induced pluripotent stem cells for modeling neurological disorders |
Q95942147 | Generating a Cost-Effective, Weekend-Free Chemically Defined Human Induced Pluripotent Stem Cell (hiPSC) Culture Medium |
Q28535131 | Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells |
Q39224040 | Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors |
Q48355403 | Generating minicorneal organoids from human induced pluripotent stem cells |
Q96683519 | Generating ventral spinal organoids from human induced pluripotent stem cells |
Q90233519 | Generation and Functional Characterization of Monocytes and Macrophages Derived from Human Induced Pluripotent Stem Cells |
Q98387899 | Generation and Optimization of Highly Pure Motor Neurons from Human Induced Pluripotent Stem Cells via Lentiviral Delivery of Transcription Factors |
Q37998022 | Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues |
Q92390924 | Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient |
Q92841145 | Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNFS621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming |
Q37963881 | Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells: an overview. |
Q27333621 | Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells |
Q39803924 | Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts |
Q36626726 | Generation and characterization of human cryptorchid-specific induced pluripotent stem cells from urine |
Q47442259 | Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant |
Q47245060 | Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant |
Q91108289 | Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN1 |
Q35944263 | Generation and characterization of human induced pluripotent stem cells |
Q90117944 | Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts |
Q99347191 | Generation and characterization of human induced pluripotent stem cells lines from four patients diagnosed with schizophrenia and one healthy control |
Q54477077 | Generation and characterization of human induced pluripotent stem cells. |
Q90125625 | Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47) |
Q21999273 | Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status |
Q91441841 | Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation |
Q57191644 | Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A) |
Q36590372 | Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases |
Q40443244 | Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells |
Q89601698 | Generation and validation of a PITX2-EGFP reporter line of human induced pluripotent stem cells enables isolation of periocular mesenchymal cells |
Q90900042 | Generation of 3 human induced pluripotent stem cell lines LUMCi005-A, B and C from a Hereditary Cerebral Hemorrhage with Amyloidosis-Dutch type patient |
Q35023324 | Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). |
Q91073755 | Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells |
Q28548080 | Generation of Brain Microvascular Endothelial-Like Cells from Human Induced Pluripotent Stem Cells by Co-Culture with C6 Glioma Cells |
Q90112313 | Generation of CCR5-ablated Human Induced Pluripotent Stem Cells as a Therapeutic Approach for Immune-mediated Diseases |
Q90228265 | Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation |
Q39461603 | Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells |
Q51623901 | Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors. |
Q40357087 | Generation of Functional Lentoid Bodies From Human Induced Pluripotent Stem Cells Derived From Urinary Cells |
Q57454541 | Generation of Functional Retinal Pigment Epithelium from Human Induced Pluripotent Stem Cells |
Q34025876 | Generation of GFP Reporter Human Induced Pluripotent Stem Cells Using AAVS1 Safe Harbor Transcription Activator-Like Effector Nuclease |
Q42145545 | Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy |
Q90834973 | Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine |
Q42161459 | Generation of Human Induced Pluripotent Stem Cells Using RNA-Based Sendai Virus System and Pluripotency Validation of the Resulting Cell Population |
Q59356125 | Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System |
Q98781217 | Generation of Human Induced Pluripotent Stem Cells and Differentiation into Cardiomyocytes |
Q38952807 | Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases. |
Q42163352 | Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus. |
Q51435627 | Generation of Human Lens Epithelial-Like Cells From Patient-Specific Induced Pluripotent Stem Cells. |
Q37707720 | Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells. |
Q67200926 | Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells |
Q58075540 | Generation of Induced Pluripotent Stem Cell-Like Lines from Human Pancreatic Ductal Adenocarcinoma |
Q58615801 | Generation of Induced Pluripotent Stem Cells from Human Epidermal Keratinocytes |
Q40444808 | Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes. |
Q41064414 | Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions |
Q38786239 | Generation of Insulin-Producing Cells From Human-Induced Pluripotent Stem Cells Using a Stepwise Differentiation Protocol Optimized With Platelet-Rich Plasma |
Q42005669 | Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes |
Q40366638 | Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors |
Q53698658 | Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells. |
Q104611557 | Generation of Keratinocytes from Human Induced Pluripotent Stem Cells Under Defined Culture Conditions |
Q38735730 | Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation. |
Q38735734 | Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation. |
Q38735739 | Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation |
Q51117408 | Generation of Neural Crest-Like Cells From Human Periodontal Ligament Cell-Derived Induced Pluripotent Stem Cells. |
Q98299855 | Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system |
Q38694961 | Generation of Oligodendrogenic Spinal Neural Progenitor Cells From Human Induced Pluripotent Stem Cells |
Q58604035 | Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway |
Q97535003 | Generation of Quiescent Cardiac Fibroblasts Derived from Human Induced Pluripotent Stem Cells |
Q91748861 | Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis |
Q63384346 | Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors |
Q63384348 | Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors |
Q55644248 | Generation of Retinal Organoids with Mature Rods and Cones from Urine-Derived Human Induced Pluripotent Stem Cells. |
Q90857017 | Generation of Retinal Progenitor Cells from Human Induced Pluripotent Stem Cell-Derived Spherical Neural Mass |
Q50010529 | Generation of Standardized and Reproducible Forebrain-type Cerebral Organoids from Human Induced Pluripotent Stem Cells |
Q48365947 | Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line. |
Q111133584 | Generation of UCiPSC-derived neurospheres for cell therapy and its application |
Q91211278 | Generation of VCCRIi001-A, a human induced pluripotent stem cell line, from a patient with spontaneous coronary artery dissection |
Q93037888 | Generation of a CFTR knock-in reporter cell line (MHHi006-A-1) from a human induced pluripotent stem cell line |
Q58585635 | Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking |
Q90130671 | Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9 |
Q93199192 | Generation of a NESTIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease |
Q91608971 | Generation of a NKX2.1 - p63 double transgenic knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-4) |
Q91832479 | Generation of a NKX2.1 knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-2) |
Q97896217 | Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing |
Q91091578 | Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system |
Q47912522 | Generation of a PXR reporter human induced pluripotent stem cell line (PXR-mCherry hiPSC) using the CRISPR/Cas9 system |
Q49788889 | Generation of a SOX2 reporter human induced pluripotent stem cell line using CRISPR/SaCas9. |
Q47360813 | Generation of a TALEN-mediated, p63 knock-in in human induced pluripotent stem cells |
Q92841152 | Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9 |
Q92208897 | Generation of a gene-corrected human induced pluripotent stem cell line derived from a patient with laterality defects and congenital heart anomalies with a c.455G > A alteration in DAND5 |
Q90167045 | Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene |
Q100723110 | Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 gene |
Q98283306 | Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi011-A) from skin fibroblasts of a healthy Jordanian male subject |
Q40249623 | Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T. |
Q52686899 | Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3. |
Q40240913 | Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma |
Q40433186 | Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene. |
Q51308356 | Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene. |
Q51308346 | Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene. |
Q91581950 | Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis |
Q96616699 | Generation of a human induced pluripotent stem cell line (CMCi001-A) from a patient with karyomegalic interstitial nephritis with homozygous frameshift deletion mutation c.1985_1994del10 of the FANCD2/FANCI-Associated Nuclease 1 gene |
Q104607938 | Generation of a human induced pluripotent stem cell line (CMCi002-A) from a patient with Gitelman's syndrome |
Q102217116 | Generation of a human induced pluripotent stem cell line (CPGHi001-A) from a hearing loss patient with the TMC1 p.M418K mutation |
Q47553899 | Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation |
Q47553574 | Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease |
Q92663849 | Generation of a human induced pluripotent stem cell line (HMGUi002-A) from a healthy male individual |
Q90898229 | Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene |
Q47549209 | Generation of a human induced pluripotent stem cell line (MUSIi001-A) from caesarean section scar fibroblasts using Sendai viral vectors |
Q91858791 | Generation of a human induced pluripotent stem cell line (MUi010-A) from skin fibroblast of patient carrying a c.2104C>T mutation in MYH9 gene |
Q92416444 | Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del) |
Q91072062 | Generation of a human induced pluripotent stem cell line (PHAi003) from a primary immunodeficient patient with CD70 mutation |
Q92998966 | Generation of a human induced pluripotent stem cell line (QBRIi009-A) from a patient with a heterozygous deletion of FOXA2 |
Q103829466 | Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene |
Q89656642 | Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation |
Q96769116 | Generation of a human induced pluripotent stem cell line (SHUPLi001-A) from PBMCs of a healthy male donor |
Q99347194 | Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease |
Q90369414 | Generation of a human induced pluripotent stem cell line (UQACi001-A) from a severe epidermolysis bullosa simplex patient with the heterozygous mutation p.R125S in the KRT14 gene |
Q53931404 | Generation of a human induced pluripotent stem cell line (VRFi001-A) from orbital adipose tissue of a bilateral retinoblastoma patient with heterozygous RB1 gene deletion. |
Q104607933 | Generation of a human induced pluripotent stem cell line (iPSC) from peripheral blood mononuclear cells of a patient with a myasthenic syndrome due to mutation in COLQ |
Q49788897 | Generation of a human induced pluripotent stem cell line CERAi001-A-6 using episomal vectors |
Q98234243 | Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease |
Q94942721 | Generation of a human induced pluripotent stem cell line derived from a Parkinson's disease patient carrying SNCA duplication |
Q47608797 | Generation of a human induced pluripotent stem cell line from a 65-year old healthy female donor with Chinese Han genetic background. |
Q89611783 | Generation of a human induced pluripotent stem cell line from a patient with Leber congenital amaurosis |
Q59360357 | Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease |
Q90188074 | Generation of a human induced pluripotent stem cell line from an epilepsy patient carrying mutations in the PIK3R2 gene |
Q38761959 | Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using an integration free vector |
Q38698106 | Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai virus technology |
Q53531093 | Generation of a human induced pluripotent stem cell line from urinary cells of a patient with primary congenital glaucoma using integration free Sendai technology. |
Q38750288 | Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B. |
Q38750285 | Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B. |
Q102149376 | Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing |
Q92230955 | Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I |
Q94951855 | Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration |
Q94951852 | Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations |
Q104130669 | Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a |
Q93057448 | Generation of a human induced pluripotent stem cell line, IMSUTi002-A-1, harboring the leukemia-specific fusion gene ETV6-RUNX1 |
Q57214322 | Generation of a human induced pluripotent stem cell line, KSCBi003-A, from human adipose tissue-derived mesenchymal stem cells using a chromosomal integration-free system |
Q100514370 | Generation of a human induced pluripotent stem cell line, YCMi002-A, from a Factor VII deficiency patient carrying F7 mutations |
Q90415335 | Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration |
Q53931366 | Generation of a transgene-free human induced pluripotent stem cell line (UNIPDi001-A) from oral mucosa epithelial stem cells. |
Q40813551 | Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors |
Q37291177 | Generation of an ICF syndrome model by efficient genome editing of human induced pluripotent stem cells using the CRISPR system |
Q101139334 | Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing |
Q50026142 | Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9. |
Q92954750 | Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia |
Q36901227 | Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. |
Q36558882 | Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture |
Q36276275 | Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions |
Q34429038 | Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. |
Q39894791 | Generation of cortical neurons from human induced-pluripotent stem cells by biodegradable polymeric microspheres loaded with priming factors. |
Q91865827 | Generation of craniofacial myogenic progenitor cells from human induced pluripotent stem cells for skeletal muscle tissue regeneration |
Q90714554 | Generation of cytochrome P450 polymorphic human induced pluripotent stem cell lines with defective CYP activities |
Q39571768 | Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy |
Q92640733 | Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUI |
Q91573087 | Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations |
Q34078669 | Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes |
Q36272752 | Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine |
Q35554963 | Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds |
Q33725270 | Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells |
Q92919183 | Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells |
Q33563392 | Generation of functional human hepatic endoderm from human induced pluripotent stem cells |
Q41002198 | Generation of functional podocytes from human induced pluripotent stem cells |
Q30542133 | Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. |
Q64041624 | Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK |
Q100961408 | Generation of genomic-integration-free human induced pluripotent stem cells and the derived cardiomyocytes of X-linked dilated cardiomyopathy from DMD gene mutation |
Q37255037 | Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells |
Q90984890 | Generation of hepatobiliary organoids from human induced pluripotent stem cells |
Q50058481 | Generation of high-yield insulin producing cells from human-induced pluripotent stem cells on polyethersulfone nanofibrous scaffold. |
Q27307424 | Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells |
Q100514214 | Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation |
Q37059614 | Generation of human cardiomyocytes: a differentiation protocol from feeder-free human induced pluripotent stem cells |
Q96155875 | Generation of human induced pluripotent stem cell (SKLRMi001-A) from a patient with partial androgen insensitivity syndrome (PAIS) |
Q98299853 | Generation of human induced pluripotent stem cell (hiPSC) line UOMi001-A from a patient with Leigh-like syndrome harbouring compound heterozygous variants in ECHS1 gene |
Q42830243 | Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder. |
Q58122854 | Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of mutation in SACSIN gene |
Q104504207 | Generation of human induced pluripotent stem cell (iPSC) lines (UUMCBi001-A, UUMCBi002-A) from two healthy donors |
Q92606027 | Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations |
Q96160646 | Generation of human induced pluripotent stem cell line (NIDCRi001-A) from a Muenke syndrome patient with an FGFR3 p.Pro250Arg mutation |
Q89729814 | Generation of human induced pluripotent stem cell line (WMUi001-A) from a patient with aortic dissection |
Q96113325 | Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation |
Q91072047 | Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease |
Q98509843 | Generation of human induced pluripotent stem cell line UNIGEi003-A from skin fibroblasts of an apparently healthy male donor |
Q91067015 | Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing |
Q97086737 | Generation of human induced pluripotent stem cell line from Alzheimer's disease patient with PSEN2 N141I mutation using integration-free non-viral method |
Q38761970 | Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2. |
Q91211300 | Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation |
Q59351673 | Generation of human induced pluripotent stem cell lines (hiPSC) from one bipolar disorder patient carrier of a DGKH risk haplotype and one non-risk-variant-carrier bipolar disorder patient |
Q91297717 | Generation of human induced pluripotent stem cell lines from a patient with ITM2B-related retinal dystrophy and a non mutated brother |
Q47242502 | Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a modified RNA system |
Q38698114 | Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system |
Q91124255 | Generation of human induced pluripotent stem cell lines from patients with selective IgA deficiency |
Q91154649 | Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations |
Q100761930 | Generation of human induced pluripotent stem cell-derived liver buds with chemically defined and animal origin-free media |
Q50168239 | Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene |
Q94447257 | Generation of human induced pluripotent stem cells (NIHTVBi004-A, NIHTVBi005-A, NIHTVBi006-A, NIHTVBi007-A, NIHTVBi008-A) from 5 CADASIL patients with NOTCH3 mutation |
Q95647847 | Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder |
Q96113329 | Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations |
Q39696652 | Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter |
Q24653753 | Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins |
Q21284148 | Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors |
Q47251246 | Generation of human induced pluripotent stem cells from Wolfram Syndrome type 2 patients bearing the c.103+1G>A CISD2 mutation for disease modeling |
Q39774972 | Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells |
Q39799520 | Generation of human induced pluripotent stem cells from cord blood cells. |
Q34588555 | Generation of human induced pluripotent stem cells from dermal fibroblasts |
Q92987975 | Generation of human induced pluripotent stem cells from individuals with a homozygous CCR5Δ32 mutation |
Q84975026 | Generation of human induced pluripotent stem cells from liver progenitor cells by only small molecules |
Q39863899 | Generation of human induced pluripotent stem cells from oral mucosa. |
Q50270780 | Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells |
Q91308568 | Generation of human induced pluripotent stem cells from peripheral blood mononuclear cells of a Senior-Loken syndrome patient |
Q41129569 | Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector |
Q95542917 | Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector |
Q33799654 | Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells |
Q38698095 | Generation of human induced pluripotent stem cells from urinary cells of a healthy donor using a non-integration system |
Q34310664 | Generation of human induced pluripotent stem cells from urine samples. |
Q51308314 | Generation of human induced pluripotent stem cells in defined, feeder-free conditions. |
Q35070581 | Generation of human induced pluripotent stem cells using epigenetic regulators reveals a germ cell-like identity in partially reprogrammed colonies |
Q38942882 | Generation of human induced pluripotent stem cells using genome integrating or non-integrating methods |
Q40807563 | Generation of human induced pluripotent stem cells using non-synthetic mRNA. |
Q33797945 | Generation of human melanocytes from induced pluripotent stem cells |
Q53116760 | Generation of human melanocytes from induced pluripotent stem cells. |
Q58763425 | Generation of human oogonia from induced pluripotent stem cells in vitro |
Q45878497 | Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette |
Q34792230 | Generation of human-induced pluripotent stem cells |
Q44541285 | Generation of human-induced pluripotent stem cells (hiPSCs) using episomal vectors on defined Essential 8™ Medium conditions |
Q34031759 | Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions |
Q86519348 | Generation of human-induced pluripotent stem cells by lentiviral transduction |
Q47135938 | Generation of human-induced pluripotent stem cells from burn patient-derived skin fibroblasts using a non-integrative method |
Q39669084 | Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG. |
Q42971176 | Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. |
Q36717931 | Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro |
Q38811442 | Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome |
Q53931504 | Generation of induced pluripotent stem cell line (ZZUi011-A) from urine sample of a normal human. |
Q39493655 | Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer |
Q57482658 | Generation of induced pluripotent stem cells (iPSCs) from human foreskin fibroblasts |
Q42163898 | Generation of induced pluripotent stem cells by reprogramming human fibroblasts with the stemgent human TF lentivirus set. |
Q39640194 | Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus |
Q36458914 | Generation of induced pluripotent stem cells from human Tenon's capsule fibroblasts |
Q39741286 | Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. |
Q37618757 | Generation of induced pluripotent stem cells from human amniotic fluid cells by reprogramming with two factors in feeder-free conditions. |
Q84427298 | Generation of induced pluripotent stem cells from human beta-thalassemia fibroblast cells |
Q37209041 | Generation of induced pluripotent stem cells from human blood |
Q60221837 | Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2 |
Q41875404 | Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. |
Q39942465 | Generation of induced pluripotent stem cells from human cord blood. |
Q39369139 | Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system. |
Q34184650 | Generation of induced pluripotent stem cells from human kidney mesangial cells |
Q36841126 | Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin |
Q34388995 | Generation of induced pluripotent stem cells from human nasal epithelial cells using a Sendai virus vector |
Q24631565 | Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2 |
Q54420423 | Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. |
Q34181340 | Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine |
Q42362477 | Generation of induced pluripotent stem cells with high efficiency from human embryonic renal cortical cells |
Q35171764 | Generation of induced pluripotent stem cells with high efficiency from human umbilical cord blood mononuclear cells. |
Q29614794 | Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts |
Q51737652 | Generation of insulin-producing cells from human induced pluripotent stem cells on PLLA/PVA nanofiber scaffold. |
Q37131138 | Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression |
Q44857288 | Generation of large pig and bovine blastocysts by culturing in human induced pluripotent stem cell medium |
Q93370539 | Generation of mature kupffer cells from human induced pluripotent stem cells |
Q92563810 | Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells |
Q34308632 | Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells |
Q33674499 | Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells |
Q38014779 | Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion |
Q35179358 | Generation of red blood cells from human induced pluripotent stem cells |
Q34017132 | Generation of retinal cells from mouse and human induced pluripotent stem cells |
Q30620032 | Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cells |
Q35894518 | Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells |
Q43810097 | Generation of robust vascular networks from cardiovascular blast populations derived from human induced pluripotent stem cells in vivo and ex vivo organ culture system |
Q52699089 | Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine. |
Q91722813 | Generation of targeted homozygosity in the genome of human induced pluripotent stem cells |
Q52717923 | Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene. |
Q52717351 | Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1. |
Q93029888 | Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation |
Q90158294 | Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation |
Q91566411 | Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 |
Q92408472 | Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene |
Q99731544 | Generation of the human induced pluripotent stem cell line (SHAMUi001-A) carrying the heterozygous c.-128G>T mutation in the 5'-UTR of the ANKRD26 gene |
Q91064526 | Generation of the human induced pluripotent stem cell line (UKWNLi001-A) from skin fibroblasts of a woman with Fabry disease carrying the X-chromosomal heterozygous c.708 G > C (W236C) missense mutation in exon 5 of the alpha-galactosidase-A gene |
Q94662507 | Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene |
Q58122852 | Generation of the human induced pluripotent stem cell line UKWNLi002-A from dermal fibroblasts of a woman with a heterozygous c.608 C>T (p.Thr203Met) mutation in exon 3 of the nerve growth factor gene potentially associated with hereditary sensory an |
Q99604391 | Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor |
Q92546590 | Generation of three human induced pluripotent stem cell (hiPSC) lines derived from one Gaucher disease patient with Parkinson's disease and two unrelated Parkinson's disease patients with GBA mutations |
Q92541741 | Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations |
Q90773050 | Generation of three human induced pluripotent stem cell sublines (MZT04D, MZT04J, MZT04C) for reproductive science research |
Q21195859 | Generation of tooth-like structures from integration-free human urine induced pluripotent stem cells |
Q53088533 | Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. |
Q42118625 | Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. |
Q34363238 | Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy |
Q93260242 | Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9 |
Q92526954 | Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population |
Q96018637 | Generation of two human induced pluripotent stem cell lines (MHHi017-A, MHHi017-B) from a patient with primary ciliary dyskinesia carrying a homozygous mutation (c.7915C > T [p.Arg2639*]) in the DNAH5 gene |
Q99731541 | Generation of two human induced pluripotent stem cell lines derived from myoblasts (MDCi014-A) and from peripheral blood mononuclear cells (MDCi014-B) from the same donor |
Q94495905 | Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion |
Q92119024 | Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 gene |
Q104130670 | Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression |
Q89362364 | Generation of two isogenic human induced pluripotent stem cell lines from a 15 year-old female patient with MERRF syndrome and A8344G mutation of mitochondrial DNA |
Q38212631 | Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns |
Q33526318 | Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells |
Q45872527 | Genetic Correction and Hepatic Differentiation of Hemophilia B-specific Human Induced Pluripotent Stem Cells |
Q102212574 | Genetic Instruction of Megakaryocytes and Platelets Derived from Human Induced Pluripotent Stem Cells for Studies of Integrin Regulation |
Q33716774 | Genetic background drives transcriptional variation in human induced pluripotent stem cells |
Q27328843 | Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy |
Q37360904 | Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells |
Q53287709 | Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards |
Q46242018 | Genetic manipulation of human induced pluripotent stem cells |
Q30529647 | Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging. |
Q30586646 | Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing |
Q40979450 | Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells |
Q37577250 | Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells |
Q35959686 | Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells |
Q95652430 | Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program |
Q91141603 | Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications |
Q91970903 | Geometrical Patterning and Constituent Cell Heterogeneity Facilitate Electrical Conduction Disturbances in a Human Induced Pluripotent Stem Cell-Based Platform: An In vitro Disease Model of Atrial Arrhythmias |
Q27342963 | Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor |
Q64236762 | Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling |
Q84103402 | Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells |
Q42119038 | Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells |
Q33693259 | Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar |
Q42857534 | Globin phenotype of erythroid cells derived from human induced pluripotent stem cells |
Q34241237 | Glucocorticoids promote neural progenitor cell proliferation derived from human induced pluripotent stem cells |
Q48261355 | Glycoconjugates reveal diversity of human neural stem cells (hNSCs) derived from human induced pluripotent stem cells (hiPSCs). |
Q51777882 | Glycogen synthase kinase-3 inhibition promotes proliferation and neuronal differentiation of human-induced pluripotent stem cell-derived neural progenitors. |
Q38695795 | Glycogen synthase kinase-3 inhibition sensitizes human induced pluripotent stem cells to thiol-containing antioxidants induced apoptosis |
Q52673132 | Glycome analysis of extracellular vesicles derived from human induced pluripotent stem cells using lectin microarray. |
Q35063280 | Glycome diagnosis of human induced pluripotent stem cells using lectin microarray |
Q38869323 | Glycomics of human embryonic stem cells and human induced pluripotent stem cells |
Q49909269 | Glycomics of human embryonic stem cells and human induced pluripotent stem cells |
Q37413408 | Glypican 6 Enhances N-Methyl-D-Aspartate Receptor Function in Human-Induced Pluripotent Stem Cell-Derived Neurons |
Q42645683 | Go to the Mattresses: A New Method for Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Maturation |
Q48109986 | Graphene Sheet-Induced Global Maturation of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. |
Q47840658 | Guggulsterone-releasing microspheres direct the differentiation of human induced pluripotent stem cells into neural phenotypes |
Q97891883 | Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions |
Q89950499 | HIF-1α/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells |
Q36190162 | HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem Cells |
Q58803020 | Hair Follicle Dermal Cells Support Expansion of Murine and Human Embryonic and Induced Pluripotent Stem Cells and Promote Haematopoiesis in Mouse Cultures |
Q106838069 | Harnessing pluripotent stem cells as models to decipher human evolution |
Q50696282 | Hear the beat: decellularized mouse heart regenerated with human induced pluripotent stem cells. |
Q35149520 | Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalon |
Q39739455 | Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence |
Q34099344 | Hematopoietic and endothelial differentiation of human induced pluripotent stem cells |
Q33770557 | Hematopoietic development from human induced pluripotent stem cells |
Q92169068 | Hemodynamic Stimulation Using the Biomimetic Cardiac Tissue Model (BCTM) Enhances Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q87993623 | Hepatectomised patient sera promote hepatocyte differentiation of human-induced pluripotent stem cells |
Q40965254 | Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor. |
Q91892253 | Hepatic spheroids derived from human induced pluripotent stem cells in bio-artificial liver rescue porcine acute liver failure |
Q51070593 | Hepatocyte Nuclear Factor 4 Alpha Promotes Definitive Endoderm Differentiation from Human Induced Pluripotent Stem Cells. |
Q28271141 | Hepatocyte differentiation of human induced pluripotent stem cells is modulated by stearoyl-CoA desaturase 1 activity |
Q39215982 | Hepatocyte nuclear factor 6 activates the transcription of CYP3A4 in hepatocyte-like cells differentiated from human induced pluripotent stem cells. |
Q36065349 | Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes |
Q99361083 | Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study |
Q43494810 | Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal |
Q36747856 | Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies |
Q51061032 | Hepatogenic Differentiation of Human Induced Pluripotent Stem cells on Collagen-Coated Polyethersulfone Nanofibers. |
Q39424722 | Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats |
Q93066151 | Heterogeneous filament network formation by myosin light chain isoforms effects on contractile energy output of single cardiomyocytes derived from human induced pluripotent stem cells |
Q112062362 | HiPS-Endothelial Cells Acquire Cardiac Endothelial Phenotype in Co-culture With hiPS-Cardiomyocytes |
Q64389495 | High Basal Levels of γH2AX in Human Induced Pluripotent Stem Cells Are Linked to Replication-Associated DNA Damage and Repair |
Q38793908 | High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis |
Q88433070 | High cell density suppresses BMP4-induced differentiation of human pluripotent stem cells to produce macroscopic spatial patterning in a unidirectional perfusion culture chamber |
Q55715579 | High content screening of induced pluripotent stem cells as a model to study human brain diseases. |
Q57097757 | High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4 |
Q53028649 | High glucose-induced hyperosmolarity impacts proliferation, cytoskeleton remodeling and migration of human induced pluripotent stem cells via aquaporin-1. |
Q35623892 | High glutathione and glutathione peroxidase-2 levels mediate cell-type-specific DNA damage protection in human induced pluripotent stem cells |
Q34213428 | High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. |
Q88670533 | High-Content Assay Multiplexing for Vascular Toxicity Screening in Induced Pluripotent Stem Cell-Derived Endothelial Cells and Human Umbilical Vein Endothelial Cells |
Q35878285 | High-Efficiency Induction of Neural Conversion in Human ESCs and Human Induced Pluripotent Stem Cells with a Single Chemical Inhibitor of Transforming Growth Factor Beta Superfamily Receptors |
Q38774693 | High-Throughput Phenotyping of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Neurons Using Electric Field Stimulation and High-Speed Fluorescence Imaging |
Q42049341 | High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins |
Q46243612 | High-efficiency generation of induced pluripotent stem cells from human foreskin fibroblast cells using the Sagunja-tang herbal formula |
Q28744346 | High-efficient generation of induced pluripotent stem cells from human astrocytes |
Q87652198 | High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition |
Q34261778 | High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells |
Q92807365 | High-throughput and high-content safety pharmacology assessments with 3-dimensional human induced pluripotent stem cell-derived cortical spheroid platforms |
Q48183777 | High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell derived neurons. |
Q89596000 | High-throughput screening of human induced pluripotent stem cell-derived brain organoids |
Q30847302 | High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. |
Q100434842 | Highlight Report: Hepatobiliary differentiation from human induced pluripotent stem cells |
Q41607547 | Highly efficient cryopreservation of human induced pluripotent stem cells using a dimethyl sulfoxide-free solution |
Q41586880 | Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells |
Q44336439 | Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes |
Q84077765 | Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells |
Q34157222 | Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells |
Q52653697 | Highly efficient methods to obtain homogeneous dorsal neural progenitor cells from human and mouse embryonic stem cells and induced pluripotent stem cells. |
Q57483002 | Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles |
Q92792761 | Highly sulfated hyaluronic acid maintains human induced pluripotent stem cells under feeder-free and bFGF-free conditions |
Q28541550 | Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells |
Q99413043 | Host Sex and Transplanted Human Induced Pluripotent Stem Cell Phenotype Interact to Influence Sensorimotor Recovery in a Mouse Model of Cortical Contusion Injury |
Q24632072 | Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells |
Q35597980 | Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa |
Q96293631 | Human Cerebrospinal Fluid Promotes Neuronal Circuit Maturation of Human Induced Pluripotent Stem Cell-Derived 3D Neural Aggregates |
Q36523519 | Human Decidua-Derived Mesenchymal Cells Are a Promising Source for the Generation and Cell Banking of Human Induced Pluripotent Stem Cells |
Q39003419 | Human Dendritic Cell-Derived Induced Pluripotent Stem Cell Lines Are Not Immunogenic. |
Q38847160 | Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery |
Q35897783 | Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy |
Q64265367 | Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions |
Q59944676 | Human Germ Cell Differentiation from Pluripotent Embryonic Stem Cells and Induced Pluripotent Stem Cells |
Q36531665 | Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues. |
Q46096606 | Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems |
Q36100103 | Human Induced Pluripotent Stem Cell Derived Neuronal Cells Cultured on Chemically-Defined Hydrogels for Sensitive In Vitro Detection of Botulinum Neurotoxin. |
Q104503486 | Human Induced Pluripotent Stem Cell Derived Sensory Neurons are Sensitive to the Neurotoxic Effects of Paclitaxel |
Q89651052 | Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy |
Q36382854 | Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System |
Q59360133 | Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector |
Q92696306 | Human Induced Pluripotent Stem Cell Reprogramming Prediction in Microscopy Images using LSTM based RNN |
Q104734891 | Human Induced Pluripotent Stem Cell-Based Skin for Assessing Transdermal Drug Permeability and Irritancy |
Q94542615 | Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres are Suitable for Neurotoxicity Screening |
Q58571221 | Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines |
Q54941216 | Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies. |
Q35873200 | Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation |
Q47590766 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction |
Q91918815 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch in Rats With Heart Failure |
Q26750618 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling |
Q59360205 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Bradycardiac Effects Caused by Co-Administration of Sofosbuvir and Amiodarone |
Q89433762 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists |
Q38530607 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease |
Q104140674 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, in Contrast to Adipose Tissue-Derived Stromal Cells, Efficiently Improve Heart Function in Murine Model of Myocardial Infarction |
Q92261429 | Human Induced Pluripotent Stem Cell-Derived Definitive Endoderm Bulk Culture and Hepatic Differentiation |
Q38700102 | Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems |
Q89169531 | Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers |
Q99635557 | Human Induced Pluripotent Stem Cell-Derived Lung Epithelial System for SARS-CoV-2 Infection Modeling and Its Potential in Drug Repurposing |
Q37644726 | Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages. |
Q49573470 | Human Induced Pluripotent Stem Cell-Derived Macrophages for Unraveling Human Macrophage Biology |
Q58697755 | Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis |
Q39000837 | Human Induced Pluripotent Stem Cell-Derived Microvesicles Transmit RNAs and Proteins to Recipient Mature Heart Cells Modulating Cell Fate and Behavior. |
Q38782443 | Human Induced Pluripotent Stem Cell-Derived Motor Neuron Transplant for Neuromuscular Atrophy in a Mouse Model of Sciatic Nerve Injury |
Q100314318 | Human Induced Pluripotent Stem Cell-Derived Neural Cells from Alzheimer's Disease Patients Exhibited Different Susceptibility to Oxidative Stress |
Q91342343 | Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions |
Q36944648 | Human Induced Pluripotent Stem Cell-Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation |
Q52652665 | Human Induced Pluripotent Stem Cell-Derived Sensory Neurons for Fate Commitment of Bone Marrow Stromal Cell-Derived Schwann Cells. |
Q92492172 | Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases |
Q35624098 | Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1 |
Q92663895 | Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform |
Q37350696 | Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects |
Q36687971 | Human Induced Pluripotent Stem Cells Re-Engineer the Study of Neurodevelopmental Disorders |
Q47124444 | Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish |
Q102212529 | Human Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure |
Q38874111 | Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine. |
Q38260806 | Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling |
Q35892824 | Human Induced Pluripotent Stem Cells for Tumor Targeted Delivery of Gold Nanorods and Enhanced Photothermal Therapy |
Q90656223 | Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead |
Q57279137 | Human Induced Pluripotent Stem Cells: A New Model for Schizophrenia? |
Q97877907 | Human Leukocyte Antigen Class I Pseudo-Homozygous Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells |
Q93388167 | Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy |
Q90450422 | Human Norovirus Propagation in Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells |
Q98718328 | Human Placenta-Derived ECM Supports Tri-Lineage Differentiation of Human Induced Pluripotent Stem Cells |
Q42817633 | Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification |
Q42332325 | Human acute leukemia induced pluripotent stem cells: a unique model for investigating disease development and pathogenesis |
Q41871049 | Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells |
Q39481077 | Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors. |
Q36882832 | Human bone marrow mesenchymal stem cells support the derivation and propagation of human induced pluripotent stem cells in culture |
Q37420441 | Human cytomegalovirus induces apoptosis in neural stem/progenitor cells derived from induced pluripotent stem cells by generating mitochondrial dysfunction and endoplasmic reticulum stress. |
Q38947458 | Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells |
Q38032401 | Human disease modeling with induced pluripotent stem cells |
Q35623887 | Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field. |
Q41452673 | Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. |
Q42915261 | Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis. |
Q37705456 | Human embryonic and induced pluripotent stem cells in basic and clinical research in cardiology. |
Q84811112 | Human embryonic and induced pluripotent stem cells in cardiovascular drug discovery: patents and patented uses |
Q38638058 | Human embryonic and induced pluripotent stem cells in clinical trials |
Q41913041 | Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor. |
Q38274269 | Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair |
Q47620425 | Human embryos from induced pluripotent stem cell-derived gametes: ethical and quality considerations |
Q42260086 | Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells. |
Q35416543 | Human endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells |
Q30577389 | Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking. |
Q34024915 | Human germ cell differentiation from fetal- and adult-derived induced pluripotent stem cells |
Q34219813 | Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies |
Q37414043 | Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining |
Q86957745 | Human induced pluripotent stem cell (hiPSC) derived cardiomyocytes to understand and test cardiac calcium handling: A glass half full |
Q38699398 | Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes |
Q38258436 | Human induced pluripotent stem cell and nanotechnology-based therapeutics |
Q47151031 | Human induced pluripotent stem cell based in vitro models of the blood-brain barrier: the future standard? |
Q35221675 | Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins |
Q41836911 | Human induced pluripotent stem cell derived neurons as a model for Williams-Beuren syndrome |
Q39543636 | Human induced pluripotent stem cell differentiation and direct transdifferentiation into corneal epithelial-like cells |
Q38487497 | Human induced pluripotent stem cell for modeling cardiovascular diseases |
Q92244214 | Human induced pluripotent stem cell line HMUi001-A derived from corneal stromal cells |
Q96346338 | Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes |
Q50137184 | Human induced pluripotent stem cell line with cytochrome P450 enzyme polymorphism (CYP2C19*2/CYP3A5*3C) generated from lymphoblastoid cells |
Q90362737 | Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis |
Q82510190 | Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells |
Q64069475 | Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies |
Q50071377 | Human induced pluripotent stem cell region recognition in microscopy images using Convolutional Neural Networks |
Q26995580 | Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development |
Q50614235 | Human induced pluripotent stem cell-derived B lymphocytes express sIgM and can be generated via a hemogenic endothelium intermediate. |
Q92880075 | Human induced pluripotent stem cell-derived GABAergic interneuron transplants attenuate neuropathic pain |
Q60952476 | Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration |
Q51480688 | Human induced pluripotent stem cell-derived beating cardiac tissues on paper. |
Q48972019 | Human induced pluripotent stem cell-derived cardiac tissue on a thin collagen membrane with natural microstructures. |
Q30586653 | Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform |
Q37378179 | Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity |
Q91598035 | Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus |
Q28081697 | Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes |
Q44578785 | Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery |
Q39209922 | Human induced pluripotent stem cell-derived ectodermal precursor cells contribute to hair follicle morphogenesis in vivo |
Q36576514 | Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity |
Q92656928 | Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis |
Q51461968 | Human induced pluripotent stem cell-derived fiber-shaped cardiac tissue on a chip. |
Q56349505 | Human induced pluripotent stem cell-derived glial cells and neural progenitors display divergent responses to Zika and dengue infections |
Q37076655 | Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus |
Q89464510 | Human induced pluripotent stem cell-derived hepatocytes and their culturing methods to maintain liver functions for pharmacokinetics and safety evaluation of pharmaceuticals |
Q48716931 | Human induced pluripotent stem cell-derived hepatocytes for toxicology testing |
Q99573174 | Human induced pluripotent stem cell-derived lung organoids in an ex vivo model of the congenital diaphragmatic hernia fetal lung |
Q48522899 | Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury |
Q91216435 | Human induced pluripotent stem cell-derived mast cells useful for in vitro mast cell activation assay exhibiting phenotypes and morphological characteristics of human mast cells |
Q37712731 | Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration |
Q90838056 | Human induced pluripotent stem cell-derived mesenchymal stem cell therapy effectively reduced brain infarct volume and preserved neurological function in rat after acute intracranial hemorrhage |
Q47139383 | Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice |
Q90317210 | Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models |
Q24570123 | Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells |
Q39208345 | Human induced pluripotent stem cell-derived neural crest stem cells integrate into the injured spinal cord in the fetal lamb model of myelomeningocele. |
Q34037179 | Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion |
Q49504590 | Human induced pluripotent stem cell-derived neuronal progenitors are a suitable and effective drug discovery model for neurological mtDNA disorders. |
Q39031960 | Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease |
Q50243876 | Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential |
Q42606979 | Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block. |
Q90261702 | Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure |
Q100431137 | Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5) |
Q89687560 | Human induced pluripotent stem cells ameliorate hyperoxia-induced lung injury in a mouse model |
Q50120400 | Human induced pluripotent stem cells and male infertility: an overview of current progress and perspectives |
Q37987327 | Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies |
Q38087489 | Human induced pluripotent stem cells and their use in drug discovery for toxicity testing |
Q33804981 | Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord |
Q39587756 | Human induced pluripotent stem cells are capable of B-cell lymphopoiesis |
Q38643034 | Human induced pluripotent stem cells as a research tool in Alzheimer's disease |
Q104068273 | Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19 |
Q39153783 | Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis. |
Q34284032 | Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. |
Q36468341 | Human induced pluripotent stem cells derived endothelial cells mimicking vascular inflammatory response under flow |
Q54411102 | Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. |
Q36923041 | Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy |
Q38502628 | Human induced pluripotent stem cells derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles |
Q24631810 | Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection |
Q41316869 | Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo |
Q84593087 | Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells |
Q34085826 | Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination |
Q94512655 | Human induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies |
Q39247913 | Human induced pluripotent stem cells for modelling neurodevelopmental disorders. |
Q26750393 | Human induced pluripotent stem cells for monogenic disease modelling and therapy |
Q29547624 | Human induced pluripotent stem cells free of vector and transgene sequences |
Q91338905 | Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells |
Q98155563 | Human induced pluripotent stem cells generated from a patient with a homozygous L272P mutation in the OTULIN gene (NIHTVBi014-A) |
Q42125464 | Human induced pluripotent stem cells generated neural cells behaving like brain and spinal cord cells: An insight into the involvement of retinoic acid and sonic hedgehog proteins |
Q39512046 | Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming |
Q49600337 | Human induced pluripotent stem cells illuminate pathways and novel treatment targets for age-related macular degeneration |
Q47760688 | Human induced pluripotent stem cells improve recovery in stroke-injured aged rats. |
Q39298289 | Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain |
Q35789181 | Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling |
Q38165608 | Human induced pluripotent stem cells in hepatology: beyond the proof of concept. |
Q36167797 | Human induced pluripotent stem cells labeled with fluorescent magnetic nanoparticles for targeted imaging and hyperthermia therapy for gastric cancer |
Q30940485 | Human induced pluripotent stem cells on autologous feeders |
Q102326911 | Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine's fast-acting antidepressant mechanisms |
Q38014251 | Human induced pluripotent stem cells--from mechanisms to clinical applications |
Q38868682 | Human induced pluripotent stem cells: A disruptive innovation. |
Q38254583 | Human induced pluripotent stem cells: A new source for brown and white adipocytes |
Q37772905 | Human induced pluripotent stem cells: a review of the US patent landscape |
Q48676118 | Human induced pluripotent stem cells: now open to discovery |
Q37856716 | Human induced pluripotent stem cells: the past, present, and future |
Q48564423 | Human induced pluripotent stem cell‑derived mesenchymal stem cells alleviate atherosclerosis by modulating inflammatory responses |
Q37736696 | Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection. |
Q33911278 | Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells |
Q28656323 | Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells |
Q54462820 | Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. |
Q37776428 | Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells |
Q36861526 | Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells. |
Q47581978 | Human neurons derived from induced pluripotent stem cells as a new platform for preclinical drug screening and development |
Q83429079 | Human periodontal ligament fibroblasts are the optimal cell source for induced pluripotent stem cells |
Q34534963 | Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection |
Q42206783 | Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy. |
Q35542968 | Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells. |
Q55499094 | Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications. |
Q38751652 | Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders |
Q52902814 | Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells as an Individual-Specific and Renewable Source of Adult Stem Cells. |
Q52620145 | Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. |
Q37153107 | Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases |
Q26852052 | Human-induced pluripotent stem cell models of inherited cardiomyopathies |
Q39129176 | Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype |
Q37142352 | Human-induced pluripotent stem cell-derived cardiomyocytes for studies of cardiac ion transporters |
Q51238944 | Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade. |
Q64902699 | Human-induced pluripotent stem cell-derived cardiomyocytes have limited IKs for repolarization reserve as revealed by specific KCNQ1/KCNE1 blocker. |
Q50355610 | Human-induced pluripotent stem cell-derived macrophages and their immunological function in response to tuberculosis infection |
Q45308555 | Human-induced pluripotent stem cells as a source of hepatocyte-like cells: new kids on the block |
Q48572358 | Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain |
Q33560423 | Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders |
Q35930059 | Human-induced pluripotent stem cells generated from intervertebral disc cells improve neurologic functions in spinal cord injury |
Q38211417 | Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease |
Q82322903 | Human-induced pluripotent stem cells produced under xeno-free conditions |
Q84889430 | Human-induced pluripotent stem cells: derivation, propagation, and freezing in serum- and feeder layer-free culture conditions |
Q34251675 | Human-induced pluripotent stem cells: in quest of clinical applications |
Q38211497 | Human-induced pluripotent stem cells: potential for neurodegenerative diseases |
Q37065853 | Humanized murine model for HBV and HCV using human induced pluripotent stem cells |
Q36040255 | Hurdles to clinical translation of human induced pluripotent stem cells |
Q38860622 | Hyaline cartilage formation and tumorigenesis of implanted tissues derived from human induced pluripotent stem cells |
Q90265530 | Hybrid poly-l-lactic acid/poly(ε-caprolactone) nanofibrous scaffold can improve biochemical and molecular markers of human induced pluripotent stem cell-derived hepatocyte-like cells |
Q39102498 | Hydrogen sulfide augments the proliferation and survival of human induced pluripotent stem cell-derived mesenchymal stromal cells through inhibition of BKCa |
Q28553287 | Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q51856108 | Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells. |
Q39559786 | ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis |
Q37071939 | IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes |
Q99237660 | IP3R-Mediated Compensatory Mechanism for Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes With Cardiac Ryanodine Receptor Deficiency |
Q56768636 | Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells |
Q39173422 | Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. |
Q34585971 | Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells |
Q27320909 | Identification and purification of human induced pluripotent stem cell-derived atrial-like cardiomyocytes based on sarcolipin expression |
Q47213431 | Identification of Cardiomyocyte-Fated Progenitors from Human-Induced Pluripotent Stem Cells Marked with CD82. |
Q31092974 | Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells |
Q38730305 | Identification of active components in Yixinshu Capsule with protective effects against myocardial dysfunction on human induced pluripotent stem cell-derived cardiomyocytes by an integrative approach |
Q100527142 | Identification of an epigenetic signature in human induced pluripotent stem cells using a linear machine learning model |
Q35078142 | Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells. |
Q42028006 | Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells |
Q39195029 | Identification of proliferating human hepatic cells from human induced pluripotent stem cells |
Q39144719 | Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency |
Q91955422 | Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q38965757 | Image-based cell quality evaluation to detect irregularities under same culture process of human induced pluripotent stem cells |
Q47808382 | Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology |
Q36219290 | Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells |
Q39833141 | Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells |
Q61811755 | Immunological Properties of Neural Crest Cells Derived from Human Induced Pluripotent Stem Cells |
Q35623479 | Immunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem Cells |
Q49289725 | Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells In Vitro and In Vivo |
Q30843677 | Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue |
Q38871991 | Impact of preconditioning with retinoic acid during early development on morphological and functional characteristics of human induced pluripotent stem cell-derived neurons |
Q36741347 | Impaired ROS Scavenging System in Human Induced Pluripotent Stem Cells Generated from Patients with MERRF Syndrome |
Q91911662 | Impairment of the transition from proliferative stage to prehypertrophic stage in chondrogenic differentiation of human induced pluripotent stem cells harboring the causative mutation of achondroplasia in fibroblast growth factor receptor 3 |
Q42174272 | Implantable tissue-engineered blood vessels from human induced pluripotent stem cells |
Q57186397 | Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine |
Q35988348 | Improved Survival and Initiation of Differentiation of Human Induced Pluripotent Stem Cells to Hepatocyte-Like Cells upon Culture in William's E Medium followed by Hepatocyte Differentiation Inducer Treatment |
Q35546995 | Improved approach for chondrogenic differentiation of human induced pluripotent stem cells |
Q39977218 | Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts |
Q53473070 | Improved efficiency of definitive endoderm induction from human induced pluripotent stem cells in feeder and serum-free culture system. |
Q44602589 | Improved hepatic differentiation strategies for human induced pluripotent stem cells |
Q93095205 | Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers |
Q37094511 | Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies. |
Q35087368 | Improvement of In Vitro Osteogenic Potential through Differentiation of Induced Pluripotent Stem Cells from Human Exfoliated Dental Tissue towards Mesenchymal-Like Stem Cells |
Q64249289 | In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids |
Q48579402 | In Vitro Generation of Glucose-Responsive Insulin-Secreting Cells from Pancreatic and Duodenal Homeobox 1-Overexpressing Human-Induced Pluripotent Stem Cell Derived from Diabetic Patient |
Q91971760 | In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells |
Q50455046 | In Vitro Modeling of Alcohol-Induced Liver Injury Using Human-Induced Pluripotent Stem Cells. |
Q94473467 | In Vivo Assessment of Size-Selective Glomerular Sieving in Transplanted Human Induced Pluripotent Stem Cell-Derived Kidney Organoids |
Q64768761 | In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study |
Q35775664 | In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases |
Q104511953 | In vitro Neuromuscular Junction Induced from Human Induced Pluripotent Stem Cells |
Q47881467 | In vitro and in vivo imaging and tracking of intestinal organoids from human induced pluripotent stem cells |
Q32181083 | In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model |
Q39141804 | In vitro characterization and engraftment of adipocytes derived from human induced pluripotent stem cells and embryonic stem cells |
Q39030890 | In vitro chondrogenesis and in vivo repair of osteochondral defect with human induced pluripotent stem cells |
Q38908532 | In vitro comparative survey of cell adhesion and proliferation of human induced pluripotent stem cells on surfaces of polymeric electrospun nanofibrous and solution-cast film scaffolds. |
Q45868109 | In vitro detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human induced pluripotent stem cells. |
Q53063943 | In vitro epithelial differentiation of human induced pluripotent stem cells for vocal fold tissue engineering. |
Q82750313 | In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells |
Q37005193 | In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells |
Q90696036 | In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells |
Q91649969 | In vitro osteogenic differentiation potential of the human induced pluripotent stem cells augments when grown on Graphene oxide-modified nanofibers |
Q39847919 | In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes |
Q34034653 | In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. |
Q35834934 | In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. |
Q92436206 | In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation |
Q45909098 | In vivo multi-modality tracking of the regenerative effects of the human induced pluripotent stem cell-derived cardiomyocytes (iCMs). |
Q60721830 | In vivo tissue engineering chamber supports human induced pluripotent stem cell survival and rapid differentiation |
Q38071032 | In-a-dish: induced pluripotent stem cells as a novel model for human diseases |
Q33992629 | In-depth characterisation of Retinal Pigment Epithelium (RPE) cells derived from human induced pluripotent stem cells (hiPSC). |
Q62001619 | Inability of Human Induced Pluripotent Stem Cell-Hematopoietic Derivatives to Downregulate MicroRNAs In Vivo Reveals a Block in Xenograft Hematopoietic Regeneration |
Q62001614 | Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration |
Q91972857 | Incorporated-bFGF polycaprolactone/polyvinylidene fluoride nanocomposite scaffold promotes human induced pluripotent stem cells osteogenic differentiation |
Q64259791 | Increased Cytotoxicity of Herpes Simplex Virus Thymidine Kinase Expression in Human Induced Pluripotent Stem Cells |
Q38695115 | Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease. |
Q50420684 | Induced Pluripotent Stem Cells and Precision Medicine in Human Liver Disease |
Q57454780 | Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development |
Q42057000 | Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva |
Q37852240 | Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia? |
Q37532537 | Induced human pluripotent stem cells: promises and open questions |
Q38295058 | Induced pluripotent cells mimicking human embryonic stem cells. |
Q38596939 | Induced pluripotent stem (iPS) cells from human fetal stem cells |
Q37265783 | Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs). |
Q39569381 | Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts |
Q27860597 | Induced pluripotent stem cell lines derived from human somatic cells |
Q51919490 | Induced pluripotent stem cell technology for the study of human disease. |
Q58782286 | Induced pluripotent stem cell-based mapping of β-globin expression throughout human erythropoietic development |
Q38095451 | Induced pluripotent stem cell-derived hepatocytes as an alternative to human adult hepatocytes |
Q33393364 | Induced pluripotent stem cell-derived human platelets: one step closer to the clinic |
Q39940953 | Induced pluripotent stem cells and human disease |
Q46150911 | Induced pluripotent stem cells derived from human amnion in chemically defined conditions. |
Q35088519 | Induced pluripotent stem cells for modelling human diseases |
Q42367676 | Induced pluripotent stem cells from human hair follicle keratinocytes as a potential source for in vitro hair follicle cloning |
Q34317885 | Induced pluripotent stem cells from human hair follicle mesenchymal stem cells |
Q84380282 | Induced pluripotent stem cells from human kidney |
Q50694660 | Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications. |
Q42468979 | Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa |
Q37479896 | Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation |
Q34034169 | Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions |
Q37598915 | Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells |
Q41862093 | Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma |
Q37860540 | Induced pluripotent stem cells: a new technology to study human diseases |
Q34852041 | Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies |
Q50352858 | Induced pluripotent stem cell–derived human platelets: one step closer to the clinic |
Q48540292 | Induced reprogramming of human somatic cells into pluripotency: a new way how to generate pluripotent stem cells |
Q89940613 | Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach |
Q53062024 | Induction and differentiation of human induced pluripotent stem cells into functional cardiomyocytes on a compartmented monolayer of gelatin nanofibers. |
Q27437615 | Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A |
Q39855160 | Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report |
Q89484546 | Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies |
Q96351295 | Induction of Skeletal Muscle Progenitors and Stem Cells from human induced Pluripotent Stem Cells |
Q36228319 | Induction of Skin-Derived Precursor Cells from Human Induced Pluripotent Stem Cells |
Q37395293 | Induction of estrogen-sensitive epithelial cells derived from human-induced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure |
Q36285923 | Induction of hair follicle dermal papilla cell properties in human induced pluripotent stem cell-derived multipotent LNGFR(+)THY-1(+) mesenchymal cells |
Q33551978 | Induction of human embryonic and induced pluripotent stem cells into urothelium |
Q48067309 | Induction of long-term potentiation and depression phenomena in human induced pluripotent stem cell-derived cortical neurons |
Q50701327 | Induction of neural crest cells from human dental pulp-derived induced pluripotent stem cells. |
Q39520271 | Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells |
Q55264050 | Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells. |
Q40911800 | Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells |
Q31121490 | Influence of field potential duration on spontaneous beating rate of human induced pluripotent stem cell-derived cardiomyocytes: Implications for data analysis and test system selection |
Q92694676 | Influence of substrate stiffness on human induced pluripotent stem cells: preliminary results |
Q51045083 | Influence of surface roughness on neural differentiation of human induced pluripotent stem cells. |
Q63740029 | Influenza a virus-triggered autophagy decreases the pluripotency of human-induced pluripotent stem cells |
Q95259987 | Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells |
Q44019514 | Inhibition of Notch signaling facilitates the differentiation of human-induced pluripotent stem cells into neural stem cells |
Q89909156 | Inhibition of Rho-associated protein kinase improves the survival of human induced pluripotent stem cell-derived cardiomyocytes after dissociation |
Q42543495 | Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS |
Q89951778 | Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity |
Q90771635 | Inhibition of long noncoding RNA BLACAT1 protects anesthesia-induced neural cytotoxicity in human induced pluripotent stem cells derived neurons |
Q49108639 | Inhibition of microRNA-495 Enhances Therapeutic Angiogenesis of Human Induced Pluripotent Stem Cells |
Q38772128 | Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes |
Q39195109 | Inhibition of neuronal nitric oxide synthase activity promotes migration of human-induced pluripotent stem cell-derived neural stem cells toward cancer cells |
Q95835600 | Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells |
Q30388647 | Innervation of Cochlear Hair Cells by Human Induced Pluripotent Stem Cell-Derived Neurons In Vitro |
Q97094347 | Inotropic Assessment in Engineered 3D Cardiac Tissues using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in the BiowireTM II Platform |
Q90468480 | Insights into the Mutational Burden of Human Induced Pluripotent Stem Cells from an Integrative Multi-Omics Approach |
Q89473781 | Insulin-Deficient Diabetic Condition Upregulates the Insulin-Secreting Capacity of Human Induced Pluripotent Stem Cell-Derived Pancreatic Endocrine Progenitor Cells After Implantation in Mice |
Q57042291 | Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage |
Q40120128 | Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix |
Q38943439 | Integration-Free Human Induced Pluripotent Stem Cells From Type 1 Diabetes Patient Skin Fibroblasts Show Increased Abundance of Pancreas-Specific microRNAs |
Q40608440 | Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC1. |
Q40608453 | Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC2. |
Q40608446 | Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC4. |
Q40681020 | Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with lymphedema-distichiasis syndrome (LDS) carrying an insertion-deletion complex mutation in the FOXC2 gene. |
Q40608434 | Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with recessive dystrophic epidermolysis bullosa (RDEB) carrying two compound heterozygous mutations in the COL7A1 gene. |
Q51094244 | Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T). |
Q42217995 | Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification |
Q59354013 | Integration-free reprogramming of human umbilical arterial endothelial cells into induced pluripotent stem cells IHSTMi001-A |
Q38467233 | Integrative genomics and transcriptomics analysis of human embryonic and induced pluripotent stem cells |
Q38752151 | Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells |
Q41239463 | Interaction of Salmonella enterica Serovar Typhimurium with Intestinal Organoids Derived from Human Induced Pluripotent Stem Cells. |
Q92141603 | Interfacing human induced pluripotent stem cell-derived neurons with designed nanowire arrays as a future platform for medical applications |
Q100558933 | Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells |
Q35816898 | Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells. |
Q58696730 | International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment |
Q42582149 | International coordination of large-scale human induced pluripotent stem cell initiatives: Wellcome Trust and ISSCR workshops white paper |
Q51790493 | Interrogation of the Atherosclerosis-Associated SORT1 (Sortilin 1) Locus With Primary Human Hepatocytes, Induced Pluripotent Stem Cell-Hepatocytes, and Locus-Humanized Mice. |
Q58802343 | Interrupted reprogramming into induced pluripotent stem cells does not rejuvenate human mesenchymal stromal cells |
Q96835280 | Intrinsic Color Sensing System Allows for Real-Time Observable Functional Changes on Human Induced Pluripotent Stem Cell Derived Cardiomyocytes |
Q42434697 | Introduction to thematic minireview series: Development of human therapeutics based on induced pluripotent stem cell (iPSC) technology |
Q37724485 | Inverting microwell array chip for the cultivation of human induced pluripotent stem cells with controlled aggregate size and geometrical arrangement. |
Q92666363 | Investigating the Therapeutic Mechanism of Cannabidiol in a Human Induced Pluripotent Stem Cell (iPSC)-Based Model of Dravet Syndrome |
Q37671529 | Investigating the feasibility of scale up and automation of human induced pluripotent stem cells cultured in aggregates in feeder free conditions |
Q40631630 | Investigating the functionality of an OCT4-short response element in human induced pluripotent stem cells |
Q96644055 | Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells |
Q53097046 | Investigation of the effect of α-melanocyte-stimulating hormone on proliferation and early stages of differentiation of human induced pluripotent stem cells. |
Q51339395 | Investigation of the effects of GABA receptor agonists in the differentiation of human induced pluripotent stem cells into dopaminergic neurons. |
Q92614219 | Investigation of the optimal suspension culture time for the osteoblastic differentiation of human induced pluripotent stem cells using the embryoid body method |
Q28550529 | Involvement of Polycomb Repressive Complex 2 in Maturation of Induced Pluripotent Stem Cells during Reprogramming of Mouse and Human Fibroblasts |
Q86235207 | Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells |
Q38976259 | Involvement of β-adrenoceptors in the differentiation of human induced pluripotent stem cells into mesodermal progenitor cells |
Q91770907 | In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids |
Q42321262 | In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts |
Q91719887 | In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: Current status and disadvantages to overcome |
Q38710931 | In vitro model of cerebral ischemia by using brain microvascular endothelial cells derived from human induced pluripotent stem cells |
Q52657121 | Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q35042164 | Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1. |
Q41510841 | Irradiation strongly reduces tumorigenesis of human induced pluripotent stem cells |
Q52631688 | Is Human-induced Pluripotent Stem Cell the Best Optimal? |
Q37014695 | Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q57962393 | Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells |
Q37660450 | Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation |
Q28830469 | JNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells |
Q90043266 | Jiadifenolide induces the expression of cellular communication network factor (CCN) genes, and CCN2 exhibits neurotrophic activity in neuronal precursor cells derived from human induced pluripotent stem cells |
Q45047169 | Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells |
Q35644491 | Ketamine causes mitochondrial dysfunction in human induced pluripotent stem cell-derived neurons |
Q36934047 | Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells. |
Q38412608 | Kidney regeneration from human induced pluripotent stem cells |
Q92150957 | Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia |
Q53083304 | Kinetic analysis of deviation from the undifferentiated state in colonies of human induced pluripotent stem cells on feeder layers. |
Q92345280 | Kinetic modeling of human induced pluripotent stem cell expansion in suspension culture |
Q91887721 | Kinetics on aggregate behaviors of human induced pluripotent stem cells in static suspension and rotating flow cultures |
Q89749893 | Kojic acid alters pheomelanin content in human induced pluripotent stem cell-derived melanocytes |
Q42177279 | Label-free characterization of living human induced pluripotent stem cells by subcellular topographic imaging technique using full-field quantitative phase microscopy coupled with interference reflection microscopy |
Q36912011 | Label-free imaging of metabolism and oxidative stress in human induced pluripotent stem cell-derived cardiomyocytes |
Q90761014 | Laminin 221 fragment is suitable for the differentiation of human induced pluripotent stem cells into brain microvascular endothelial-like cells with robust barrier integrity |
Q38776304 | Laminin 411 and 511 promote the cholangiocyte differentiation of human induced pluripotent stem cells. |
Q64231116 | Laminin as a Potent Substrate for Large-Scale Expansion of Human Induced Pluripotent Stem Cells in a Closed Cell Expansion System |
Q92274416 | Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells |
Q37972793 | Large animal induced pluripotent stem cells as pre-clinical models for studying human disease |
Q34581070 | Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells |
Q46686884 | Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells. |
Q59808929 | Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes |
Q89480082 | Large-Scale Single-Cell RNA-Seq Reveals Molecular Signatures of Heterogeneous Populations of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells |
Q42245259 | Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies |
Q51415999 | Laser bioprinting of human induced pluripotent stem cells - the effect of printing and biomaterials on cell survival, pluripotency, and differentiation. |
Q35389798 | Laser-assisted generation of human induced pluripotent stem cells |
Q93095848 | Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models |
Q50054103 | Lessons for reviewing clinical trials using induced pluripotent stem cells: examining the case of a first-in-human trial for age-related macular degeneration |
Q92155288 | Letter by Hilfiker-Kleiner et al Regarding Article, "Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes" |
Q36182364 | Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells |
Q92365585 | Leveraging Human Induced Pluripotent Stem Cell-Based Models Provides Biological Context to Genome-wide Association Study Findings |
Q36667033 | Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q47317638 | Light-focusing human micro-lenses generated from pluripotent stem cells model lens development and drug-induced cataract in vitro |
Q87664417 | Light-sensitive retina tissue developed from human-induced pluripotent stem cells |
Q39619838 | Limited Immunogenicity of Human Induced Pluripotent Stem Cell-Derived Cartilages. |
Q36484426 | Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells |
Q53226699 | Limited hair cell induction from human induced pluripotent stem cells using a simple stepwise method. |
Q33774097 | Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes |
Q53715675 | Live Cell Imaging in Microfluidic Device Proves Resistance to Oxygen/Glucose Deprivation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q64074244 | Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells |
Q89963823 | Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease |
Q28542672 | Long non-coding RNAs as surrogate indicators for chemical stress responses in human-induced pluripotent stem cells |
Q38716434 | Long-Distance Axonal Growth and Protracted Functional Maturation of Neurons Derived from Human Induced Pluripotent Stem Cells After Intracerebral Transplantation. |
Q91193940 | Long-Term Retinal Differentiation of Human Induced Pluripotent Stem Cells in a Continuously Perfused Microfluidic Culture Device |
Q92256841 | Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells |
Q34088886 | Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury |
Q100507586 | Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes |
Q87061647 | Long-term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture |
Q59062372 | Long-term expansion of human induced pluripotent stem cells in a microcarrier-based dynamic system |
Q27306156 | Long-term maintenance of human induced pluripotent stem cells by automated cell culture system |
Q42815582 | Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension |
Q24600170 | Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa |
Q39679915 | Long-term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors |
Q99200483 | Loss-of-function mutations of CUL3, a high confidence gene for psychiatric disorders, lead to aberrant neurodevelopment in human induced pluripotent stem cells |
Q33830565 | Low extracellular potassium prolongs repolarization and evokes early afterdepolarization in human induced pluripotent stem cell-derived cardiomyocytes |
Q34030950 | Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression |
Q83347934 | Low microRNA-199a expression in human amniotic epithelial cell feeder layers maintains human-induced pluripotent stem cell pluripotency via increased leukemia inhibitory factor expression |
Q50210670 | Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells |
Q35983860 | Lower Oncogenic Potential of Human Mesenchymal Stem Cells Derived from Cord Blood Compared to Induced Pluripotent Stem Cells. |
Q64443825 | Luminescent peptide tagging enables efficient screening for CRISPR-mediated knock-in in human induced pluripotent stem cells |
Q64443829 | Luminescent peptide tagging enables efficient screening for CRISPR-mediated knock-in in human induced pluripotent stem cells |
Q92298903 | Luminescent peptide tagging enables efficient screening for CRISPR-mediated knock-in in human induced pluripotent stem cells |
Q49787437 | Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells. |
Q50432427 | Lysophosphatidic acid signaling regulates the KLF9-PPARγ axis in human induced pluripotent stem cell-derived neurons |
Q38834263 | Machine Learning Approach to Automated Quality Identification of Human Induced Pluripotent Stem Cell Colony Images. |
Q100526114 | Machine learning identifies abnormal Ca2+ transients in human induced pluripotent stem cell-derived cardiomyocytes |
Q96685995 | Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated "Naïve-Like" Cells Capable of Restricting Mycobacteria Growth |
Q98394701 | Magnetic heating of nanoparticles as a scalable cryopreservation technology for human induced pluripotent stem cells |
Q38281927 | Maintenance of an undifferentiated state of human induced pluripotent stem cells through migration-dependent regulation of the balance between cell-cell and cell-substrate interactions. |
Q53521428 | Maintenance of undifferentiated state of human induced pluripotent stem cells through cytoskeleton-driven force acting to secreted fibronectin on a dendrimer-immobilized surface. |
Q42819036 | Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells |
Q36800354 | Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons. |
Q58111146 | Many Cells Make Life Work-Multicellularity in Stem Cell-Based Cardiac Disease Modelling |
Q37410193 | Marked Differences in C9orf72 Methylation Status and Isoform Expression between C9/ALS Human Embryonic and Induced Pluripotent Stem Cells. |
Q36283727 | Marked hyperglycemia attenuates anesthetic preconditioning in human-induced pluripotent stem cell-derived cardiomyocytes. |
Q50052667 | Mast cells derived from human induced pluripotent stem cells are useful for allergen tests |
Q36348901 | Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q91456454 | Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells |
Q34344826 | Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). |
Q39126523 | May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells |
Q34764182 | MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. |
Q50140931 | Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells |
Q34153953 | Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts |
Q43276365 | Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue. |
Q54539986 | Mechanical stimulation of cyclic tensile strain induces reduction of pluripotent related gene expressions via activation of Rho/ROCK and subsequent decreasing of AKT phosphorylation in human induced pluripotent stem cells. |
Q41109305 | Mechanically stable fibrin scaffolds promote viability and induce neurite outgrowth in neural aggregates derived from human induced pluripotent stem cells. |
Q35538120 | Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells |
Q36675819 | Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells |
Q42445977 | Mechanistic basis of excitation-contraction coupling in human pluripotent stem cell-derived ventricular cardiomyocytes revealed by Ca2+ spark characteristics: direct evidence of functional Ca2+-induced Ca2+ release |
Q39915269 | Mechano-Pharmacological Characterization of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells |
Q35997943 | Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells |
Q43087804 | Melanocytes derived from transgene-free human induced pluripotent stem cells. |
Q101372450 | Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells |
Q39649746 | Memory in Induced Pluripotent Stem Cells: Reprogrammed Human Retinal-Pigmented Epithelial Cells Show Tendency for Spontaneous Redifferentiation |
Q49065473 | Mesenchymal Stem Cells Contribute to Hepatic Maturation of Human Induced Pluripotent Stem Cells. |
Q37712716 | Mesenchymal stem cell-conditioned medium enhances osteogenic and chondrogenic differentiation of human embryonic stem cells and human induced pluripotent stem cells by mesodermal lineage induction |
Q39217547 | Mesenchymal stem cells as an appropriate feeder layer for prolonged in vitro culture of human induced pluripotent stem cells |
Q36563846 | Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis |
Q38843031 | Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity |
Q91154199 | Metabolic Changes in Focal Brain Ischemia in Rats Treated With Human Induced Pluripotent Stem Cell-Derived Neural Precursors Confirm the Beneficial Effect of Transplanted Cells |
Q57463835 | Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay |
Q50132961 | Metabolism of Fentanyl and Acetylfentanyl in Human-Induced Pluripotent Stem Cell-Derived Hepatocytes |
Q38831212 | Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes |
Q91665722 | Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming |
Q92208910 | Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells |
Q89073952 | Metformin Preconditioning of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells Promotes Their Engraftment and Improves Post-Stroke Regeneration and Recovery |
Q48156971 | Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells. |
Q88588355 | Method for High Speed Stretch Injury of Human Induced Pluripotent Stem Cell-derived Neurons in a 96-well Format |
Q45943932 | Method for evaluation of human induced pluripotent stem cell quality using image analysis based on the biological morphology of cells. |
Q38954631 | Methylation and transcripts expression at the imprinted GNAS locus in human embryonic and induced pluripotent stem cells and their derivatives |
Q27318046 | Mfn2 is Required for Mitochondrial Development and Synapse Formation in Human Induced Pluripotent Stem Cells/hiPSC Derived Cortical Neurons |
Q50478331 | MiRNA Profiling in Human Induced Pluripotent Stem Cells. |
Q92083559 | Micro Vacuum Chuck and Tensile Test System for Bio-Mechanical Evaluation of 3D Tissue Constructed of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPS-CM) |
Q38046102 | MicroRNA expression profiling of human-induced pluripotent and embryonic stem cells |
Q55318216 | MicroRNA profiling during directed differentiation of cortical interneurons from human-induced pluripotent stem cells. |
Q42798873 | MicroRNA profiling of human-induced pluripotent stem cells |
Q36889862 | MicroRNA-122 influences the development of sperm abnormalities from human induced pluripotent stem cells by regulating TNP2 expression |
Q41913466 | MicroRNA-211 and autophagy-related gene 14 signaling regulate osteoblast-like cell differentiation of human induced pluripotent stem cells |
Q38823327 | MicroRNA-494 plays a role in fiber type-specific skeletal myogenesis in human induced pluripotent stem cells |
Q38012445 | MicroRNAs and induced pluripotent stem cells for human disease mouse modeling |
Q40026732 | MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes |
Q93344756 | Microarray analysis of long non-coding RNA and mRNA expression profiles in diabetic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes |
Q85676794 | Microencapsulation of dopamine neurons derived from human induced pluripotent stem cells |
Q90370147 | Microfluidic Assay for the Assessment of Leukocyte Adhesion to Human Induced Pluripotent Stem Cell-derived Endothelial Cells (hiPSC-ECs) |
Q35754348 | Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction |
Q39316508 | Microfluidic perfusion culture of human induced pluripotent stem cells under fully defined culture conditions |
Q93229669 | Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms |
Q35904629 | Micropattern size-dependent endothelial differentiation from a human induced pluripotent stem cell line |
Q92312924 | Micropatterned substrates with physiological stiffness promote cell maturation and Pompe disease phenotype in human induced pluripotent stem cell-derived skeletal myocytes |
Q92562613 | Migration and Synaptic Aspects of Neurons Derived from Human Induced Pluripotent Stem Cells from Patients with Focal Cortical Dysplasia II |
Q39112938 | Mild hypothermia inhibits differentiation of human embryonic and induced pluripotent stem cells |
Q34613151 | Mineralized gelatin methacrylate-based matrices induce osteogenic differentiation of human induced pluripotent stem cells |
Q50050496 | Mining Exosomal MicroRNAs from Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes for Cardiac Regeneration. |
Q36444101 | Mitochondrial Respiratory Defect Causes Dysfunctional Lactate Turnover via AMP-activated Protein Kinase Activation in Human-induced Pluripotent Stem Cell-derived Hepatocytes |
Q38786696 | Mitomycin C-treated human-induced pluripotent stem cells as a safe delivery system of gold nanorods for targeted photothermal therapy of gastric cancer |
Q28076026 | Modeling ALS with motor neurons derived from human induced pluripotent stem cells |
Q43167876 | Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells. |
Q59050623 | Modeling Cardiac Congenital Diseases: From Mathematic Tools to Human Induced Pluripotent Stem Cells |
Q36864827 | Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes |
Q63740043 | Modeling Herpes Simplex Virus 1 Infections in Human Central Nervous System Neuronal Cells Using Two- and Three-Dimensional Cultures Derived from Induced Pluripotent Stem Cells |
Q38745828 | Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma |
Q92881218 | Modeling Leukemia with Human Induced Pluripotent Stem Cells |
Q49601349 | Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells |
Q38772990 | Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells |
Q50303436 | Modeling Non-Syndromic Autism with Human-Induced Pluripotent Stem Cells |
Q90667226 | Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes |
Q38806507 | Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells |
Q97553886 | Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q52638086 | Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q58562640 | Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic Mutations |
Q41628207 | Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells. |
Q26799933 | Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems |
Q100533628 | Modeling alcohol-induced neurotoxicity using human induced pluripotent stem cell-derived three-dimensional cerebral organoids |
Q42590003 | Modeling and therapy of human liver diseases using induced pluripotent stem cells: how far have we come? |
Q92570903 | Modeling blood diseases with human induced pluripotent stem cells |
Q47109981 | Modeling cadmium-induced endothelial toxicity using human pluripotent stem cell-derived endothelial cells |
Q27314983 | Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells |
Q37896861 | Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells |
Q37377238 | Modeling early retinal development with human embryonic and induced pluripotent stem cells |
Q35787014 | Modeling hepatitis C virus infection using human induced pluripotent stem cells |
Q34639912 | Modeling human cortical development in vitro using induced pluripotent stem cells |
Q51417867 | Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. |
Q55294567 | Modeling human early otic sensory cell development with induced pluripotent stem cells. |
Q35056065 | Modeling human neurological disorders with induced pluripotent stem cells |
Q39190546 | Modeling human protein aggregation cardiomyopathy using murine induced pluripotent stem cells |
Q39023402 | Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeobox 2. |
Q57167748 | Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells |
Q33672762 | Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. |
Q92385002 | Modeling methodology for defining a priori the hydrodynamics of a dynamic suspension bioreactor. Application to human induced pluripotent stem cell culture |
Q27011777 | Modeling neurological disorders by human induced pluripotent stem cells |
Q94596059 | Modeling neuronal consequences of autism-associated gene regulatory variants with human induced pluripotent stem cells |
Q92330251 | Modeling neuropsychiatric disorders using human induced pluripotent stem cells |
Q92816390 | Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells |
Q45145500 | Modeling of Menkes disease via human induced pluripotent stem cells |
Q44692219 | Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells |
Q34322985 | Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells |
Q38493320 | Modeling of human cardiomyopathy with induced pluripotent stem cells |
Q30696630 | Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells |
Q41660541 | Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. |
Q38741408 | Modeling the C9ORF72 repeat expansion mutation using human induced pluripotent stem cells |
Q46068455 | Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells |
Q42654196 | Modeling the behavior of human induced pluripotent stem cells seeded on melt electrospun scaffolds |
Q92807303 | Modeling the congenital heart condition of pulmonary atresia with intact ventricular septum using human induced pluripotent stem cells |
Q38979888 | Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells. |
Q38795021 | Modelling Chemotherapy-induced Cardiotoxicity by Human Pluripotent Stem Cells |
Q91037322 | Modelling Neurotropic Flavivirus Infection in Human Induced Pluripotent Stem Cell-Derived Systems |
Q60618587 | Modelling a Genetic Risk for Schizophrenia in Human Induced Pluripotent Stem Cells (Ipscs): Phenotypic Differences in Patients with Mutations in Nde1 |
Q35088526 | Modelling familial dysautonomia in human induced pluripotent stem cells |
Q55060450 | Modelling human calmodulinopathies with induced pluripotent stem cells: progress and challenges. |
Q38114432 | Modelling human channelopathies using induced pluripotent stem cells: a comprehensive review |
Q91249900 | Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential |
Q92573469 | Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells |
Q24633007 | Modelling schizophrenia using human induced pluripotent stem cells |
Q91644609 | Modelling the neuropathology of lysosomal storage disorders through disease-specific human induced pluripotent stem cells |
Q84450860 | Modified hyaluronan hydrogels support the maintenance of mouse embryonic stem cells and human induced pluripotent stem cells |
Q90848932 | Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes |
Q35211486 | Modulating notochordal differentiation of human induced pluripotent stem cells using natural nucleus pulposus tissue matrix |
Q89515762 | Modulation of oxygen tension, acidosis, and cell density is crucial for neural differentiation of human induced pluripotent stem cells |
Q36968311 | Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis |
Q93159513 | Molecular Profiling of Human Induced Pluripotent Stem Cell Derived Cells and Their Application for the Drug Safety Study |
Q39029598 | Molecular Profiling of Human Induced Pluripotent Stem Cell-Derived Hypothalamic Neurones Provides Developmental Insights into Genetic Loci for Body Weight Regulation. |
Q91590685 | Molecular Signatures of Beneficial Class Effects of Statins on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q35746644 | Molecular analyses of human induced pluripotent stem cells and embryonic stem cells |
Q39162404 | Molecular and functional analyses of motor neurons generated from human cord-blood-derived induced pluripotent stem cells |
Q51902673 | Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. |
Q36655275 | Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes |
Q34494232 | Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters |
Q50059582 | Monitoring cell line identity in collections of human induced pluripotent stem cells. |
Q99349125 | Monoclonal antibodies specific for podocalyxin expressed on human induced pluripotent stem cells |
Q42014277 | Morphologic and gene expression criteria for identifying human induced pluripotent stem cells. |
Q38942575 | Morphological analysis of human induced pluripotent stem cells during induced differentiation and reverse programming |
Q40596694 | Morphological and functional characterization of human induced pluripotent stem cell-derived neurons (iCell Neurons) in defined culture systems |
Q45774385 | Morphological differences of primary cilia between human induced pluripotent stem cells and their parental somatic cells |
Q26822886 | Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives |
Q39784395 | Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors |
Q48375979 | Mouse decellularised liver scaffold improves human embryonic and induced pluripotent stem cells differentiation into hepatocyte-like cells |
Q52683830 | Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity. |
Q26750384 | Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases |
Q35088938 | Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells |
Q101571298 | Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells |
Q24612314 | Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts |
Q28828176 | Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch |
Q36937559 | Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells |
Q34294018 | Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterparts |
Q35982232 | Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells |
Q43203940 | Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia. |
Q50960979 | Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold. |
Q49957679 | Myofilament Calcium-Buffering Dependent Action Potential Triangulation in Human-Induced Pluripotent Stem Cell Model of Hypertrophic Cardiomyopathy |
Q98938385 | Myogenic progenitor cells derived from human induced pluripotent stem cell are immune-tolerated in humanized mice |
Q39216159 | Myostatin acts as an autocrine/paracrine negative regulator in myoblast differentiation from human induced pluripotent stem cells. |
Q36607500 | Myotubes derived from human-induced pluripotent stem cells mirror in vivo insulin resistance |
Q39102919 | N-glycoprotein surfaceome of human induced pluripotent stem cell derived hepatic endoderm. |
Q101136121 | NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells |
Q89896107 | NOTO Transcription Factor Directs Human Induced Pluripotent Stem Cell-Derived Mesendoderm Progenitors to a Notochordal Fate |
Q90799505 | NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells |
Q47706784 | Nanaomycin A treatment promotes hepatoblast differentiation from human induced Pluripotent Stem cells |
Q58555372 | Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2 |
Q46838606 | Nanofiber-based polyethersulfone scaffold and efficient differentiation of human induced pluripotent stem cells into osteoblastic lineage. |
Q38792064 | Nanotopography Promotes Pancreatic Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells |
Q45041720 | Nanotopography promoted neuronal differentiation of human induced pluripotent stem cells |
Q38909521 | Nanotopography-Induced Structural Anisotropy and Sarcomere Development in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells. |
Q38989028 | Native nucleus pulposus tissue matrix promotes notochordal differentiation of human induced pluripotent stem cells with potential for treating intervertebral disc degeneration. |
Q91584029 | Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells |
Q91550207 | Natural killer cell alloreactivity against human induced pluripotent stem cells and their neuronal derivatives into dopaminergic neurons |
Q51068795 | Negating the dominant-negative allele: a new treatment paradigm for arrhythmias explored in human induced pluripotent stem cell-derived cardiomyocytes. |
Q35517873 | Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts |
Q47325614 | Neonatal mouse cortical but not isogenic human astrocyte feeder layers enhance the functional maturation of induced pluripotent stem cell-derived neurons in culture. |
Q38751444 | Neural Stem Cell or Human Induced Pluripotent Stem Cell-Derived GABA-ergic Progenitor Cell Grafting in an Animal Model of Chronic Temporal Lobe Epilepsy. |
Q33365627 | Neural Stem Cells and Human induced pluripotent stem cells to model rare CNS diseases |
Q100726173 | Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington's Disease |
Q47573614 | Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II. |
Q33732735 | Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency |
Q50605036 | Neural differentiation of human induced pluripotent stem cells on polycaprolactone/gelatin bi-electrospun nanofibers. |
Q48655584 | Neural patterning of human induced pluripotent stem cells in 3-D cultures for studying biomolecule-directed differential cellular responses |
Q87128799 | Neural progenitor cells from human induced pluripotent stem cells generated less autogenous immune response |
Q40884175 | Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis |
Q48260036 | Neurite extension and neuronal differentiation of human induced pluripotent stem cell derived neural stem cells on polyethylene glycol hydrogels containing a continuous Young's Modulus gradient. |
Q35917058 | Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity |
Q42385406 | Neurobiology meets genomic science: the promise of human-induced pluripotent stem cells |
Q92504798 | Neuroinflammatory astrocytes generated from cord blood-derived human induced pluripotent stem cells |
Q37344024 | Neuronal Differentiation of a Human Induced Pluripotent Stem Cell Line (FS-1) Derived from Newborn Foreskin Fibroblasts |
Q51039524 | Neuronal cells derived from human induced pluripotent stem cells as a functional tool of melanocortin system. |
Q92623489 | Neurons Derived from Human Induced Pluripotent Stem Cells Integrate into Rat Brain Circuits and Maintain Both Excitatory and Inhibitory Synaptic Activities |
Q60921210 | Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons |
Q87155469 | Neurotrophic activity of jiadifenolide on neuronal precursor cells derived from human induced pluripotent stem cells |
Q39644354 | Neutrophil differentiation from human‐induced pluripotent stem cells |
Q64265388 | Neutrophils Derived from Genetically Modified Human Induced Pluripotent Stem Cells Circulate and Phagocytose Bacteria In Vivo |
Q53086270 | New Method for Sorting Endothelial and Neural Progenitors from Human Induced Pluripotent Stem Cells by Sedimentation Field Flow Fractionation. |
Q35109502 | New approaches in the differentiation of human embryonic stem cells and induced pluripotent stem cells toward hepatocytes |
Q42993190 | New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells |
Q33716184 | Next-generation sequencing traces human induced pluripotent stem cell lines clonally generated from heterogeneous cancer tissue |
Q35215395 | No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells. |
Q36781413 | Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions |
Q90575279 | Non-viral vector based gene transfection with human induced pluripotent stem cells derived cardiomyocytes |
Q30557594 | Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced pluripotent stem cells through ROCK activation |
Q96769666 | Noninvasive OCT Imaging of Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells |
Q45838181 | Noninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrin-targeting agent (99m)Tc-3PRGD2. |
Q39178214 | Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells |
Q46772364 | Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells |
Q35839545 | Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection |
Q64100497 | Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold |
Q52610364 | Novel imprinted single CpG sites found by global DNA methylation analysis in human parthenogenetic induced pluripotent stem cells. |
Q39265792 | Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology |
Q39014752 | Nuclear receptor gene alteration in human induced pluripotent stem cells with hepatic differentiation propensity. |
Q41851864 | Nuclease-mediated double-strand break (DSB) enhancement of small fragment homologous recombination (SFHR) gene modification in human-induced pluripotent stem cells (hiPSCs) |
Q42238779 | ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells |
Q50624142 | Objective evaluation of the degree of pigmentation in human induced pluripotent stem cell-derived RPE. |
Q50763906 | Oncostatin M in William's E medium is suitable for initiation of hepatocyte differentiation in human induced pluripotent stem cells. |
Q46499884 | Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart |
Q92628886 | Opacification of lentoid bodies derived from human induced pluripotent stem cells is accelerated by hydrogen peroxide and involves protein aggregation |
Q64060127 | Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients |
Q94475324 | Optimization of activin-A: a breakthrough in differentiation of human induced pluripotent stem cell into definitive endoderm |
Q59350450 | Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts |
Q57188589 | Optimization of the treatment conditions with glycogen synthase kinase-3 inhibitor towards enhancing the proliferation of human induced pluripotent stem cells while maintaining an undifferentiated state under feeder-free conditions |
Q95642495 | Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors |
Q50090393 | Optimizing Human Induced Pluripotent Stem Cell Expansion in Stirred-Suspension Culture |
Q100438710 | Optimizing the Direction and Order of the Motion Unveiled the Ability of Conventional Monolayers of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Show Frequency-Dependent Enhancement of Contraction and Relaxation Motion |
Q55452593 | Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood. |
Q48567791 | Optogenetics reveal delayed afferent synaptogenesis on grafted human-induced pluripotent stem cell-derived neural progenitors |
Q39013563 | Osteogenesis from human induced pluripotent stem cells: an in vitro and in vivo comparison with mesenchymal stem cells |
Q98283289 | Overexpression of TBX3 in human induced pluripotent stem cells (hiPSCs) increases their differentiation into cardiac pacemaker-like cells |
Q52659786 | Overexpression of miR-219 promotes differentiation of human induced pluripotent stem cells into pre-oligodendrocyte. |
Q92285222 | Overexpression of microRNA-375 and microRNA-122 promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells |
Q37664120 | Overexpression of myocardin induces partial transdifferentiation of human-induced pluripotent stem cell-derived mesenchymal stem cells into cardiomyocytes |
Q40972000 | PAX2 is dispensable for in vitro nephron formation from human induced pluripotent stem cells. |
Q58200104 | PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells |
Q104075976 | PHBV nanofibers promotes insulin-producing cells differentiation of human induced pluripotent stem cells |
Q98196242 | PKD1-Dependent Renal Cystogenesis in Human Induced Pluripotent Stem Cell-Derived Ureteric Bud/Collecting Duct Organoids |
Q92337887 | Paracrine interactions involved in human induced pluripotent stem cells differentiation into chondrocytes |
Q48148269 | Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells |
Q47648262 | Parallel derivation of isogenic human primed and naive induced pluripotent stem cells |
Q24304882 | Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells |
Q91835827 | Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells |
Q91925734 | Particulate matter 2.5 induced arrhythmogenesis mediated by TRPC3 in human induced pluripotent stem cell-derived cardiomyocytes |
Q41661139 | Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp |
Q36440760 | Patient-Derived Human Induced Pluripotent Stem Cells From Gingival Fibroblasts Composited With Defined Nanohydroxyapatite/Chitosan/Gelatin Porous Scaffolds as Potential Bone Graft Substitutes |
Q36409821 | Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2. |
Q36169155 | Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia |
Q90030588 | Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome |
Q100669767 | Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells |
Q38819350 | Peptide-conjugated hyaluronic acid surface for the culture of human induced pluripotent stem cells under defined conditions |
Q54498000 | Peptide-decorated polyvinyl alcohol/hyaluronan nanofibers for human induced pluripotent stem cell culture. |
Q33529091 | Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells |
Q38183732 | Perspectives for induced pluripotent stem cell technology: new insights into human physiology involved in somatic mosaicism |
Q60303926 | Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research |
Q92086356 | Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies |
Q45843465 | Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes |
Q97527445 | Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells |
Q92984643 | Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes |
Q45366611 | Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells |
Q92396903 | Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells |
Q62272168 | Phenotypic and Transcriptional Modulation of Human Pluripotent Stem Cells Induced by Nano/Microfabrication Materials |
Q47109455 | Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach. |
Q98391970 | Phenyl saligenin phosphate disrupts cell morphology and the actin cytoskeleton in differentiating H9c2 cardiomyoblasts and human induced pluripotent stem cell derived cardiomyocyte progenitor cells |
Q24305292 | Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons |
Q91431991 | Photoactivable Elimination of Tumorigenic Human Induced Pluripotent Stem Cells by Using a Lectin-Doxorubicin Prodrug Conjugate |
Q33730362 | Physiological and ultrastructural features of human induced pluripotent and embryonic stem cell-derived skeletal myocytes in vitro |
Q27314513 | Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture |
Q55434077 | Physiological oxygen culture reveals retention of metabolic memory in human induced pluripotent stem cells. |
Q41136107 | Pig Induced Pluripotent Stem Cell-Derived Neural Rosettes Developmentally Mimic Human Pluripotent Stem Cell Neural Differentiation |
Q51108524 | Pig Induced Pluripotent Stem Cell-Derived Neural Rosettes Parallel Human Differentiation Into Sensory Neural Subtypes. |
Q64966916 | Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells. |
Q55342040 | Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration. |
Q47694823 | Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells |
Q39081304 | Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells. |
Q93384307 | Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) improved osteogenic differentiation of the human induced pluripotent stem cells while considered as an artificial extracellular matrix |
Q60920471 | Polybenzyl Glutamate Biocompatible Scaffold Promotes the Efficiency of Retinal Differentiation toward Retinal Ganglion Cell Lineage from Human-Induced Pluripotent Stem Cells |
Q92519813 | Polyethylene Terephthalate Textiles Enhance the Structural Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q92316020 | Polyvinyl alcohol modified polyvinylidene fluoride-graphene oxide scaffold promotes osteogenic differentiation potential of human induced pluripotent stem cells |
Q35049000 | Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes. |
Q92698612 | Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes |
Q64446003 | Population-scale proteome variation in human induced pluripotent stem cells |
Q98286407 | Population-scale proteome variation in human induced pluripotent stem cells |
Q37681399 | Porcine induced pluripotent stem cells may bridge the gap between mouse and human iPS. |
Q33937512 | Possible linkages between the inner and outer cellular states of human induced pluripotent stem cells |
Q35702033 | Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy |
Q37772900 | Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types |
Q38287145 | Potential of human induced pluripotent stem cells in studies of liver disease |
Q45200161 | Potentially immunogenic proteins expressed similarly in human embryonic stem cells and induced pluripotent stem cells |
Q34045087 | Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells |
Q97540541 | Precision installation of a highly efficient suicide gene safety switch in human induced pluripotent stem cells |
Q90737717 | Preclinical Study of Human Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelium Cell Sheets Transplantation |
Q49884846 | Predicting cardiac safety using human induced pluripotent stem cell-derived cardiomyocytes combined with multi-electrode array (MEA) technology: A conference report |
Q91318745 | Prediction of Drug Permeability Using In Vitro Blood-Brain Barrier Models with Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells |
Q98466551 | Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling |
Q92808008 | Prediction of cardiotoxicity potential using targeted metabolomics and human induced pluripotent stem cell-derived cardiomyocytes |
Q35891133 | Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods. |
Q104574122 | Predictive network modeling in human induced pluripotent stem cells identifies key driver genes for insulin responsiveness |
Q60309231 | Preparation of Induced Pluripotent Stem Cells Using Human Peripheral Blood Monocytes |
Q36317433 | Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells |
Q54565602 | Prerequisite OCT4 Maintenance Potentiates the Neural Induction of Differentiating Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. |
Q39763013 | Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging |
Q94570334 | Primary proprioceptive neurons from human induced pluripotent stem cells: a cell model for afferent ataxias |
Q97643519 | Pro-angiogenic scaffold-free Bio three-dimensional conduit developed from human induced pluripotent stem cell-derived mesenchymal stem cells promotes peripheral nerve regeneration |
Q46247292 | Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform |
Q52725671 | Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes. |
Q35064977 | Probing the secrets of Alzheimer's disease using human-induced pluripotent stem cell technology |
Q35552111 | Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population |
Q50421379 | Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smith-Magenis syndrome |
Q92766650 | Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome |
Q50045199 | Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850). |
Q90594747 | Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS) |
Q47797992 | Production of Single Contracting Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Matrigel Mattress Technique. |
Q21560913 | Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells |
Q42959563 | Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS). |
Q50672712 | Production of pancreatic progenitor cells from human induced pluripotent stem cells using a three-dimensional suspension bioreactor system. |
Q92089407 | Progress in understanding Friedreich's ataxia using human induced pluripotent stem cells |
Q36916743 | Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes |
Q46887066 | Promise of human induced pluripotent stem cells in skin regeneration and investigation |
Q57463476 | Promoting osteogenic differentiation of human-induced pluripotent stem cells by releasing Wnt/β-catenin signaling activator from the nanofibers |
Q92534470 | Propagation and Purification of Human Induced Pluripotent Stem Cells with Selective Homopolymer Release Surfaces |
Q30432985 | Propagation of human embryonic and induced pluripotent stem cells in an indirect co-culture system |
Q99237786 | Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model |
Q47104449 | Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells |
Q39660981 | Protecting against wayward human induced pluripotent stem cells with a suicide gene |
Q101478141 | Protection of human induced pluripotent stem cells against shear stress in suspension culture by Bingham plastic fluid |
Q54955237 | Protective effects of human induced pluripotent stem cell-derived exosomes on high glucose-induced injury in human endothelial cells. |
Q91516180 | Proteomic Analysis Reveals Temporal Changes in Protein Expression in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes In Vitro |
Q101044500 | Proteomic analysis of mitochondrial biogenesis in cardiomyocytes differentiated from human induced pluripotent stem cells |
Q48018020 | Protocol for Directed Differentiation of Human Induced Pluripotent Stem Cells (iPSCs) to a Hepatic Lineage |
Q42362129 | Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing |
Q52780259 | Public attitudes in Japan towards human-animal chimeric embryo research using human induced pluripotent stem cells. |
Q47768216 | Purification of human induced pluripotent stem cell-derived neural precursors using magnetic activated cell sorting |
Q40381516 | Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system |
Q28385927 | Putative Epimutagens in Maternal Peripheral and Cord Blood Samples Identified Using Human Induced Pluripotent Stem Cells |
Q91390067 | Quality control guidelines for clinical-grade human induced pluripotent stem cell lines |
Q38683295 | Quantitative Assessment of Sialo-Glycoproteins and N-Glycans during Cardiomyogenic Differentiation of Human Induced Pluripotent Stem Cells. |
Q39331956 | Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient |
Q35086192 | RNA polymerase III transcriptomes in human embryonic stem cells and induced pluripotent stem cells, and relationships with pluripotency transcription factors |
Q35671522 | ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. |
Q39653187 | ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system. |
Q46378775 | ROCK inhibitor primes human induced pluripotent stem cells to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation |
Q58756538 | Random migration of induced pluripotent stem cell-derived human gastrulation-stage mesendoderm |
Q97641752 | Rapamycin Promotes Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells in a Stage-Dependent Manner |
Q91320419 | Rapid Differentiation of Multi-Zone Ocular Cells from Human Induced Pluripotent Stem Cells and Generation of Corneal Epithelial and Endothelial Cells |
Q89139083 | Rapid Electrical Stimulation Increased Cardiac Apoptosis Through Disturbance of Calcium Homeostasis and Mitochondrial Dysfunction in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q37042656 | Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium |
Q57474491 | Rapid Nanofabrication of Nanostructured Interdigitated Electrodes (nIDEs) for Long-Term In Vitro Analysis of Human Induced Pluripotent Stem Cell Differentiated Cardiomyocytes |
Q39232666 | Rapid and deep profiling of human induced pluripotent stem cell proteome by one-shot NanoLC-MS/MS analysis with meter-scale monolithic silica columns |
Q27342678 | Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions |
Q41749908 | Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors. |
Q21560823 | Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells |
Q41587125 | Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors |
Q37188211 | Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol |
Q98461144 | Rapid generation of regionally specified CNS neurons by sequential patterning and conversion of human induced pluripotent stem cells |
Q46394495 | Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells. |
Q84431119 | Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells |
Q51361258 | Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A. |
Q41573786 | Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing. |
Q91940179 | Real-time observation of pancreatic beta cell differentiation from human induced pluripotent stem cells |
Q91355902 | Real-time visualization of titin dynamics reveals extensive reversible photobleaching in human induced pluripotent stem cell-derived cardiomyocytes |
Q58772479 | Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells |
Q42378343 | Recombination activating gene-2null severe combined immunodeficient pigs and mice engraft human induced pluripotent stem cells differently. |
Q101476036 | Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells |
Q92954030 | Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp |
Q84306754 | Recurrent copy number variations in human induced pluripotent stem cells |
Q34166525 | Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. |
Q50519748 | Redefining definitive endoderm subtypes by robust induction of human induced pluripotent stem cells. |
Q39963839 | Reduction in Na(+) current by angiotensin II is mediated by PKCα in mouse and human-induced pluripotent stem cell-derived cardiomyocytes |
Q33761070 | Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions |
Q38840374 | Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment. |
Q92163279 | Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells |
Q53763530 | Regenerative therapy for vestibular disorders using human induced pluripotent stem cells (iPSCs): neural differentiation of human iPSC-derived neural stem cells after in vitro transplantation into mouse vestibular epithelia. |
Q33809316 | Regional differentiation of retinoic acid-induced human pluripotent embryonic carcinoma stem cell neurons |
Q90719933 | Regulation of Ca2+ signaling by acute hypoxia and acidosis in cardiomyocytes derived from human induced pluripotent stem cells |
Q42863318 | Regulation of WNT Signaling by VSX2 During Optic Vesicle Patterning in Human Induced Pluripotent Stem Cells |
Q50251918 | Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-à-go-go 1 (hEAG1) potassium channel |
Q30603966 | Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines |
Q41811170 | Removal of reprogramming transgenes improves the tissue reconstitution potential of keratinocytes generated from human induced pluripotent stem cells |
Q37401842 | Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. |
Q34363778 | Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells |
Q91211284 | Reporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible |
Q98891533 | Reproducible production and image-based quality evaluation of retinal pigment epithelium sheets from human induced pluripotent stem cells |
Q37631694 | Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells |
Q91006460 | Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells |
Q40394357 | Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα. |
Q48702779 | Reprogramming human endometrial fibroblast into induced pluripotent stem cells |
Q34227398 | Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP. |
Q47210326 | Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells |
Q40899679 | Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery |
Q93058158 | Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene |
Q40249650 | Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene |
Q100696638 | Reprogramming of a human induced pluripotent stem cell (iPSC) line from a patient with neurodegeneration with brain iron accumulation (NBIA) harboring a novel frameshift mutation in C19orf12 gene |
Q48120995 | Reprogramming of adult human neural stem cells into induced pluripotent stem cells |
Q91310967 | Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit |
Q51923085 | Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. |
Q83453599 | Reprogramming of human hair follicle dermal papilla cells into induced pluripotent stem cells |
Q34048915 | Reprogramming of human peripheral blood cells to induced pluripotent stem cells |
Q38313677 | Reprogramming of somatic cells: possible methods to derive safe, clinical-grade human induced pluripotent stem cells |
Q34139562 | Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives |
Q39276619 | Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells |
Q36511186 | Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells |
Q58551139 | Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on in vitro Cardiac Safety Evaluation |
Q92807458 | Resolving the reversed rate effect of calcium channel blockers on human induced pluripotent stem cell-derived cardiomyocytes and the impact on in vitro cardiac safety evaluation |
Q92155325 | Response by Naftali-Shani et al to Letter Regarding Article, "Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes" |
Q50059743 | Response of human induced pluripotent stem cell-derived cardiomyocytes to several pharmacological agents when intrinsic syncytial pacing is overcome by acute external stimulation |
Q90114145 | Response to Stimulations Inducing Circadian Rhythm in Human Induced Pluripotent Stem Cells |
Q90341396 | Restoring Fertility with Human Induced Pluripotent Stem Cells: Are We There Yet? |
Q41332519 | Resveratrol Enhances Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells through Inhibiting Canonical WNT Signal Pathway and Enhancing Serum Response Factor-miR-1 Axis |
Q50960628 | Retention of Human-Induced Pluripotent Stem Cells (hiPS) With Injectable HA Hydrogels for Vocal Fold Engineering. |
Q37348903 | Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes in vitro and in vivo. |
Q47106515 | Retinal regeneration by transplantation of retinal tissue derived from human embryonic or induced pluripotent stem cells |
Q96581215 | Retinoic acid receptor γ activation promotes differentiation of human induced pluripotent stem cells into esophageal epithelium |
Q101474192 | Retraction notice to "MicroRNA-211 and autophagy-related gene 14 signaling regulate osteoblast-like cell differentiation of human induced pluripotent stem cells"[Exp. Cell Res. 331 (2015) 105-114] |
Q101474197 | Retraction notice to "MicroRNA-211 and autophagy-related gene 14 signaling regulate osteoblast-like cell differentiation of human induced pluripotent stem cells"[Exp. Cell Res. 352 (2017) 63-74] |
Q86905923 | Retraction. Human induced pluripotent stem cell-derived cardiomyocytes serve as in vitro model of cardiac hypertrophy. Heart;2011:97.e7 |
Q50282106 | Retrograde interferon-gamma signaling induces major histocompatibility class I expression in human-induced pluripotent stem cell-derived neurons. |
Q90149608 | Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy |
Q89742670 | Reversible expansion of pancreatic islet progenitors derived from human induced pluripotent stem cells |
Q38864676 | Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas |
Q40832972 | Rewiring the ischaemic brain with human-induced pluripotent stem cell-derived cortical neurons |
Q37042653 | Rho Kinase Inhibition Is Essential During In Vitro Neurogenesis and Promotes Phenotypic Rescue of Human Induced Pluripotent Stem Cell-Derived Neurons With Oligophrenin-1 Loss of Function |
Q36702988 | Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage |
Q90170586 | Robust induction of neural crest cells to derive peripheral sensory neurons from human induced pluripotent stem cells |
Q92383816 | Robust induction of retinal pigment epithelium cells from human induced pluripotent stem cells by inhibiting FGF/MAPK signaling |
Q104747810 | Robust parameter design of human induced pluripotent stem cell differentiation protocols defines lineage-specific induction of anterior-posterior gut tube endodermal cells |
Q91881627 | Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro |
Q33942366 | Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells. |
Q91698293 | Role of cell-secreted extracellular matrix formation in aggregate formation and stability of human induced pluripotent stem cells in suspension culture |
Q93028546 | Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes |
Q33752469 | Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells |
Q39790397 | Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin |
Q64054825 | SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation |
Q37158574 | SNL fibroblast feeder layers support derivation and maintenance of human induced pluripotent stem cells |
Q98183271 | SSEA-1-positive fibronectin is secreted by cells deviated from the undifferentiated state of human induced pluripotent stem cells |
Q88044288 | Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes? |
Q38916832 | Safe and efficient method for cryopreservation of human induced pluripotent stem cell-derived neural stem and progenitor cells by a programmed freezer with a magnetic field. |
Q46425614 | Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology. |
Q59062636 | Scalable Expansion of Human-Induced Pluripotent Stem Cells in Xeno-Free Microcarriers |
Q42606543 | Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions |
Q43010381 | Scalable generation of universal platelets from human induced pluripotent stem cells. |
Q48313751 | Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors. |
Q35891769 | Scalable topographies to support proliferation and Oct4 expression by human induced pluripotent stem cells. |
Q92961908 | Screening ToxCast™ for Chemicals That Affect Cholesterol Biosynthesis: Studies in Cell Culture and Human Induced Pluripotent Stem Cell-Derived Neuroprogenitors |
Q30558954 | Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays |
Q45729179 | Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs |
Q96168644 | Selected Ionotropic Receptors and Voltage-Gated Ion Channels: More Functional Competence for Human Induced Pluripotent Stem Cell (iPSC)-Derived Nociceptors |
Q42204239 | Selecting and isolating colonies of human induced pluripotent stem cells reprogrammed from adult fibroblasts. |
Q90403956 | Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor |
Q59349753 | Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury |
Q58737221 | Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine |
Q42247805 | Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets |
Q58605987 | Selective Laminin-Directed Differentiation of Human Induced Pluripotent Stem Cells into Distinct Ocular Lineages |
Q41141279 | Selective cell targeting and lineage tracing of human induced pluripotent stem cells using recombinant avian retroviruses. |
Q87789606 | Selective culture method for hepatocyte-like cells differentiated from human induced pluripotent stem cells |
Q43021229 | Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells |
Q34511100 | Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells |
Q27324311 | Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes |
Q99408528 | Self-Organizing Human Induced Pluripotent Stem Cell Hepatocyte 3D Organoids Inform the Biology of the Pleiotropic TRIB1 Gene |
Q38216498 | Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. |
Q53240627 | Sensitivity of human embryonic and induced pluripotent stem cells to a topoisomerase II poison etoposide. |
Q41073477 | Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: considerations on process development. |
Q55383139 | Sequential Application of Discrete Topographical Patterns Enhances Derivation of Functional Mesencephalic Dopaminergic Neurons from Human Induced Pluripotent Stem Cells. |
Q61817595 | Serum-Free Manufacturing of Mesenchymal Stem Cell Tissue Rings Using Human-Induced Pluripotent Stem Cells |
Q47203424 | Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells. |
Q39954500 | Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. |
Q52663980 | Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes. |
Q47197360 | Significance of dopamine D1 receptor signalling for steroidogenic differentiation of human induced pluripotent stem cells |
Q36707521 | Significant differences in genotoxicity induced by retrovirus integration in human T cells and induced pluripotent stem cells |
Q27335280 | Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells. |
Q89105699 | Silver nanoparticles inhibit neural induction in human induced pluripotent stem cells |
Q34752315 | Simple generation of human induced pluripotent stem cells using poly-beta-amino esters as the non-viral gene delivery system |
Q89408767 | Simultaneous recordings of action potentials and calcium transients from human induced pluripotent stem cell derived cardiomyocytes |
Q36176876 | Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers |
Q30498340 | Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells |
Q64283216 | Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes |
Q35637909 | Single-Cell XIST Expression in Human Preimplantation Embryos and Newly Reprogrammed Female Induced Pluripotent Stem Cells |
Q88645537 | Single-cell RNA-seq of human induced pluripotent stem cells reveals cellular heterogeneity and cell state transitions between subpopulations |
Q38952473 | Single-cell cloning and expansion of human induced pluripotent stem cells by a microfluidic culture device |
Q37641841 | Single-step protocol for the differentiation of human-induced pluripotent stem cells into hepatic progenitor-like cells |
Q47207100 | Size- and time-dependent growth properties of human induced pluripotent stem cells in the culture of single aggregate. |
Q92345261 | Size-dependent hepatic differentiation of human induced pluripotent stem cells spheroid in suspension culture |
Q35657562 | Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells |
Q44730429 | Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts. |
Q34314607 | Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells |
Q47796199 | Small molecule promoted feeder free and adherent differentiation of functional neurons from human embryonic and induced pluripotent stem cells. |
Q35074117 | Small molecule screening in human induced pluripotent stem cell-derived terminal cell types |
Q87952031 | Small molecules differentiate definitive endoderm from human induced pluripotent stem cells on PCL scaffold |
Q35919331 | Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage |
Q34067797 | Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells |
Q37581655 | Small-molecule induction promotes corneal epithelial cell differentiation from human induced pluripotent stem cells |
Q57467044 | Small-molecule-based generation of functional cardiomyocytes from human umbilical cord-derived induced pluripotent stem cells |
Q49255066 | Small-scale screening of anticancer drugs acting specifically on neural stem/progenitor cells derived from human-induced pluripotent stem cells using a time-course cytotoxicity test |
Q41809549 | Sodium butyrate promotes generation of human induced pluripotent stem cells through induction of the miR302/367 cluster |
Q29616798 | Somatic coding mutations in human induced pluripotent stem cells |
Q36493686 | Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells |
Q50618088 | Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states. |
Q56765219 | Some Ethical Concerns About Human Induced Pluripotent Stem Cells |
Q92600242 | Spatiotemporal imaging documented the maturation of the cardiomyocytes from human induced pluripotent stem cells |
Q101154920 | Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells |
Q33649644 | Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells |
Q35686200 | Sphere-shaped nano-hydroxyapatite/chitosan/gelatin 3D porous scaffolds increase proliferation and osteogenic differentiation of human induced pluripotent stem cells from gingival fibroblasts |
Q88308959 | Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice |
Q52359314 | Squaramide-Based Supramolecular Materials for Three-Dimensional Cell Culture of Human Induced Pluripotent Stem Cells and Their Derivatives. |
Q34696537 | Stability of genomic imprinting in human induced pluripotent stem cells. |
Q35075314 | Stable X chromosome reactivation in female human induced pluripotent stem cells |
Q36792141 | Stable engineered vascular networks from human induced pluripotent stem cell-derived endothelial cells cultured in synthetic hydrogels |
Q30422111 | Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases. |
Q44958991 | Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates |
Q40328357 | Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia |
Q38148755 | State of the art in stem cell research: human embryonic stem cells, induced pluripotent stem cells, and transdifferentiation. |
Q34845881 | Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells |
Q64977637 | Stem cells purified from human induced pluripotent stem cell-derived neural crest-like cells promote peripheral nerve regeneration. |
Q58092070 | Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing |
Q99615846 | Stepwise differentiation and functional characterization of human induced pluripotent stem cell-derived choroidal endothelial cells |
Q35053840 | Stimulation of GABA-induced Ca2+ influx enhances maturation of human induced pluripotent stem cell-derived neurons |
Q39136573 | Stimulation of α₁-adrenoceptor or angiotensin type 1 receptor enhances DNA synthesis in human-induced pluripotent stem cells via Gq-coupled receptor-dependent signaling pathways |
Q57823790 | Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q42218179 | Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones |
Q90169505 | Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-Wheel™ bioreactors |
Q37285544 | Stretch Injury of Human Induced Pluripotent Stem Cell Derived Neurons in a 96 Well Format. |
Q42180819 | Striatal Transplantation of Human Dopaminergic Neurons Differentiated From Induced Pluripotent Stem Cells Derived From Umbilical Cord Blood Using Lentiviral Reprogramming |
Q33660591 | Structural and electrophysiological dysfunctions due to increased endoplasmic reticulum stress in a long-term pacing model using human induced pluripotent stem cell-derived ventricular cardiomyocytes |
Q46748779 | Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types |
Q37062484 | Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells |
Q91399403 | Substrate elasticity dependent colony formation and cardiac differentiation of human induced pluripotent stem cells |
Q34280866 | Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification. |
Q57491141 | Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes |
Q42379230 | Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells. |
Q36221227 | Successful Generation of Human Induced Pluripotent Stem Cell Lines from Blood Samples Held at Room Temperature for up to 48 hr. |
Q92297928 | Successful Prediction of Human Pharmacokinetics After Oral Administration by Optimized Physiologically Based Pharmacokinetics Approach and Permeation Assay Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells |
Q28551775 | Supervised Machine Learning for Classification of the Electrophysiological Effects of Chronotropic Drugs on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q93131799 | Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells |
Q42708770 | Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis. |
Q35809643 | Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model |
Q47811023 | Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. |
Q34964650 | Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine |
Q54430186 | Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. |
Q41627139 | Switch From Fetal to Adult SCN5A Isoform in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Unmasks the Cellular Phenotype of a Conduction Disease-Causing Mutation |
Q39002903 | Switching between self-renewal and lineage commitment of human induced pluripotent stem cells via cell-substrate and cell-cell interactions on a dendrimer-immobilized surface. |
Q42175649 | Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. |
Q43167964 | TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells |
Q54265820 | TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells. |
Q37443725 | Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition. |
Q34088395 | Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. |
Q34504908 | Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs |
Q52431369 | Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system. |
Q47550261 | Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model |
Q42263979 | Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells. |
Q91975109 | Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes |
Q35060433 | Targeting of herpes simplex virus 1 thymidine kinase gene sequences into the OCT4 locus of human induced pluripotent stem cells |
Q37642100 | Technical challenges in using human induced pluripotent stem cells to model disease |
Q28066087 | Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation |
Q35563251 | Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling |
Q47319555 | Temporally coordinated spiking activity of human induced pluripotent stem cell-derived neurons co-cultured with astrocytes |
Q47869495 | Tenogenic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells dictated by properties of braided submicron fibrous scaffolds |
Q101154749 | Terahertz pulse-altered gene networks in human induced pluripotent stem cells |
Q92571185 | Teratogenic Rubella Virus Alters the Endodermal Differentiation Capacity of Human Induced Pluripotent Stem Cells |
Q33778800 | Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells. |
Q50045548 | Thalidomide induces apoptosis during early mesodermal differentiation of human induced pluripotent stem cells |
Q38636369 | Thalidomide induces apoptosis in undifferentiated human induced pluripotent stem cells. |
Q37182424 | The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling |
Q36060189 | The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture |
Q90425960 | The Effect of Antiarrhythmic Drugs on the Beat Rate Variability of Human Embryonic and Human Induced Pluripotent Stem Cell Derived Cardiomyocytes |
Q92815378 | The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases |
Q82783882 | The European Court of Justice ruling in Brüstle v. Greenpeace: the impacts on patenting of human induced pluripotent stem cells in Europe |
Q37184632 | The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation. |
Q47160680 | The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture |
Q94603287 | The Genetic Relevance of Human Induced Pluripotent Stem Cell-Derived Microglia to Alzheimer's Disease and Major Neuropsychiatric Disorders |
Q49903176 | The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons |
Q88979288 | The Nucleocapsid Protein of SARS-CoV-2 Abolished Pluripotency in Human Induced Pluripotent Stem Cells |
Q89770387 | The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model |
Q93156382 | The Role of MicroRNAs in Early Chondrogenesis of Human Induced Pluripotent Stem Cells (hiPSCs) |
Q102978381 | The StemCellFactory: A Modular System Integration for Automated Generation and Expansion of Human Induced Pluripotent Stem Cells |
Q88655552 | The Transcriptional Changes of trim Genes Associated with Parkinson's Disease on a Model of Human Induced Pluripotent Stem Cells |
Q91419044 | The Use of Human Induced Pluripotent Stem Cells for Testing Neuroprotective Activity of Pharmacological Compounds |
Q39398161 | The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
Q92281525 | The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM) |
Q87752823 | The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system |
Q92509179 | The effect of magnetic stimulation on differentiation of human induced pluripotent stem cells into neuron |
Q36708327 | The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells |
Q45873959 | The effect of nanofibre-based polyethersulfone (PES) scaffold on the chondrogenesis of human induced pluripotent stem cells. |
Q38805393 | The effects of LSD1 inhibition on self-renewal and differentiation of human induced pluripotent stem cells |
Q84250613 | The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells |
Q46837447 | The effects of electrospun substrate-mediated cell colony morphology on the self-renewal of human induced pluripotent stem cells. |
Q49392131 | The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system |
Q39905518 | The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands |
Q40203868 | The generation and functional characterization of induced pluripotent stem cells from human intervertebral disc nucleus pulposus cells |
Q34628718 | The homeobox gene DLX4 promotes generation of human induced pluripotent stem cells |
Q36161963 | The human-induced pluripotent stem cell initiative-data resources for cellular genetics |
Q42600241 | The impact of commercialisation on public perceptions of stem cell research: exploring differences across the use of induced pluripotent cells, human and animal embryos |
Q50033819 | The impact of growth factors on human induced pluripotent stem cells differentiation into cardiomyocytes. |
Q38698411 | The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells |
Q37695727 | The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes |
Q38733127 | The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages. |
Q47631241 | The moral value of induced pluripotent stem cells: a Japanese bioethics perspective on human embryo research |
Q59335130 | The paracrine effects of human induced pluripotent stem cells promote bone-like structures via the upregulation of BMP expression in a mouse ectopic model |
Q90946560 | The potential of human induced pluripotent stem cells for modelling diabetic wound healing in vitro |
Q37242440 | The promise of human induced pluripotent stem cells for research and therapy |
Q41901236 | The promise of human induced pluripotent stem cells in dental research |
Q34281949 | The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability |
Q59340242 | The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathways |
Q35682113 | The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells |
Q34598659 | The role of NF-κB signaling in the maintenance of pluripotency of human induced pluripotent stem cells |
Q91348386 | The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients |
Q30540850 | The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells |
Q39449356 | The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines |
Q90028454 | The roles of human induced pluripotent stem cell-derived cardiomyocytes in drug discovery: managing in vitro safety study expectations |
Q43143482 | The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells |
Q91692316 | The stimulation of osteogenic differentiation of embryoid bodies from human induced pluripotent stem cells by akermanite bioceramics |
Q37666286 | The translational potential of human induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology |
Q37851350 | The tumorigenicity of human embryonic and induced pluripotent stem cells |
Q101242167 | The use of voltage sensitive dye di-4-ANEPPS and video-based contractility measurements to assess drug effects on excitation-contraction coupling in human induced pluripotent stem cell-derived cardiomyocytes |
Q90548109 | Therapeutic efficacy of catalpol against apoptosis in cardiomyocytes derived from human induced pluripotent stem cells |
Q44414964 | Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure |
Q38457655 | Therapeutic potential of human induced pluripotent stem cells in experimental stroke |
Q39469987 | Therapeutic potential of human-induced pluripotent stem cell-derived endothelial cells in a bleomycin-induced scleroderma mouse model. |
Q38993609 | Thermo-responsive polymeric nanoparticles for enhancing neuronal differentiation of human induced pluripotent stem cells |
Q46418471 | Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells |
Q28554402 | Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells |
Q41528472 | Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q42119735 | Three-dimensional Quantification of Dendritic Spines from Pyramidal Neurons Derived from Human Induced Pluripotent Stem Cells |
Q93075184 | Three-dimensional decellularized amnion membrane scaffold promotes the efficiency of male germ cells generation from human induced pluripotent stem cells |
Q53327491 | Three-dimensional functional human myocardial tissues fabricated from induced pluripotent stem cells. |
Q47609413 | Three-dimensional hydrogel culture conditions promote the differentiation of human induced pluripotent stem cells into hepatocytes |
Q48965950 | Thymoquinone protects cultured hippocampal and human induced pluripotent stem cells-derived neurons against α-synuclein-induced synapse damage |
Q47703951 | Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q34368460 | Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model. |
Q36735280 | Tissue-Mimicking Geometrical Constraints Stimulate Tissue-Like Constitution and Activity of Mouse Neonatal and Human-Induced Pluripotent Stem Cell-Derived Cardiac Myocytes |
Q90340354 | Tissue-engineered blood-brain barrier models via directed differentiation of human induced pluripotent stem cells |
Q37460446 | Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model |
Q38941979 | Tissue-engineered vascular grafts created from human induced pluripotent stem cells |
Q89560945 | Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling |
Q47995305 | Topographic effect on human induced pluripotent stem cells differentiation towards neuronal lineage. |
Q100568078 | Toward Brain-on-a-Chip: Human Induced Pluripotent Stem Cell-Derived Guided Neuronal Networks in Tailor-Made 3D Nanoprinted Microscaffolds |
Q38552249 | Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells |
Q41835898 | Towards the safer clinical translation of human induced pluripotent stem cell-derived cells to regenerative medicine |
Q93163272 | Toxicity of ionizing radiation (IR) in a human induced pluripotent stem cell (hiPSC)-derived 3D early neurodevelopmental model |
Q55629490 | Toxicological evaluation of convulsant and anticonvulsant drugs in human induced pluripotent stem cell-derived cortical neuronal networks using an MEA system. |
Q51559790 | Transcription Factors and Medium Suitable for Initiating the Differentiation of Human-Induced Pluripotent Stem Cells to the Hepatocyte Lineage. |
Q27318385 | Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines |
Q33504601 | Transcriptional signature and memory retention of human-induced pluripotent stem cells |
Q38837066 | Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling |
Q55382813 | Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21. |
Q35009147 | Transcriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblasts |
Q93024453 | Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture |
Q91834502 | Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods |
Q91056666 | Transcriptomic features of trophoblast lineage cells derived from human induced pluripotent stem cells treated with BMP 4 |
Q39478620 | Transfecting and nucleofecting human induced pluripotent stem cells |
Q35162010 | Transfection, selection, and colony-picking of human induced pluripotent stem cells TALEN-targeted with a GFP gene into the AAVS1 safe harbor. |
Q60907699 | Transfer of Synthetic Human Chromosome into Human Induced Pluripotent Stem Cells for Biomedical Applications |
Q38762144 | Transgene-free human induced pluripotent stem cell line (HS5-SV.hiPS) generated from cesarean scar-derived fibroblasts. |
Q33392928 | Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells |
Q64914010 | Transient c-Src Suppression During Endodermal Commitment of Human Induced Pluripotent Stem Cells Results in Abnormal Profibrotic Cholangiocyte-Like Cells. |
Q28076397 | Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine |
Q28072402 | Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery |
Q84388618 | Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models |
Q37772899 | Translational prospects for human induced pluripotent stem cells |
Q61654762 | Transmission Mechanism of Lewy Body-Like α-Synucleinopathies in Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells |
Q48776350 | Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodi |
Q61808643 | Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction |
Q47982837 | Transplantation of feeder-free human induced pluripotent stem cell-derived cortical neuron progenitors in adult male Wistar rats with focal brain ischemia |
Q89836034 | Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts |
Q44450400 | Transplantation of human neuro-epithelial-like stem cells derived from induced pluripotent stem cells improves neurological function in rats with experimental intracerebral hemorrhage |
Q88240704 | Transplantation of human-induced pluripotent stem cells carried by self-assembling peptide nanofiber hydrogel improves bone regeneration in rat calvarial bone defects |
Q36931277 | Transplantation of ovarian granulosa‑like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure |
Q57183080 | Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury |
Q91997217 | Transplanted Human Induced Pluripotent Stem Cell-Derived Neurons Wire and Fire with Balanced Excitation-Inhibition in Rat Cortex |
Q43459920 | Transplanted motoneurons derived from human induced pluripotent stem cells form functional connections with target muscle. |
Q47561695 | Tranylcypromine Causes Neurotoxicity and Represses BHC110/LSD1 in Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids Model |
Q48713811 | Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells |
Q100994314 | Trends and Limitations in the Assessment of the Contractile Properties of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Patients With Dilated Cardiomyopathy |
Q30579627 | Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells |
Q58783132 | Tributyltin Inhibits Neural Induction of Human Induced Pluripotent Stem Cells |
Q38774003 | Tributyltin induces mitochondrial fission through Mfn1 degradation in human induced pluripotent stem cells |
Q30543752 | Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering |
Q36378400 | Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells |
Q101233076 | TrkC Overexpression Protects Sevoflurane-Induced Neurotoxicity in Human Induced Pluripotent Stem Cell-Derived Neurons |
Q37112574 | Trophoblast lineage cells derived from human induced pluripotent stem cells |
Q54248635 | Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in vitro model for drug screening for Chagas disease. |
Q30843275 | Tubular Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells Generate Pulse Pressure In Vivo |
Q45876898 | Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. |
Q38948896 | Tumorigenic risk of human induced pluripotent stem cell explants cultured on mouse SNL76/7 feeder cells |
Q95815914 | Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53 |
Q84492167 | Tuning Wnt-signaling to enhance cardiomyogenesis in human embryonic and induced pluripotent stem cells |
Q48562448 | Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation. |
Q39629058 | Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines |
Q47305844 | Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy |
Q88442626 | Type 3 iodothyronine deiodinase is expressed in human induced pluripotent stem cell derived cardiomyocytes |
Q98771654 | Ultrarapid Delayed Rectifier K+ Channelopathies in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q39561626 | Ultrastructural demonstration of Cx43 gap junctions in induced pluripotent stem cells from human cord blood |
Q39196379 | Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture |
Q53661862 | Ultrastructural visualization of the Mesenchymal-to-Epithelial Transition during reprogramming of human fibroblasts to induced pluripotent stem cells. |
Q55486639 | Uninterrupted monitoring of drug effects in human-induced pluripotent stem cell-derived cardiomyocytes with bioluminescence Ca2+ microscopy. |
Q48142719 | Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state. |
Q90042227 | Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Fit for Purpose or Forever Elusive? |
Q89980408 | Unraveling Mechanisms of Patient-Specific NRXN1 Mutations in Neuropsychiatric Diseases Using Human Induced Pluripotent Stem Cells |
Q52715883 | Unraveling the Inconsistencies of Cardiac Differentiation Efficiency Induced by the GSK3β Inhibitor CHIR99021 in Human Pluripotent Stem Cells. |
Q91119326 | Unveiling the molecular crosstalk in a human induced pluripotent stem cell-derived cardiac model |
Q28073204 | Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases |
Q36506609 | Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia. |
Q39738113 | Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes |
Q30402943 | Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways |
Q90165282 | Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association |
Q90541471 | Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis |
Q52428477 | Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced Cardiotoxicity. |
Q43042479 | Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection |
Q58568612 | Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity |
Q40712641 | Use of human induced pluripotent stem cell-derived neurons as a model for Cerebral Toxoplasmosis |
Q64105170 | Use of human intra-tissue stem/progenitor cells and induced pluripotent stem cells for hair follicle regeneration |
Q48719082 | Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes |
Q64285907 | User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip |
Q64910433 | Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model to Study Trypanosoma cruzi Infection. |
Q58407064 | Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery |
Q92314185 | Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens |
Q91223575 | Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells |
Q38304056 | Using Human Induced Pluripotent Stem Cells to Model Skeletal Diseases |
Q89596058 | Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk |
Q36357156 | Using human induced pluripotent stem cells to model cerebellar disease: hope and hype. |
Q27015087 | Using human induced pluripotent stem cells to treat retinal disease |
Q38080496 | Using human-induced pluripotent stem cells to model monogenic metabolic disorders of the liver |
Q39873476 | Using induced human pluripotent stem cells to study Diamond-Blackfan anemia: an outlook on the clinical possibilities. |
Q37963576 | Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality? |
Q42949002 | Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells |
Q89967586 | Utilization of Human Induced Pluripotent Stem Cells for Cardiac Repair |
Q92807294 | Utilization of human induced pluripotent stem cell-derived cardiomyocytes on an MEA platform for prediction of liabilities with chronic drug treatment |
Q28081565 | Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons |
Q35028679 | Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160. |
Q35141241 | Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation. |
Q96960914 | Video-based assessment of drug-induced effects on contractile motion properties using human induced pluripotent stem cell-derived cardiomyocytes |
Q57073476 | Viral-free generation and characterization of a human induced pluripotent stem cell line from dermal fibroblasts |
Q48202406 | Visualization of migration of human cortical neurons generated from induced pluripotent stem cells |
Q43207059 | Vitamin C enhances the generation of mouse and human induced pluripotent stem cells |
Q51682046 | Vitamin C promotes pluripotency of human induced pluripotent stem cells via the histone demethylase JARID1A. |
Q38762076 | WITHDRAWN: Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai technology. |
Q33834358 | Ways Out of the Patenting Prohibition? Human Parthenogenetic and Induced Pluripotent Stem Cells |
Q41311411 | Well-aligned chitosan-based ultrafine fibers committed teno-lineage differentiation of human induced pluripotent stem cells for Achilles tendon regeneration |
Q26751606 | What Kind of Signaling Maintains Pluripotency and Viability in Human-Induced Pluripotent Stem Cells Cultured on Laminin-511 with Serum-Free Medium? |
Q37302100 | What is the point of large-scale collections of human induced pluripotent stem cells? |
Q64004902 | Widespread conservation of chromatin accessibility patterns and transcription factor binding in human and chimpanzee induced pluripotent stem cells |
Q47307855 | Wnt/Yes-Associated Protein Interactions During Neural Tissue Patterning of Human Induced Pluripotent Stem Cells |
Q35849292 | X-chromosome inactivation in rett syndrome human induced pluripotent stem cells |
Q101139000 | Xenogeneic-free Generation of Vascular Smooth Muscle Cells from Human Induced Pluripotent Stem Cells for Vascular Tissue Engineering |
Q35533016 | ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin |
Q37344268 | Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells |
Q88205936 | [An improved method for generating integration-free human induced pluripotent stem cells] |
Q98906494 | [Availability of a novel cardiotoxicity evaluation system using human induced pluripotent stem cell-derived atrial-like myocytes] |
Q57150898 | [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells] |
Q87405705 | [Differentiation of in vitro induced human pluripotent stem cells into hematopoietic stem/progenitor cells] |
Q53100454 | [Effects of microRNA-494 on the fiber type-specific skeletal myogenesis in human induced pluripotent stem cells]. |
Q87026501 | [Efficient reprogramming of human cord blood CD34(+) cells for formation of induced pluripotent stem cells with non-integrating plasmid system] |
Q95587002 | [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes] |
Q54236584 | [Establishment of Integration-Free Human Induced Pluripotent Stem Cells from A Patient with Primary Myelofibrosis]. |
Q53549669 | [Establishment of induced pluripotent stem cell lines from human amniotic fluid cells with 1q21.1 microdeletion]. |
Q91581674 | [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity] |
Q53244762 | [Generation of three-dimensional pancreatic tissue from human induced pluripotent stem cells]. |
Q46074785 | [In vitro tumorigenicity tests for process control of health care products derived from human induced pluripotent stem cells]. |
Q53085859 | [Induced pluripotent stem cells: a new paradigm to study human tissues]. |
Q100667584 | [Joint regulation of Wnt and bone morphogenetic protein signaling pathways to promote differentiation of human induced pluripotent stem cells into cardiomyocytes] |
Q100433832 | [Novel platelet pharming using human induced pluripotent stem cells] |
Q83187097 | [Perspectives regarding the potential use of human induced pluripotent stem cells for the development of and research on medicinal products] |
Q88874591 | [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application] |
Q89895010 | [Research progress in human induced pluripotent stem cells in pathogenesis of cardiomyopathy] |
Q87079593 | [Research progress in tumorigenicity of human induced pluripotent stem cells] |
Q93083260 | [Role of over-expression of TBX3 and TBX18 in the enrichment and differentiation of human induced pluripotent stem cells into sinoatrial node-like cells] |
Q84950217 | [Simple test for the evaluation of the safety of human induced pluripotent stem cells] |
Q59791860 | bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling |
Q91802468 | cGMP Generation of Human Induced Pluripotent Stem Cells with Messenger RNA |
Q34045021 | cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications |
Q96431014 | microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2 |
Q51079814 | Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells. |
Q39269802 | γ-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells |
Search more.